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Abstract
A core focus in medicinal chemistry is the interpretation of structure-activity
relationships (SARs) of small molecules. SAR analysis is typically carried out
on a case-by-case basis for compound sets that share activity against a given
target. Although SAR investigations are not a priori dependent on compu-
tational approaches, limitations imposed by steady rise in activity informa-
tion have necessitated the use of such methodologies. Moreover, understanding
SARs in multi-target space is extremely difficult. Conceptually different com-
putational approaches are reported in this thesis for graphical SAR analysis in
single- as well as multi-target space. Activity landscape models are often used
to describe the underlying SAR characteristics of compound sets. Theoretical
activity landscapes that are reminiscent of topological maps intuitively repre-
sent distributions of pair-wise similarity and potency difference information as
three-dimensional surfaces. These models provide easy access to identification
of various SAR features. Therefore, such landscapes for actual data sets are
generated and compared with graph-based representations. Existing graphical
data structures are adapted to include mechanism of action information for
receptor ligands to facilitate simultaneous SAR and mechanism-related anal-
yses with the objective of identifying structural modifications responsible for
switching molecular mechanisms of action. Typically, SAR analysis focuses on
systematic pair-wise relationships of compound similarity and potency differ-
ences. Therefore, an approach is reported to calculate SAR feature probabilities
on the basis of these pair-wise relationships for individual compounds in a lig-
and set. The consequent expansion of feature categories improves the analysis
of local SAR environments. Graphical representations are designed to avoid a
dependence on preconceived SAR models. Such representations are suitable for
systematic large-scale SAR exploration. Methods for the navigation of SARs
in multi-target space using simple and interpretable data structures are intro-
duced. In summary, multi-faceted SAR analysis aided by computational means
forms the primary objective of this dissertation.
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Introduction
The development of compounds that specifically interact with given biological
targets is the central aspect of medicinal chemistry research. It is often as-
sumed that the chemical structures of these compounds determine their bioac-
tivity. The study of structure-activity relationships (SARs) is largely (but not
exclusively) based upon this premise. Furthermore, in accordance with an intu-
itive postulate, the similarity-property principle (SPP), one can also extrapolate
that compounds having similar chemical structures would most likely have sim-
ilar biological activities [1]. Consequently, minor modifications of the chemical
structure of an active compound would alter its activity only within a narrow
range. However, such straightforward assumptions are not always valid. In
many cases, simple structural modifications in a molecule are accompanied by
large changes in biological activity, either by dramatically increasing its exist-
ing activity or rendering it inactive [2]. Furthermore, despite being structurally
related, active compounds may interact differently with their targets [3]. Thus,
determining the underlying SARs of bioactive compounds remains a significant
challenge in medicinal chemistry.
Computational Chemical Space and Similarity
Computational approaches are often favored while investigating SARs on a
large-scale as systematic comparisons of molecular structure and activity be-
come exceedingly difficult. Such analyses often require a computationally ac-
cessible representation for molecular structures and a reference framework that
allows their comparison [4]. Mathematical formulations that encode physical
and chemical properties of active compounds, known as molecular descriptors,
are commonly used molecular representations. A chemical reference space, de-
fined using a set of molecular descriptors, wherein each descriptor constitutes
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a dimension, would correspond to a coordinate-based chemical space. Thus,
compounds projected in such a chemical space would be represented by vec-
tors of their respective descriptor values [4]. Molecules that are structurally
similar would ideally be located in close proximity within this space, whereas
increasing distances between molecular positions would account for dissimilar
compounds. Therefore, construction of meaningful chemical reference spaces is
crucial to similarity assessment, and the selection of activity-relevant descrip-
tors is a major challenge [5].
A plethora of descriptors are available as molecular representations [6, 7].
Molecular fingerprints, a popular type of molecular representation, are bit-
strings that encode the chemical structure and properties of the compounds [4].
Such fingerprints usually are binary in nature and the bits indicate the pres-
ence or absence of specific structural features. Depending on how these features
are determined, the resulting fingerprints may vary in their size and complex-
ity. For instance, fragment-based fingerprints like MACCS [8] are generated
from a set of predefined structural features. Furthermore, atom environment
[9] and extended connectivity [10] fingerprints are derived from all connectivity
pathways of specified lengths that exist in a given molecule. Moreover, fin-
gerprints may also be designed to capture possible pharmacophore elements
within compounds [11]. Therefore, different types of fingerprints resolve molec-
ular structure at various levels [5].
In addition to generating computationally accessible molecular representa-
tions, one must also consider ways to compare them in a quantitative manner
and assess the similarity or distance between these representations (and con-
sequently the molecules) within the chemical reference space. However, the
concept of similarity in general is representation-dependent [12]. Besides, de-
velopment of methods that quantify the degree of similarity or dissimilarity
between compounds is also required. Many such similarity and distance mea-
sures have been reported [6].
Medicinal chemists often need to establish chemically interpretable trends
during exploration of SARs. Identifying structural determinants of activity
using molecular descriptors or fingerprints is often difficult. The concept of
matched molecular pairs (MMPs) has become popular as it provides a frame-
2
work for studying the structural relatedness among bioactive compounds on a
large scale [13]. An MMP consists of a pair of compounds that can be inter-
converted by a well-defined structural modification restricted to a single site.
In addition to single-point MMPs, multi-point MMPs with changes at more
than one site have also been defined [14]. Given that the primary objective of
MMP analyses is to account for all possible MMPs for given sets of compounds,
several algorithms have been reported for such pairwise molecular comparisons.
Two widely employed methodologies include maximum common substruc-
ture (MCS) based and systematic molecular fragmentation approaches [13]. A
popular fragmentation scheme reported by Hussain and Rea produces molecular
fragments through systematic deletion of up to three acyclic single bonds re-
sulting in single, double and triple cuts. Bond deletions result in larger common
substructures and smaller transformations. Each larger substructure fragment
and the corresponding transformation is indexed as a key and value pair, re-
spectively. The value fragments may have one (single cuts) or more (double and
triple cuts) attachment points [15]. Initially, the MMP concept was applied to
analyze bioisosteric replacements within drugs and drug-like compounds that
conserved the activity against their targets [16]. Several unique bioisosteric
transformations have been identified after systematic examination of MMPs
formed within compound sets active against different targets and target fami-
lies obtained from public repositories [17, 18]. Molecular transformations that
produce significant variation in potency within and across target sets have also
been investigated [1922]. In addition, MMP-based analyses have also been
performed to assess the effects of replacing various chemical groups on differ-
ent experimentally determined and calculated properties [2326]. MMP-based
analyses are devoid of the black box nature often associated with other compu-
tational approaches. In these cases, the association between biological activity
and molecular structure is evident and interpretable in an intuitive manner [13].
Methods for Dimension Reduction
Projection of compounds into a chemical reference space represented either by
molecular fingerprints or descriptors is often a prerequisite for computational
analyses. However, such reference spaces are high-dimensional and as such
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their intuitive depiction is rather difficult. Reduction of these multi-dimensional
spaces to two or three dimensions is often performed in order to ease their nav-
igation. The resulting low-dimensional data is used to represent bioactive com-
pounds which can then be readily visualized by routinely used methodologies.
However, molecular structures need to be examined separately and extraction
of pertinent SAR information requires chemical expertise [27]. Transformation
of multivariate data into a space of lower dimensionality is frequently referred
to as nonlinear mapping and represents one possible approach to dimension
reduction [28]. The primary objective of nonlinear mapping is the conservation
of neighborhood relationships such that proximity in multi-dimensional space
is reproduced in the lower dimensions [29]. To this end, several mathematical
techniques have been applied to perform dimension reduction [28, 30].
Another popular dimension reduction technique is principal component anal-
ysis (PCA), which generates linear orthogonal combinations of original descrip-
tor sets. The smaller set of novel variables generated by PCA is sufficient to
account for a certain degree of variance produced by the original descriptor
set [27]. PCA results in a coordinate-based low-dimensional reference space
and can be applied to large data sets. By contrast, multi-dimensional scaling
(MDS), a classical example of the nonlinear mapping technique, is used for
the transformation of the coordinate-free reference space obtained by pairwise
molecular fingerprint comparisons. MDS is better suited for preserving similar-
ity relationships while decreasing dimensionality, although it is less favorable for
large compound sets due to computational challenges. This issue can be circum-
vented by using MDS in combination with feed-forward neural networks [30].
Alternate approaches to dimension reduction also include Kohonen networks
or self-organizing maps (SOMs) [31]. Irrespective of the dimension reduction
technique used to transform multi-dimensional data, one can only minimize but
never completely avoid the associated loss of information.
Attributes of Structure-Activity Relationships
SAR characteristics of bioactive compound sets are determined by the degree
of change in activity accompanied by their structural modifications [32]. When
clear trends in bioactivity arise due to systematic chemical changes of bioactive
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compounds, they represent continuous SARs [33]. The presence of structurally
similar compounds with comparable potencies is indicative of continuous SARs.
Therefore, such SARs are consistent with the SPP and constitute a global molec-
ular similarity perspective [32]. Additionally, structural modifications may also
lead to increasingly diverse compounds with conserved activity, a phenomenon
known as scaffold hopping [34]. In such cases, these compounds often have simi-
lar shapes or pharmacophores that represent local activity-relevant similarities.
Thus, scaffold hopping also falls within the spectrum of continuous SARs. Con-
versely, if minor chemical replacements induce large changes in activity within
a compound set, the underlying SAR is said to be discontinuous [33]. The
distinguishing feature of discontinuous SARs is the presence of structurally sim-
ilar compounds with significantly different potencies. Such pairs of compounds
are often referred to as activity cliffs [35]. Discontinuous SARs fall outside the
SPP applicability domain and often pose an impediment to molecular similarity
analysis. However, these two SAR categories do not necessarily occur indepen-
dently of each other. Rather, continuous and discontinuous SAR elements often
co-exist within compound sets and consequently, the ensuing SAR category is
heterogeneous [36]. In general, the global SAR for a set of compounds that
share activity against a given target, i.e. an activity class, can belong only to
one of the above mentioned categories [33].
Conventional SAR Analysis
In medicinal chemistry, SARs are typically investigated on a case-by-case ba-
sis and the analysis entails studying structurally similar compound series ac-
tive against a biological target. Exploration of closely related series is carried
out to understand how structural perturbations influence the bioactivity of
compounds. Such investigations usually involve manual comparison of the 2D
molecular graphs of bioactive analogs. The analogs are often represented in a
tabular format as core structures (or scaffolds) and various substituents, along
with their biological activities. Such R-group tables are intuitive tools most
commonly used in SAR analysis. These are also suitable to determine SAR
trends that aid in compound design and lead optimization [37].
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Despite their clear merits, these R-group tables become increasingly diffi-
cult to interpret as the number of analogs increases. Moreover, such traditional
SAR analyses rely heavily on the experience and intuition of medicinal chemists.
As a result, the outcome is often subjective and prone to inconsistencies [38].
Generation of core and R-group matrices using a computational approach has
also been performed [39]. Numerous other representations, like tree maps and
radial clustergrams, that depict structural similarity and bioactivity distribu-
tion as well as other molecular properties have also been designed [40, 41].
Recently, MMP-based SAR matrices that capture SAR information content in
large compound sets in various intuitive ways have been reported [42]. Al-
though, computational methods can be utilized to organize large compound
sets into SAR tables, the chemical structures of individual molecules may still
require a thorough examination.
In order to facilitate derivation of quantitative SAR information, mathe-
matical functions are employed that relate structural features and properties of
compounds to their activity. Such methodologies follow the quantitative SAR
(QSAR) analysis paradigm [43, 44]. Despite variations in their design, the pri-
mary objective of QSAR methods is to facilitate activity prediction for novel
compounds. QSAR models were initially generated using linear 2D approaches,
but nonlinear as well as 3D modeling have also been attempted [4448]. Recent
advances incorporating machine-learning techniques and artificial intelligence
have resulted in QSAR methodologies with improved prediction capabilities
[48, 49].
An inherent limitation common to all QSAR methodologies is that their
application is confined to congeneric compound series, i.e. compounds that bear
close structural resemblance. Thus, other compounds with dissimilar structures
fall outside the applicability domain of QSAR models [50]. Even within the
applicability domain, credibility of QSAR modeling is only ensured when the
underlying SAR of the compounds is continuous. Presence of activity cliffs often
impede the success of QSAR for which predictions can be inconsistent [35].
Nevertheless, activity cliffs are considered important by medicinal chemists as
they serve as centers on which hit-to-lead and lead optimizations studies can
be focused in order to obtain compounds with improved bioactivity [2, 35].
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Activity Landscape Representation
SARs for different compound sets are often described using the activity land-
scape concept modeled after actual geographic landscapes [51]. An activity
landscape representation combines chemical similarities and activity differences
between compounds active against a given biological target. Compounds that
constitute the chemical reference space are positioned along the xy-plane in a
way that captures molecular similarity. Thus, structurally related compounds
are proximal in this two-dimensional projection while dissimilar compounds are
separated from each other. Activity information pertaining to every constituent
compound is incorporated as the third dimension.
The result can be envisioned as a topological surface with variable levels
of elevation [52]. Accordingly, structural alterations of compounds would con-
stitute transitions in the chemical space and the resulting effects on activity
may be perceived as variations in surface elevation. Therefore, small chemical
transformations accompanied by small potency changes, i.e. SAR continuity,
would produce a smooth activity landscape. Alternatively, SAR discontinuity,
which is typified by minor structural modifications leading to large potency
differences, would generate a rugged landscape [35, 52]. An activity landscape
containing smooth regions interspersed with rugged topological features would
represent a heterogeneous SAR [32, 33].
These idealized activity landscapes are shown in Figure 1. It is, however,
important to note that representation of SARs as well as the rationalization of
their information content is far from trivial. For medicinal chemists, SARs with
predictable potency progression are of high interest in compound design. In
such cases, SAR continuity is an essential consideration. Moreover, continuous
SARs are also relevant when multiple starting points are required for hit-to-lead
studies. However, when the focus shifts to lead optimization, SAR discontinuity
is also important and activity cliffs are considered. Thus, methodologies that
link SAR continuity and discontinuity are an implicit requirement for SAR
exploration and exploitation [37, 38]. Such approaches are often referred to as
SAR profiling methods.
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Figure 1: Idealized activity landscapes. Hypothetical activity landscape representations
exhibiting (a) SAR continuity, (b) discontinuity and (c) heterogeneity are shown. These
hypersurfaces are generated by projecting compounds into xy-plane derived from chemical
reference space, followed by the addition of potency data as the z-axis. Here, increase in the
distances along the 2D plane reflect decrease in chemical similarity and potency distribution
is related to surface elevation. (adapted from Wassermann et al.[38])
Numerical Functions for SAR Analysis
Numerical SAR analysis functions like the SAR index (SARI) and structure-
activity landscape index (SALI) quantify SAR features by taking into account
pairwise structural similarities and potency differences within compound sets
[53, 54]. By systematic evaluation of structural similarity and activity distri-
bution within data sets, these functions provide direct access to various SAR
relevant characteristics. SARI comprises of two separately calculated compo-
nents, the continuity and the discontinuity scores. Raw continuity scores are
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derived from potency weighted average of pairwise chemical similarities and
calculated as
rawcont = −
∑
compounds i6=j
wij × sim(i, j)∑
compounds i6=j
wij
where the weight wij for each compound pair (i,j ) is set to
wij =
pot(i)× pot(j)
1+ | pot(i)− pot(j) |
Raw discontinuity scores are generated as follows
rawdisc =
∑
{i,j|sim(i,j)>thres, i6=j}
| pot(i)− pot(j) | ×sim(i, j)
| {i, j | sim(i, j) > thres, i 6= j} |
Here, pot(i), pot(j) represent the potency values of compounds i and j, sim(i, j)
denotes their similarity value and thres corresponds to a predefined similarity
threshold. The raw scores are transformed to the value range [0,1] after sta-
tistical normalization. SARI is calculated as the mean between the continuity
score and the complement of the discontinuity score
SARI =
1
2
(contnorm + 1− discnorm)
where contnorm and discnorm are the normalized continuity and discontinuity
scores. Therefore, high, intermediate and low SARI scores are indicative of
global SAR continuity, heterogeneity and discontinuity, respectively.
The objective of SALI scoring function is to prioritize potency differences
of large magnitude between structurally similar compounds and the scores are
calculated as
SALI(i, j) =
pot(i)− pot(j)
1− sim(i, j)
SALI scores are designed to describe activity cliffs of varying magnitude in com-
pound data sets. Although, both SALI and SARI discontinuity scores encode
activity cliff information, unlike SARI discontinuity scores that can have a max-
imum value of unity, SALI scores may have a value range of [0,∞]. Moreover,
SALI scores are local in nature while SARI scores are global [27].
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SAR Visualization Techniques
Numerous attempts have been made in the SAR visualization area to system-
atically identify relevant features in large sets of compounds with activity an-
notations. Such tools also allow intuitive and interpretable representation of
SARs [27]. For example, structure-activity similarity (SAS) maps constitute a
2D graphical representation where pairwise structural and activity similarities
between compounds are plotted along x- and y-axes respectively [51]. A variant
of SAS maps that accounts for molecular properties has also been designed [55].
Molecular network representations such as network-like similarity graphs
(NSGs) also constitute a popular SAR visualization technique [56, 57]. Like SAS
maps, NSGs are graphical networks in which compounds are depicted as nodes
and similarity relationships between them as edges. Edges are drawn only if
pairwise similarities exceed a predefined threshold. Per-compound discontinuity
score calculated as
rawdisc(i) =
∑
{i,j|sim(i,j)>thres, i 6=j}
∆pot(i, j)× sim(i, j)
| {i, j | sim(i, j) > thres, i 6= j} |
determines the node size where sim(i, j), ∆pot(i, j) denote the chemical similar-
ity and potency difference between compounds i and j while thres corresponds
to the similarity threshold. Potency data is encoded as the node color. Ad-
ditionally, compound clustering is performed and cluster SARI discontinuity
scores calculated to identify individual groups with high SAR discontinuity.
NSGs have also been successfully used to automatically extract pertinent SAR
information from high-throughput screening data [58]. An exemplary NSG and
the various elements of its design are reported in Figure 2. These network-
based landscape models are designed to study both global as well as local SAR
characteristics [56]. Other network representations like similarity-potency trees
(SPTs) are centered on individual compounds and provide a local view of SARs
[59]. SPTs are generated for individual compounds in a data set and ranked ac-
cording to their local SAR information content. Such a systematic exploration
of SPTs limits the loss of SAR information in data analysis [38]. Similar analy-
ses of SARs in the vicinity of reference compounds can also be carried out with
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the help of chemical neighborhood graphs (CNGs) [60]. CNGs are very useful
for analyzing complex SAR features and provide multiple local SAR views [27].
Figure 2: Single-target activity landscape representation. An exemplary NSG for a
set of 71 squalene synthase inhibitors is shown. The principal design elements are described
in the legend below the graph. Compound subsets identified by hierarchical clustering are
displayed against a light blue background and annotated with cluster discontinuity scores.
A compound pair forming an activity cliff is highlighted in the graph (labeled 1 and 2) and
their structures as well as potencies are reported. (taken from Wassermann et al.[38])
Most SAR visualization tools are designed to enable the analysis of large
sets of compounds. However, lead optimization approaches usually require the
exploration of analog series. For this purpose, combinatorial analog graphs
(CAGs) have been introduced. CAGs systematically organize analog series
according to substitution site combinations on the basis of R-group decompo-
sition [61]. Substitution patterns that produce SAR discontinuity and possible
yet unexplored analogs can be easily identified.
Graphical SAR representations based on calculated structural similarities
often require close inspection of compound structures to rationalize the SAR
information content. This inherent limitation can be circumvented by utilizing
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well-defined substructure relationships instead of calculated similarities. Such
substructure relationships can be systematically generated for compounds com-
prising a data set using MMPs. Compounds that differ by a single substructure,
are further organized into matching molecular series (MMS). These MMS are
represented in a network representation known as the bipartite matching molec-
ular series graph (BMMSG) [62].
Substructure-based approaches focus on compound design strategies that
associate structural fragments with bioactivity information. Substructures can
either be predefined or generated systematically from compounds sets by first
removing all side chains, followed by iterative pruning of rings. The latter
approach results in the generation of molecular frameworks or scaffolds that
can be annotated with activity information of the compounds from which they
were obtained and organized into a hierarchy [63, 64]. Chemical space traversal
using such scaffold hierarchies can aid in compound design [65].
Multi-Target SAR Analysis
SAR investigations routinely focus on sets of compounds that are active against
specific targets with the objective of yielding novel compounds with improved
potency [66]. Many compound sets are also active against more than one target,
thereby, forming multi-target SARs and techniques that aid in their analyses
need to be developed.
Adaptation of the activity landscape concept to systematically account for
dual target activities of compounds in the form of potency ratios has recently
been attempted using NSGs [67]. Thus, the resultant NSGs form a selectivity
landscape. Figure 3 illustrates the design as well as rationalization of se-
lectivity NSGs and indicates the conceptual difference with respect to NSGs
generated for single targets. SAS maps have also been extended to accommo-
date compound selectivity information [68]. Compound selectivity analysis has
also been carried out in analog series such that R-groups are expressed as pre-
defined pharmacophore features and similarity is assessed locally in the form
of pharmacophore edit distances [69]. Pairs of structurally similar compounds
with a large difference in their target selectivity, referred to as selectivity cliffs,
form the most prominent features of such landscapes.
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Figure 3: From activity to selectivity landscapes. An exemplary selectivity NSG for a
set of 234 inhibitors active against cathepsins K and L is shown. The principal design elements
are described in the legend below the graph. A selectivity cliff formed by a compound pair
(labeled 1 and 2) is highlighted and the structures are shown. In addition, selectivities (i.e.
potency ratios) are reported. (adapted from Wassermann et al.[38] and Peltason et al.[67])
Efforts to generate graphical activity landscape representations for com-
pound sets with activity against three or more targets have also been made.
Similarity relationships for such multi-target sets are depicted using a regular
NSG and a potency binning scheme is used to generate compound activity pro-
files that are then provided as node annotations [70]. Multi-target discontinuity
scores that quantitatively compare the potency differences of compounds with
their structural neighbors across multiple targets in a pairwise manner are used
to scale the nodes. The elements of multi-target NSG generation as well as an
example is shown in Figure 4.
Compound activity profile encoding also facilitates the identification of sin-
gle and multi-target cliffs and has been employed to systematically analyze such
cliffs in publicly available bioactive compounds [71].
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Figure 4: Multi-target activity landscape. Figure 4 (a) explains the details of various
features present in multi-target network-based landscape design. An exemplary multi-target
NSG for a set of 299 monoamine transporter inhibitors is displayed in (b). Selected compound
subsets with multi-target cliffs are encircled and numbered. An enlarged view of cluster 4
containing a dual-target cliff is shown in (c). Structures and activity profiles of compounds
representing the dual-target cliff are also reported. (adapted from Dimova et al.[70])
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A second numerical function to assess the ability of compounds to distin-
guish between various targets within target families has recently been reported
[72]. In addition, SAS maps have been modified to incorporate multi-target
activity information by calculating activity similarity between vectors of com-
pound potencies against multiple targets [73].
Multi-target activity landscapes designed so far have an inherent limitation
that they become increasingly difficult to interpret with increasing numbers
of targets. Moreover, calculation of activity similarity potentially also results
in loss of SAR information. Second-generation multi-target activity landscape
models have been introduced in order to circumvent such limitations [74].
This 3D multi-target activity landscape combines chemical and target spaces
in circular representations supporting interactive analysis of projected com-
pounds. Compounds with clearly defined selectivity patterns and structure-
activity profiles can be identified. However, multi-target graphical represen-
tations require that compounds comprising the data sets have potency anno-
tations for all the targets under consideration. Thus, they are not capable
of handling incomplete activity matrices. In addition to various multi-target
graphical representations, various systematic analyses at the level of molecular
scaffolds have also been performed to account for multi-target activity infor-
mation. Such studies have led to the identification of scaffolds selective for
closely related targets [75] as well as those that are promiscuously active across
multiple target families [76].
Thesis Outline
The primary objective of this dissertation is the development of methodologies
for systematic single and multi-target SAR analyses. The dissertation consists
of eight individual chapters that form a sequence of studies.
Chapter 1 of this dissertation reports the design of 3D activity landscapes for
compound data sets. Chapter 2 provides a comparison of 3D activity landscapes
with 2D landscape representations (NSGs). Chapter 3 reports the application of
conditional feature probability calculations for individual compounds in ligand
data sets to provide a higher resolution graphical analysis of SAR relevant
characteristics.
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Chapters 4 and 5 introduce graphical methodologies to analyze compounds
with different mechanisms of action for a target receptor and identify structural
changes that lead to mechanistic changes.
A novel multi-target activity landscape representation generated using SOMs
that encodes target selectivity profiles of compounds is presented in Chapter
6. Furthermore, the development of a second multi-target activity landscape
that is suitable for data sets with incomplete multi-target activity annotations
is introduced in Chapter 7. Assessment of differentiation potential of imidazole-
based inhibitors for various kinases is reported in Chapter 8.
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Chapter 1
Rationalizing three-dimensional
activity landscapes and the
influence of molecular
representations on landscape
topology and the formation of
activity cliffs
Introduction
Systematic structural similarity and activity relationships can be captured and
represented using the activity landscape concept. Activity landscapes are anal-
ogous to geographical maps and intuitively characterize the SARs underlying
sets of bioactive molecules. Various attributes of SAR have previously been
elucidated using theoretical 3D models. Nevertheless, such models have not
been generated for actual compound sets. In the following, generation of real
3D activity landscapes using a novel computational approach is reported. The
methodology has been applied to various activity-annotated compound sets in-
cluding a high-throughput screening data set. In addition, three conceptually
different molecular representations have been used for landscape generation.
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Rationalizing Three-Dimensional Activity Landscapes and the Influence of Molecular
Representations on Landscape Topology and the Formation of Activity Cliffs
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Activity landscapes are defined by potency and similarity distributions of active compounds and reflect the
nature of structure-activity relationships (SARs). Three-dimensional (3D) activity landscapes are reminiscent
of topographical maps and particularly intuitive representations of compound similarity and potency
distributions. From their topologies, SAR characteristics can be deduced. Accordingly, idealized theoretical
landscape models have been utilized to rationalize SAR features, but “true” 3D activity landscapes have not
yet been described in detail. Herein we present a computational approach to derive approximate 3D activity
landscapes for actual compound data sets and to analyze exemplary landscape representations. These activity
landscapes are generated within a consistent reference frame so that they can be compared across different
activity classes. We show that SAR features of compound data sets can be derived from the topology of
landscape models. A notable correlation is observed between global SAR phenotypes, assigned on the basis
of SAR discontinuity scoring, and characteristic landscape topologies. We also show that different molecular
representations can substantially alter the topology of activity landscapes for a given data set and modulate
the formation of activity cliffs, which represent the most prominent landscape features. Depending on the
choice of molecular representations, compounds forming a steep activity cliff in a given landscape might be
separated in another and no longer form a cliff. However, comparison of alternative activity landscapes
makes it possible to focus on compound subsets having high SAR information content.
INTRODUCTION
The concept of activity landscapes plays a key role in
understanding structure-activity relationships (SARs).1-3
Activity landscapes are best rationalized as hypersurfaces
in biologically relevant chemical space, where biological
activity (compound potency) adds another dimension.3 The
interpretation of high-dimensional activity landscapes is
generally difficult and, consequently, two- and three-
dimensional (2D and 3D, respectively) representations of
activity landscapes have been taken into consideration. If
we envision a 2D projection of chemical space with
compound potency added as a third dimension, then activity
landscapes become reminiscent of geographical maps that
can readily be interpreted.2,3 Smooth regions that are
reminiscent of rolling hills1 correspond to areas where
gradual changes in chemical structure are accompanied by
moderate changes in biological activity. Compounds mapping
to such areas are related by so-called continuous SARs.3 By
contrast, rugged regions in activity landscapes that are
canyon-like1 correspond to areas where small chemical
changes have dramatic effects on the biological response,
and hence, compounds mapping to these areas form discon-
tinuous SARs.3 The strongest articulation of SAR disconti-
nuity are so-called activity cliffs1 that are formed by pairs
of structurally very similar compounds with large differences
in potency, i.e., small steps in chemical space are ac-
companied by large changes in activity.
Numerical analysis functions including the SAR index
(SARI)4 or the structure-activity landscape index (SALI)5
have been introduced to characterize global SAR features
present in compound data sets on a large scale4 and to
quantify SAR discontinuity.4,5 These analysis functions
systematically relate compound similarity and potency to
each other and can also be applied to quantify how well a
computational model fits a given activity landscape.6 In
combination with similarity-based molecular network repre-
sentations,5,7 these calculations make it possible to identify
and compare activity cliffs in compound data sets. Annotating
or combining network representations, such as SALI maps5
or network-like similarity graphs7 (NSGs), with potency and
SAR continuity and/or discontinuity score4,5 information
enables the 2D representation of activity landscapes, includ-
ing the identification of compounds that are related by
continuous or discontinuous SARs, and the comparison of
global and local SAR features. Systematic NSG analysis has
revealed that a significant degree of SAR heterogeneity exists
in most compound data sets, due to the presence of different
continuous and discontinuous local SARs.7,8 Activity cliffs
of varying magnitude can essentially be found in compound
data sets of any source, including raw screening data,
irrespective of the nature of the biological targets.7-9 It
follows that most activity landscapes are likely to display
variable topology, i.e., in terms of an idealized 3D landscape
model, they consist of smooth rolling hill-type regions that
are interspersed with cliff areas and canyons. Such variable
activity landscapes provide the basis for the identification
of structurally diverse compounds having similar activity (in
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smooth regions) and for the optimization of compound
potency (at activity cliffs).3
It is also well-appreciated that the nature of activity
landscapes is much influenced by chosen molecular repre-
sentations and the way compound similarity is assessed.2,3
The choice of molecular representations determines chemical
reference spaces. For example, compound similarity relation-
ships within a data set are expected to differ, dependent on
whether the molecules are represented as different binary
fingerprint vectors or arrays of numerical property descrip-
tors. These different types of molecular descriptors yield
distinct chemical reference spaces where given molecules
might be more or less similar to each other. Hence, the
topology of the corresponding activity landscapes is expected
to change. Accordingly, different chemical space representa-
tions have been investigated for compound data sets and
activity cliffs formed on the basis of different molecular
representations have been compared,10 giving rise to the
notion of consensus activity cliffs, i.e., activity cliffs that
are consistently observed when applying different molecular
descriptors and chemical similarity methods.10
For the visualization of activity landscapes, 2D representa-
tions have thus far predominantly been used. Activity
landscape representations originated with the introduction
of structure-activity similarity (SAS) maps,11 plots of
structural similarity versus calculated activity similarity that
delineate smooth landscape regions of high activity similarity
and low structural similarity and rugged regions of high
structural similarity and low activity similarity. In these plots,
each data point represents a comparison of a pair of
compounds in a data set. Prior to the introduction of SALI
maps and NSGs, as discussed above, 2D similarity/potency
correlation graphs were introduced4 that are reminiscent of
SAS maps but report 2D compound similarity relative to
differences in potency and color-code compound pairs
according to absolute potency values. These graphs were
designed to compare 2D similarity and potency relationships
of ligand sets, describe variable activity landscapes, and
identify continuous and discontinuous SAR regions.4 Another
recent derivative of SAS maps are so-called multifusion
similarity (MFS) maps12 that utilize different compound 2D
similarity measures and represent them following data fusion.
Although much information can be deduced from 2D
representations of activity landscapes, 3D representations that
are reminiscent of topographical maps are probably the most
intuitive and elegant way of visualizing activity landscapes.
Accordingly, this model has often been utilized to illustrate
eminent features of activity landscapes, such as smooth
regions and activity cliffs, and to rationalize conceptual
relationships to continuous, discontinuous, and heterogeneous
SARs.1-3 However, although this idealized 3D landscape
model has been widely discussed, actual 3D landscapes of
compound data sets, i.e., “true” activity landscapes, have thus
far not been described in detail.
Herein we present activity landscape representations of
different types of compound sets that are calculated from
potency data and pairwise compound distances in chemical
space. A methodological framework is introduced for a
consistent 3D approximation of activity landscapes of
different compound sets. These representations are generated
utilizing a conserved reference frame, which renders activity
landscapes of different data sets directly comparable and
makes it possible to study how different molecular repre-
sentations might change the topology of landscapes. Visu-
alization of 3D landscapes provides an intuitive access to
prominent activity cliffs and the compounds that form them.
In addition, activity landscapes of compound data sets having
different characteristics according to SAR discontinuity score
calculations can be compared.
METHODOLOGY
Activity Landscape Construction. First we outline the
approach to generate an activity landscape representation.
For a given compound data set, 2D molecular graphs and
potency measurements are required as basic input data.
Figure 1a shows a schematic representation of a similarity/
potency correlation graph as a prototypic 2D landscape
visualization. For this landscape view, molecular representa-
tions are calculated from 2D graphs, and their similarity is
calculated in a pairwise manner. Each data point represents
a pairwise comparison yielding structural similarity and
potency differences. In order to generate a 3D landscape
representation with intuitive topological features, as sche-
matically shown in Figure 1b, other types of calculations
are required. For such a 3D representation, molecules must
be projected into a 2D chemical reference space that is
spanned by two molecular descriptors defining the x- and
y-direction. These descriptors can be of a different type, for
example, selected or combined contributions from molecular
property descriptors or coordinates derived from molecular
fingerprint similarity. A primary feature of 3D activity
landscapes we need to capture are the activity cliffs that are
formed by structurally similar molecules having dramatic
potency differences. Figure 1c shows representative examples
of compounds forming steep activity cliffs of large magni-
tude. Three-dimensional landscape design also starts with
calculating molecular descriptors/representations. From a
chosen molecular representation (herein different fingerprints
are used), a coordinate-free chemical reference space is
generated by calculation of pairwise compound distances
(dissimilarities). The set of all pairwise distances defines this
reference space. Then, multidimensional scaling13 is used
to project these molecules from the coordinate-free reference
space onto an x/y-plane on the basis of their chemical
dissimilarities. The z-axis reports the potency values of the
molecules. In order to obtain a coherent potency surface that
is required to obtain an interpretable landscape topology, we
utilize a geostatistical technique termed Kriging14 to inter-
polate between data points. The individual steps involved
in 3D activity landscape generation are described in detail
in the following sections.
Compound Data Sets. For our analysis, we assembled
six classes of specific enzyme inhibitors with reported
potency values from the MDDR.15 As summarized in Table
1, these data sets include between 112 and 252 compounds.
The compound sets were assembled to span different
dissimilarity ranges, vary in their potency distributions and
display different SAR characteristics (as further described
below). In addition to these lead optimization sets, a high-
throughput screening (HTS) hit set was taken from Pub-
Chem16 that contained 2398 active compounds and had
consistently lower potency ranges, hence resulting in a very
low degree of SAR discontinuity (Table 1).
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Molecular Representation. Test compounds are initially
projected into a low-dimensional chemical reference space.
For this purpose, we define a coordinate-free reference space
based on Euclidean distances between molecular fingerprint
representations. Three conceptually different fingerprint
designs are applied: MACCS,17 TGT,18 and Molprint2D.19
Figure 1. Schematic activity landscape representations and activity cliffs. (a) Similarity-potency plot. Pairwise structural similarity of
active molecules is plotted against differences in logarithmic potency. Each data point represents a pairwise compound comparison and is
colored according to the sum of the respective potency values using a continuous gradient from black for the lowest to red for the highest
sum of potency values within a data set. Two characteristic regions are distinguished that contain pairs of molecules with low structural
similarity and low potency difference, populating smooth regions of an activity landscape, or molecules with high structural similarity and
large differences in potency, forming rough landscape regions. These regions contain activity cliffs. (b) Schematic 3D representation of an
activity landscape. The x/y-plane represents a 2D projection of chemical space spanned by two descriptors that can be derived from different
molecular representations, and the z-axis reports compound potency. The landscape contains idealized smooth and rugged (rough) regions
and activity cliffs and hence corresponds to a heterogeneous SAR phenotype. (c) Examples of activity cliffs. Two exemplary compound
pairs are shown from the LIP and FAR data sets, respectively, which have very similar structure but potency differences of several orders
of magnitude and thus form activity cliffs of large magnitude.
Table 1. Summary of the Analyzed Enzyme Inhibitor Classesa
MACCS Molprint2D TGT
activity class no. of compounds potency range avg max avg max avg /max
FAR 146 3.52-10.54 6.33 9.22 7.01 8.83 14.05 23.39
LIP 252 4.00-9.00 6.56 9.11 6.03 8.25 12.28 19.80
ACA 195 3.92-9.59 6.16 8.83 6.17 8.94 12.02 20.86
THR 172 4.25-11.72 6.05 9.27 6.87 9.79 15.23 26.15
ACH 112 4.07-10.70 5.91 8.72 6.06 8.00 11.30 18.57
5HT 129 5.57-11.00 5.68 8.54 6.06 7.94 11.36 20.03
HADH2 2398 4.40-7.60 6.53 9.49 6.00 8.60 12.04 23.17
a For the seven compound activity classes discussed in the text, the number of compounds, potency range, and average (avg) and maximum
(max) Euclidean fingerprint distances are reported. The minimum distance was 0 for all classes and fingerprint representations. Activity classes
are abbreviated as follows: protein farnesyltransferase inhibitors (FAR), lipoxygenase inhibitors (LIP), acyl-CoA:cholesterol acyltransferase
inhibitors (ACA), thrombin inhibitors (THR), acetylcholinesterase inhibitors (ACH), 5HT reuptake inhibitors (5HT), and human hydroxyacyl-
CoA dehydrogenase II (PubChem BioAssay ID 886).
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MACCS is a widely used structural key-type fingerprint that
monitors the presence or absence of predefined structural
features in a molecule. With 166 bit positions corresponding
to 166 distinct structural features, its structural “resolution”
is relatively low. By contrast, TGT represents a topological
three-point pharmacophore fingerprint that monitors all
triplets of predefined pharmacophore features with a given
bond distance in a molecule and consists of 1704 bits.
Molprint2D captures layered atom environments as a mea-
sure of the global topology of a molecule. Because it does
not rely on a catalogue of predefined substructures, its format
is flexible, and Molprint2D can generate a theoretically
unlimited number of features for a molecule. Thus, this
fingerprint representation is of high structural resolution.
Chemical Dissimilarity Assessment. A variety of similar-
ity or distance measures are available for the comparison of
molecular fingerprints.20 In this study, the dissimilarity of
two molecules is calculated as the Euclidean distance
between their fingerprint representations. For binary finger-
prints, the Euclidean distance is defined as follows:
where Ni and Nj denote the number of fingerprint features
present in molecules i and j, respectively, and Nij denotes
the number of features shared by both molecules. The
Euclidean distance is chosen here instead of the widely
applied Tanimoto similarity coefficient20 for two reasons.
First, the Tanimoto coefficient is calculated only on the basis
of features that are present in two molecules and does not
account for features that are absent. By contrast, the
Euclidean distance calculates molecular dissimilarity on
the basis of features that differ between two molecules. For
the purpose of landscape visualization, we found that simple
Euclidean distance calculations often better differentiated
between similar molecules than those of Tanimoto similarity
calculations, which is relevant with respect to data spread
and surface coverage. However, landscapes produced on the
basis of Tanimoto similarity and Euclidean distances were
often rather similar, suggesting that Tanimoto similarity could
also be utilized. Nevertheless, for our purposes, Euclidian
distance has a second principal advantage because it provides
a standard framework for the comparison of numerical
molecular descriptors, which might also be used for land-
scape generation, as an alternative to fingerprints.
Reference Space Construction. For computational analy-
sis, molecules are generally projected into a chemical
reference space that is defined by a set of molecular
descriptors or fingerprint vectors. Reference spaces are
typically high-dimensional and hence difficult to represent
in an intuitive and readily interpretable manner. To enable
the visualization of chemical space distributions of large
molecular data sets, various dimensionality reduction tech-
niques have been introduced that aim at mapping multidi-
mensional data into 2D or 3D reference spaces.21 These
reference spaces can either be coordinate-based or coordinate-
free, depending on the dimension reduction method that is
used. One of the most common techniques is principal
component analysis (PCA) that generates a low-dimensional
coordinate-based space from linear combinations of original
descriptors with minimal loss of data variance.22 An advan-
tage of this method is that novel molecules can easily be
mapped into principal components space. This provides the
basis for the ChemGPS method23 that utilizes principal
components precalculated on a set of active compounds to
generate coordinates of novel input molecules. By contrast,
methods like nonlinear mapping (NLM)24 or multidimen-
sional scaling (MDS)13 aim at preserving relative similarity
relationships between input data points by minimizing a stress
function (see below) and thus produce coordinate-free low-
dimensional reference spaces. These methods often reflect
close similarity relationships better than coordinate-dependent
approaches. However, they are computationally demanding
and not easily applicable to large data sets. This problem
can be overcome, for example, by combining MDS with
artificial neural networks.25 Another alternative is presented
by Kohonen networks that project data onto a 2D map using
a self-organizing learning algorithm.26
Here we apply a nonmetric multidimensional scaling
algorithm to visualize molecular dissimilarity relationships.
For a set of n molecules, the algorithm takes as input an
nxn matrix of pairwise Euclidean distances δij of molecular
fingerprints, as defined above, and calculates n points with
2D coordinates (xi,yi), whose pairwise Euclidean distances
dij best approximate the input dissimilarities δij. Specifically,
we aim to find n 2D vectors pi ) (xi,yi) such that Kruskal’s
stress function27 is minimal:
where dij denotes the Euclidean distance between points pi
and pj:
and δˆ ij denotes an optimal monotonic transformation of the
input dissimilarities δij that is determined by the optimization
algorithm.28 The optimization problem is solved by means
of an iterative steepest-descent algorithm implemented in the
“MASS” package29 of R.30 The resulting coordinates as-
signed to each molecule are then scaled to the range [0,1]
by subtracting the minimum and dividing by the range of
the x- and y-values. Subsequently, the scaled coordinates are
multiplied by the maximal chemical dissimilarity between
two molecules in the current data set. Thus, the range of the
planar coordinates (and hence the size of the landscape plots)
reflects the overall chemical dissimilarity within a data set.
Surface Interpolation. Multidimensional scaling generates
an embedding of active molecules in a 2D plane. Potency
values are then added as the third dimension for the activity
landscape model. In general, however, the data points are
sparse and unevenly distributed and must be interpolated to
obtain a coherent surface. For this purpose, a geostatistical
technique termed Kriging14 is applied to fit a coherent surface
to the data points. This method aims at estimating the value
of a random field, in our case the surface elevation, at
unobserved locations from observations at n data points, i.e.,
the n given molecules with their position on the x/y-plane
and their potency value on the z-axis. Based on the expected
value and a covariance function that describes the spatial
dependence of the given data points, the Kriging method
δij ) √Ni + Nj - 2Nij
stress ) ∑i<j (dij - δˆ ij)2∑i<j dij2
dij ) d(pi, pj) ) √(xi - xj)2 + (yi - yj)2
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calculates the best linear unbiased estimator for the surface
elevation by minimizing the variance of the prediction error.
The surface is calculated on a regular grid consisting of 80
× 80 grid points. Because the molecules are in most cases
not evenly distributed on this grid, border regions occur
where no data points are present to support the interpolation.
These regions are omitted in the landscape plots, which can
sometimes result in irregularly shaped borders of the images.
We utilize the Kriging function as implemented in the
“fields” package of R.31
Graphical Display. The resulting activity landscapes are
displayed as perspective plots generated with R. To enable
the comparison of landscapes across different activity classes
and fingerprint representations, all landscape representations
have been generated from the same viewpoint (i.e., with an
azimuth of 45° and a colatitude of 25°). Moreover, a common
scale for the z-axis is applied for all data sets, ranging from
the lowest (3.72) to the highest (11.55) interpolated z-values
observed for all six MDDR activity classes. In addition, for
each fingerprint representation, a common scale is utilized
on the x- and y-axes to make the landscapes for a given
fingerprint comparable to each other. This scale ranges from
the lowest (0.00) to the highest values of chemical distances
for the respective fingerprints over all six MDDR classes
(MACCS - 9.27, Molprint2D - 9.79, and TGT - 26.15).
The surface facets are colored according to z-values. Areas
with a z-value below a lower threshold of 5.78 are colored
in green, and areas with a z-value above an upper threshold
of 8.75 are colored in red. These threshold values are
determined as the highest minimal and the lowest maximal
z-values of the six MDDR activity classes, respectively, and
make it possible to directly identify regions in a landscape
where interpolated potency values are above or below a given
value, which might be difficult to recognize on the basis of
surface elevation alone. Intermediate values are colored using
a continuous gradient from green via yellow to red. For the
HTS data, we set the thresholds for green and red coloring
to 4 and 7, respectively, in order to account for the narrow
potency range and the presence of large numbers of only
very weakly active molecules in this compound set. In
addition, coloring is designed to convey information about
the data sampling of the surface: colors fade with increasing
distance of a surface facet to a data point; hence, white areas
denote regions that are not populated by data points and
represent interpolated surface areas. The transparency (R)
value of each grid point p is determined from the Euclidean
distance d(p,(xi, yi)) of p to the closest data point (xi, yi),
representing the coordinates of a molecule i calculated by
multidimensional scaling:
Here, xmax and xmin denote the largest and smallest
x-coordinates of the landscape area, and k is a scaling factor
that determines the slope of the transparency gradient. In
our calculations, k was empirically set to 1800. With this
formulation, grid points that map close to a data point obtain
R values near 255, which corresponds to an opaque coloring,
whereas grid points whose distance to the closest data point
is large obtain low R values near 0, which results in fully
transparent (or white) representation. Negative R values are
set to 0. It follows from the equation that grid points whose
distance to the nearest data point is (255)/(k)(xmax - xmin)
or larger will obtain a minimal transparency value of 0 and
are displayed in white; these grid points form purely
interpolated surface areas. The percentage of these grid points
is reported in Table 2 for each activity class and for all three
fingerprint representations, which provides a quantitative
comparison of the landscape representations.
SAR Discontinuity Scores. To quantify the presence of
activity cliffs in a compound data set, we calculate the SARI
discontinuity score.4,7 This score has been introduced to
estimate the global SAR character of an activity class A and
computes the average potency difference between pairs of
similar compounds, scaled by pairwise similarity:
Here, Pi denotes the negative decadic logarithm of the
potency value of compound i, and δij is the Euclidean
fingerprint distance of compounds i and j; t denotes a
fingerprint distance threshold that was set to 4.90 for
MACCS, 8.31 for TGT, and 5.29 for Molprint2D. These
values were chosen to eliminate the same percentage (9.24%)
of pairwise compound distances from a set of 13 reference
classes originally used for MACCS Tc calculations.7 The
global discontinuity scores for each activity class and
fingerprint combination are given in Table 3. In addition,
Table 3 also reports the number of activity cliff markers in
landscapes that correspond to individual compounds partici-
Table 2. Evaluation of the Interpolated Activity Landscapesa
correlation between chemical and
geometric distances
correlation between interpolated and
original potency values
percentage of interpolated surface
area
activity class MACCS M2D TGT MACCS M2D TGT MACCS M2D TGT
FAR 0.73 0.51 0.81 0.98 0.96 0.85 23.2 28.7 27.7
LIP 0.75 0.71 0.68 0.97 0.92 0.88 6.0 10.4 20.4
ACA 0.78 0.80 0.79 0.96 0.92 0.94 12.3 7.7 15.7
THR 0.69 0.50 0.76 0.93 0.93 0.92 20.5 17.3 9.9
ACH 0.81 0.60 0.74 0.98 0.97 0.96 14.8 18.1 19.2
5HT 0.81 0.73 0.81 0.96 0.97 0.94 17.1 15.1 25.7
HADH2 0.55 0.27 0.69 0.77 0.66 0.61 6.8 9.1 13.7
a For the three fingerprint representations, MACCS, Molprint2D (M2D), and TGT, correlations between calculated Euclidean fingerprint
distances (chemical distances), and geometric distances between 2D molecular coordinates obtained by multidimensional scaling are reported.
Furthermore, correlations between the interpolated surface values and the original potency values are provided. In addition, the percentage of
grid points that are displayed fully transparent (white) and represent purely interpolated surface area is given (see text for details).
R(p) ) 255 - min
i
{d(p, (xi, yi)} · kxmax - xmin
discraw(A) ) mean{(i,j)∈A|δij<t,|Pi-Pj|>1 }(
|Pi-Pj|/1+δij)
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pating in at least one compound pair with fingerprint distance
less than the threshold specified above and the potency
differences of at least 3 orders of magnitude. If such
compound pairs are proximal on an activity landscape, then
they participate in the formation of an activity cliff region
consisting of multiple and in part overlapping cliffs.
Compound Clustering. In order to enable a detailed
analysis of compound classes forming different parts of
activity landscapes, in particular, activity cliffs, we also
clustered the molecules in a data set on the basis of pairwise
Euclidean fingerprint distances. For this purpose, the hier-
archical clustering scheme of Ward’s minimum-variance
linkage method was applied.32 The resulting dendrograms
were pruned at various heights to obtain a reasonable number
of clusters with balanced cluster composition. We also
calculated the discontinuity score for each resulting cluster
to evaluate local SAR features that might coexist within a
given data set. Cluster results for all seven activity classes
are provided in the Supporting Information.
The landscape display and analysis tools introduced herein
enable rotatable landscape views, molecule selection, and
interactive structure display. Upon publication, these tools
are made freely available via the following: http://www.
lifescienceinformatics.uni-bonn.de.
RESULTS AND DISCUSSION
Landscape Generation and Interpretation. We have
generated both 2D and 3D activity landscape models for
seven enzyme inhibitor sets, including six compound opti-
mization sets and one screening set, using three different
molecular fingerprint representations. Figure 2a shows a
representative example for the ACH data set and MACCS
fingerprints that is utilized to rationalize key features of
landscapes revealed by our analysis and to illustrate how
3D landscape representations should be interpreted in order
to identify key compounds. In the 2D representation of the
ACH landscape, molecules are represented by data points
whose coordinates were obtained by multidimensional scal-
ing, as used for the generation of the 3D landscape
representation. The interpolated surface elevation is repre-
sented by shading, using the same color code as in the 3D
landscape. Corresponding exemplary data points in the 2D
and 3D representations are connected by dashed lines. The
2D landscape representation is intuitive and mirrors the data
distribution, but the 3D landscape further emphasizes the
formation of activity cliffs and their spatial arrangement.
Only three major analysis criteria must be applied, as
indicated on the left in Figure 2a, to interpret activity
landscapes in a step-by-step manner, to evaluate characteristic
landscape features, and to focus on key compounds:
(i) Regions of interpolated surface area (white) are identified
that are particularly “smooth” but lack compound data.
These regions contribute to landscape topology but lack
interpretable local SAR information. Hence, this infor-
mation can be utilized to assess the sampling of a
compound data set and to identify chemical space regions
that have not been thoroughly explored.
(ii) Regions with green to yellow peaks of limited magnitude
are then identified that result from dense data sampling
but do not correspond to local regions of significant SAR
discontinuity, as we discuss in more detail below.
Therefore, these moderate surface elevations are termed
“data peaks”. This is an important point to be made
because not every peak on a 3D landscape represents an
activity cliff.
(iii) True activity cliffs become immediately apparent on a
3D landscape in regions of large-magnitude peaks that
are characterized by a red-yellow-green color spectrum.
These peaks are formed by groups of similar molecules
that map close to each other in the reference space but
have distinct potency levels. Hence, to identify prominent
activity cliffs, color-code information, indicating absolute
potency differences among similar molecules, must be
taken into account, as is also further discussed below.
In Figure 2b, the results of compound clustering and
landscape mapping are shown, revealing that different
chemotypes form spatially separated activity cliffs in the
ACH data set, as one would expect. The individual clusters
obtain discontinuity scores that span the entire range from 0
to 1, which indicates the coexistence of different local SAR
features within the compound set. Molecules belonging to
two clusters characterized by a notable degree of SAR
discontinuity are mapped on the 3D landscape view in Figure
2b, and the structures of two compound pairs forming
prominent activity cliffs are shown. Furthermore, representa-
tive data points that correspond to the most active compounds
in each cluster are displayed on the 3D surface in Figure
2b, and their structures are shown in Figure 2c. These
molecules represent different chemotypes and produce
distinct peaks in the activity landscape that are scattered
around the surface area. Similar observations were made for
all seven compound data sets, as shown in Supporting
Information, Figure S1.
Table 3. Discontinuity Scores and Activity Cliffsa
discontinuity score no. of activity cliff markers
activity class MACCS M2D TGT MACCS M2D TGT
FAR 0.79 0.64 0.77 39 (26.7%) 13 (8.9%) 30 (20.5%)
LIP 0.09 0.04 0.14 8 (3.2%) 11 (4.4%) 12 (4.8%)
ACA 0.23 0.34 0.18 24 (12.3%) 45 (23.1%) 20 (10.3%)
THR 0.59 0.69 0.56 71 (41.3%) 25 (14.5%) 7 (4.1%)
ACH 0.75 0.83 0.64 48 (42.9%) 41 (36.6%) 30 (26.8%)
5HT 0.24 0.33 0.27 24 (18.6%) 21 (16.3%) 18 (13.9%)
HADH2 0.05 0.06 0.07 48 (2.0%) 452 (18.8%) 37 (1.5%)
a SARI discontinuity scores calculated on the basis of Euclidean distance between MACCS, Molprint2D (M2D), and TGT fingerprints are
reported for the seven compound activity classes. In addition, we report the number and percentage (in parentheses) of “activity cliff markers”,
i.e., molecules that participate in at least one compound pair with fingerprint distance that is lower than the distance threshold applied for
discontinuity score calculations and potency differences of more than three orders of magnitude.
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Landscape Quality Assessment. The six lead optimiza-
tion sets produced characteristic 3D landscape topologies that
differed in part substantially depending on the choice of the
molecular representation. These differences are discussed
Figure 2. Interpretation of activity landscape representations. For the ACH data set and MACCS fingerprints, 2D and 3D activity landscape
representations are shown. (a) Comparison of 2D and 3D landscape. The 3D landscape (left) contains distinct regions that are discussed in
the text. These regions can be mapped onto a 2D representation of the same landscape (right) obtained by multidimensional scaling. In the
2D plot, the interpolated surface elevation is represented by shading, using the same color scheme as in the 3D landscape. Data points
representing molecules are also shown and colored according to their potency values, with green indicating potency values of 5.78 and
below and red indicating potency values of 8.75 and above. (b) Cluster analysis. The compounds in the data set were clustered using
Ward’s hierarchical clustering based on Euclidean fingerprint distances. In the 2D plot (left), data points representing molecules are colored
according to their cluster membership. SARI discontinuity scores calculated for each cluster are in the box (“Cluster disc”). The most
active compound in each cluster is encircled and also shown on the 3D landscape (right). In addition, two clusters are mapped onto the 3D
landscape. (c) Cluster representatives. Shown are the structures of the most potent compounds in each cluster marked in (b).
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below in detail. In order to evaluate the overall quality of
the models, we compared the modeled parameters for
molecular distance and surface elevation to the chemical
descriptor distance and measured potency data, respectively.
The correlation values are reported in Table 2. For distance
comparison, we calculated the pairwise Euclidean distances
between molecule coordinates obtained through multidimen-
sional scaling and correlated these geometric distances to
the Euclidean fingerprint distances. On average, geometric
and fingerprint distances correlated well (0.72) and exceeded
a correlation of 0.6, with the exception of only 2 of 18
compound class/fingerprint combinations (Molprint2D for
classes FAR and THR). However, geometric distances
calculated with a conventional multidimensional scaling
algorithm33 displayed consistently lower correlation with
fingerprint distances, which supported our choice of a
nonmetric approach to multidimensional scaling.
Comparison of interpolated surface elevation with mea-
sured potency values yielded correlations that were greater
than 0.85 for all activity class/fingerprint combinations (and
exceeded 0.9, except for FAR and LIP with TGT finger-
prints). Hence, according to parameter correlation analysis,
the 3D activity landscape models were generally of good
quality. Importantly, all activity landscapes studied here were
generated using a consistent data reference frame that made
it possible to compare landscapes across different activity
classes.
Global SAR Features of Lead Optimization Sets. The
SARI discontinuity scores reported in Table 3 are a global
measure of SAR characteristics. Discontinuity scores range
from 0 to 1. The higher the discontinuity score is the more
structurally similar compounds with significant potency
differences are contained in a data set (and the more activity
cliffs are formed). By contrast, low discontinuity scores
indicate the presence of only small potency differences
among structurally dissimilar compounds and the absence
of activity cliffs of large magnitude. Hence, these global
discontinuity scores should correlate with notable differences
in landscape topology. The scores were calculated with three
different fingerprints. As can be seen in Table 3, the values
differ in each case but are comparable in magnitude for each
class, indicating the presence of high SAR discontinuity for
the activity classes farnesyltransferase (FAR) and acetyl-
cholinesterase (ACH) inhibitors, intermediate discontinuity
for thrombin (THR) inhibitors, and low discontinuity for
inhibitors of lipoxygenase (LIP), acyl-CoA:cholesterol acyl-
transferase (ACA), and 5HT reuptake (5HT). Thus, these
activity classes cover a wide range of SAR discontinuity.
Table 3 also lists the number of prominent activity cliffs
contained in each compound set.
Landscape Topology and Molecular Representations.
The calculated FAR activity landscapes in Figure 3a clearly
reflect the high degree of SAR discontinuity contained in
this data set, which is particularly well illustrated by the
landscape calculated with Molprint2D. Here, compounds are
distributed over the entire landscape, resulting in the presence
of only small interpolated (white) surface regions. The
landscape is rugged and characterized by multiple cliffs,
some of which are not separated and form a plateau of highly
potent compounds (coherent red region). The MACCS- and
TGT-based landscapes also display a rugged topology.
Different from the landscape calculated with Molprint2D,
the MACCS-based landscape is characterized by a large
interpolated surface area, which is a consequence of clear
separation of highly (red areas) and weakly potent (green)
compounds. Similarly, the TGT-based landscape also con-
tains a large interpolated surface area, but the topology of
this landscape differs substantially from the others. This is
the case because the calculation of TGT pharmacophore
feature fingerprints results in clustering of different com-
pound subsets, rather than a separation of molecules accord-
ing to potency. Thus, the comparison of the three FAR
landscapes illustrates a strong influence of the chosen
molecular representation on landscape topology, although all
three landscapes capture the high degree of SAR discontinu-
ity within the FAR data set well. Similar observations can
be made for all activity landscapes studied here, as discussed
in the following.
SAR Discontinuity versus Continuity. Comparison of
activity landscapes for the different compound sets shows
that they all include a number of peaks and rugged regions,
despite differences in global SAR character. For example,
the LIP data set is characterized by a very low discontinuity
score for all three fingerprints. Inspecting its activity
landscapes, shown in Figure 3b, reveals that this large data
set evenly populates the landscapes, except for the TGT
representation where clustering effects also occur in this case.
The MACCS- and Molprint2D-based landscapes are rather
similar, despite minor differences in topology. In these
landscapes that are dominated by moderately potent mol-
ecules (green and yellow areas) prominent cliffs are absent;
however, many small peaks are scattered over the surface.
It should be noted, however, that these peaks primarily result
from the underlying data point distribution and are in this
case not indicative of SAR discontinuity. This is the case
because their height is rather limited and they are mostly
colored in similar green and yellow shades, which indicates
that the corresponding molecules have similarly weak
potency values and do not form activity cliffs. As illustrated
in the bottom part of Figure 3b, removing the 30 and 100
most active molecules from the LIP data set makes these
landscapes smoother. However, even after removal of 100
molecules (which limits logarithmic potency to the range
between 6.9 and 9), the landscape still contains a number of
small peaks. Hence, these peaks represent molecules whose
potency is only slightly higher than that of its neighbors.
By contrast, the classes FAR or ACH (see below) are
characterized by a high discontinuity score, and accordingly,
their landscapes contain rugged regions where peaks colored
in red that are formed by highly potent molecules are in close
proximity to valleys or canyons where weakly active
molecules are located. Thus, in order to detect SAR
discontinuity and activity cliffs in a 3D activity landscape,
the height and color of neighboring peaks and valleys must
be taken into account.
Similar to LIP, the ACA data set also contains many
weakly to moderately potent compounds but is characterized
by a higher degree of discontinuity, which becomes apparent
in its activity landscapes shown in Figure 3c. Here the
compounds are also well distributed over most of the surface
areas, but the landscapes consist of different regions that are
predominantly populated by either weakly or moderately to
highly potent compounds. In the latter regions, small- to
moderate-sized activity cliffs are formed.
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Different from LIP and ACA, the THR inhibitor set is
dominated by highly potent compounds. It yields intermedi-
ate discontinuity scores that indicate SAR heterogeneity,
which usually results from the presence of subsets of
Figure 3. Activity landscapes. For the six compound data sets according to Table 1, activity landscapes were calculated on the basis of
Euclidean fingerprint distances for three fingerprint representations, MACCS (top left), TGT (top right), and Molprint2D (bottom). The
surface is colored according to interpolated surface elevation, using a continuous spectrum from green for values smaller than or equal to
5.78 to red for values equal to or greater than 8.75. For all combinations of the six activity classes and three fingerprints, the same color
spectrum and a common coordinate reference frame are applied. Interpolated surface area not populated with molecules is colored white.
Activity landscape representations are shown for inhibitors of: (a) protein farnesyltransferase (FAR), (b) lipoxygenase (LIP), (c) acyl-CoA:
cholesterol acyltransferase (ACA), (d) thrombin (THR), (e) acetylcholinesterase (ACH), and (f) 5HT reuptake (5HT). The box in the lower
part of Figure 3b shows activity landscape representations for class LIP that were calculated after removal of the 30 (top) and 100 (bottom)
most active compounds from the data set. Relatively high peaks are smoothed out in the resulting landscapes, but small peaks are retained.
The comparison of these landscapes illustrates the effect of data sampling and the difference between peaks produced by dense data points
and actual activity cliffs (see text for details).
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compounds displaying different SAR characteristics. Given
the potency distribution within this compound set, its activity
landscapes, shown in Figure 3d, predominantly consist of
red and yellow regions. Here differences in landscape
topologies produced by different fingerprints are again rather
obvious, and depending on the fingerprint, different clustering
patterns are observed. Although the MACCS- and TGT-
based landscapes contain extended regions of interpolated
surface, all three landscapes are characterized, despite
topology differences, by smooth and relatively flat regions
and also by regions that are enriched with cliffs of varying
magnitude. The Molprint2D-based landscape has compounds
distributed over most of its surface, and best reflects these
features that are consistent with SAR heterogeneity. Taken
together, these findings illustrate that the topological details
of the individual activity landscapes of the four compound
data sets discussed so far are much influenced by the different
molecular representations. However, the results also show
that compound set characteristic features common to these
four activity landscapes are consistent with global SAR
phenotypes assigned on the basis of discontinuity scoring.
Variable Activity Cliffs. Activity cliffs represent the most
informative and characteristic features of activity landscapes.
Consistent with the previously observed predominance of
SAR heterogeneity in many compound data sets,4,7 we find
that essentially all activity landscapes, except those repre-
senting the most continuous SARs, contain activity cliffs of
varying magnitude.
Consistent with high discontinuity scores for all three
fingerprint representations, the landscapes for the ACH data
set, shown in Figure 3e, are dominated by pronounced
activity cliffs that are formed by compounds covering a large
potency range from subnanomolar to micromolar potencies.
However, the distribution of these cliff marker compounds
differs substantially in the three landscapes, depending on
the chosen fingerprint representation. Figure 4a shows four
exemplary molecules representing different potency levels,
whose positions on the landscapes in Figure 3e are indicated.
These molecules share a common tricyclic substructure and
mark activity cliffs. In the MACCS-based landscape, they
map to the same surface area that contains a prominent
activity cliff. The two highly potent molecules 1 and 2
contribute to a peak that is produced by a number of similarly
potent molecules that map to this surface region. By contrast,
the other two fingerprint representations clearly separate these
compounds. In the Molprint2D-based landscape, the mol-
ecule pairs 1-3 and 2-4 form two separate activity cliffs
of similar magnitude. By contrast, in the TGT-based
landscape, the least potent (and smallest) molecule 4 maps
to a different area distant from the location of the other three
selected molecules. Hence, the formation of activity cliffs
also varies with chosen molecular representations, more so
than overall landscape topology.
The 5HT data set is characterized by a lower discontinuity
score than ACH, which is due to the prevalence of highly
potent compounds in the 5HT set. The 5HT activity
landscapes in Figure 3f also include moderately sized activity
cliffs that are formed by neighboring molecules with high
and moderate (and, in a few cases, low) potency levels. Three
exemplary molecules are labeled in Figure 3f and shown in
Figure 4b. Molecules 1 and 2 are structurally very similar
and located close to each other in all three activity landscapes,
producing the highest peaks. Compound 3 is four to five
orders of magnitude less potent than these two compounds
Figure 4. Exemplary compounds. For (a) ACH and (b) 5HT molecules are shown that are labeled in the activity landscapes in Figure 2e
and Figure 2f, respectively. Depending on the chosen fingerprint representation, these molecules map to different regions of the landscapes
and form, or do not form, activity cliffs.
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and structurally distinct from them. However, due to the
presence of a common substructure, all three molecules map
proximal to each other in a contiguous region in the MACCS-
based landscape. By contrast, the other two higher-resolution
fingerprint representations clearly separate compound 3 from
the two highly potent molecules and place it into a more
distant region in the corresponding activity landscapes. In
this case, the higher-resolution fingerprints further emphasize
activity cliffs and separate them on their activity landscapes.
Activity Landscape Analysis of Screening Data. In
addition to compound optimization sets, we have also
analyzed HTS data, given their relevance for initial SAR
Figure 5. Activity landscape for HTS data. Activity landscape representations for a set of 2398 inhibitors of hydroxyacyl-CoA dehydrogenase
II taken from a screening set are shown for three different fingerprint representations. (a) 3D landscape representations for MACCS (left),
TGT (right), and Molprint2D (bottom) fingerprints. Representative molecules belonging to different clusters are indicated on the surface
and are colored according to cluster membership. (b) 2D representations of the same activity landscapes, arranged according to (a). (c)
Representative molecules belonging to different clusters marked in (a) are shown together with their potency values.
THREE-DIMENSIONAL ACTIVITY LANDSCAPES J. Chem. Inf. Model., Vol. 50, No. 6, 2010 1031
exploration and hit selection. Screening data sets generally
present challenging cases for systematic SAR analysis
because their potency and similarity distributions differ
substantially from compound optimization sets. To account
for the narrow potency range, the color code applied for the
3D landscape representations has been modified: green
coloring now corresponds to an interpolated surface elevation
of 4 and lower, whereas red indicates a surface elevation of
7 and higher. This modification makes it possible to evaluate
small potency differences in the data set (but the landscape
coloring cannot be directly compared to the six MDDR data
sets). The hydroxyacyl-CoA dehydrogenase II (HADH2)
data set is characterized by the presence of many weakly or
borderline active molecules that dominate its SAR character
and lead to a very low degree of SAR discontinuity. Its
activity landscape representations, shown in Figure 5a, clearly
reflect this SAR phenotype. Many small green data peaks
are seen that arise from dense data sampling. As a conse-
quence of data density, purely interpolated surface area
(represented as white regions) is much reduced compared
to the compound optimization sets discussed above (Table
2). Data peaks are clearly distinguished from several notable
activity cliffs that are also contained in the screening set.
These cliffs become much more apparent in the 3D land-
scapes than the corresponding 2D representations shown in
Figure 5b, due to the large number of data points. Figure 5c
shows the structures of representative active compounds that
are mapped in Figure 5a. These compounds are structurally
diverse and include the most active molecules from selected
compound clusters. Taken together, these results illustrate
that 3D activity landscape representations are also applicable
to raw screening data and clearly help to quickly focus on
compound subsets that form activity cliffs and contain SAR
information.
CONCLUSIONS
Herein we have focused on generating activity landscape
views for actual compound data sets that can be compared
and analyzed in qualitative and quantitative terms. As we
expected, details of approximated “true” activity landscapes
depart from the idealized canyon/rolling hills landscape view
that we utilize to rationalize principal relationships between
activity landscapes and structure-activity relationships.
However, we have found that different compound data sets
produce different types of activity landscapes that are readily
interpretable, despite molecular representation-dependent
differences in their topology. Furthermore, we have found
that landscape features can be related to global SAR
characteristics of compound data sets deduced from system-
atic pairwise comparisons of compound similarity and
potency and quantified by SAR discontinuity scoring.
Visualizing similarity and potency relationships in three-
dimensional landscape representations makes it possible to
assess SAR characteristics of a compound data set and to
identify activity cliffs of varying magnitude. Activity land-
scapes of different compound sets mirror previous findings
that SARs are predominantly heterogeneous in nature and
that even largely continuous SARs contain elements of
discontinuity, which become apparent as shallow activity
cliffs in landscape models. However, activity cliffs that occur
in an activity landscape for a given molecular representation
might be modified or even leveled out in a different chemical
reference space. Hence, for a comprehensive description and
prioritization of activity cliffs in a data set, the choice of
molecular representations is rather critical. Furthermore,
activity landscape visualization also provides an intuitive way
to identify molecular representations that best separate highly
and weakly potent molecules in a given data. Such repre-
sentations are most suitable for many practical applications
of molecular similarity analysis.
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Summary
Herein, a novel computational approach for the generation of 3D activity land-
scapes has been reported. In addition, these 3D activity landscapes generated
for different compound sets were analyzed in detail. Such true landscapes dis-
played substantial variations compared to conceptualized smooth/rugged views
frequently employed to explain SAR features. Moreover, the generated 3D
landscapes showed notable dependence on the chosen molecular representa-
tion and variation in their topologies. In order to enable direct comparisons,
the landscapes were represented within a consistent framework. Despite clear
differences, the overall SAR characteristics obtained after systematic pairwise
comparison of structural similarities and activity differences, correlated well
with the landscape features. In addition, the activity cliffs were readily identi-
fiable, although, they were dependent on the chosen molecular representation.
The 3D activity landscapes also aided in the intuitive identification of chemical
reference spaces that allowed the separation of compounds according to their
potency levels. Therefore, these landscape representations were well suited for
qualitative analysis of SAR.
Following the successful generation of 3D activity landscape representations for
real data sets, a follow-up study was performed to compare these with standard
2D representations reported in the next chapter.
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Chapter 2
Comparison of two- and
three-dimensional activity
landscape representations for
different compound data sets
Introduction
The SARs associated with bioactive compound data are routinely investigated
with the help of the activity landscape concept as it is intuitive and fairly easy
to interpret. The important advantage provided by the landscape representa-
tions is the relative ease in the visual accessibility of characteristic SAR features
prevalent in various sets of active compounds. Indeed, several methodologies
for activity landscape modeling have been developed. The common objective
of these conceptually different modeling approaches is to combine the pair-
wise chemical similarity and activity relationships existing in a given data set.
Herein, a comparative study has been outlined where exemplary 2D activity
landscape representations, i.e. NSGs, generated for data sets with different
SAR phenotypes were compared with the 3D models. The study clearly re-
vealed that both 2D and 3D landscapes capture the overall SAR content of
the data sets used in an analogous manner, despite their distinctive topologies.
Additionally, it has also be observed that local SAR features are perceived
differently in these representations.
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Summary
A comparative analysis performed using the activity landscape representations
generated by two conceptually different computational techniques has been re-
ported. The 2D representations, i.e. the NSGs, integrate systematic similarity
and potency relationships in data sets in the form of a network and therefore, do
not require dimension reduction. On the other hand, 3D activity landscapes are
contiguous surfaces generated after interpolation of activity information of con-
stituent compounds and their 2D projection obtained as a result of dimension
reduction. From the study, it was observed that in spite of their visual differ-
ences, these representations perceived global SAR content in a similar manner.
In addition, 3D models demonstrated the influence exerted by the choice of the
molecular presentations on the underlying chemical spaces and as a result the
analysis of SAR. The 2D and 3D models provided different perspectives dur-
ing the analysis of local SAR environments, as expected. Activity cliffs of large
magnitude that represent centers of SAR discontinuity information were readily
identifiable using 3D representations. However, SAR exploration in the vicinity
of such cliffs was better facilitated by NSGs. Prominent activity cliffs identified
in NSGs were also found to be consistently represented in the 3D models. Thus,
this study clearly indicated that the complementarity of these representations
can be exploited during detailed exploration of activity cliffs. It is important
to note that the comparison of different activity landscape representations pro-
vides valuable indicators as to how these models can be maximally utilized
during practical SAR investigations.
Pairwise comparisons of compound structures and activities form the core as-
pect of activity landscape models despite differences in their conceptual de-
sign. Accordingly, various landscape features (e.g. activity cliffs) are typically
characterized at the level of compound pairs. A computational approach that
resolves different landscape features at the level of individual compounds has
been introduced in the following chapter.
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Chapter 3
Conditional probabilities of
activity landscape features for
individual compounds
Introduction
Activity landscape modeling is frequently utilized during SAR analysis of large
data sets as it combines pairwise chemical similarities and potency differences
between active compounds [1]. Various computational methodologies for the
construction of landscape representations to study single- as well as multi-
target SAR have been introduced, ranging from molecular networks and 2D
plots to 3D landscape models [1, 2]. In spite of their conceptual differences,
these approaches for activity landscape generation require systematic pairwise
comparisons of molecular similarities and potency differences. Therefore, the
resulting landscape features are often resolved at the level of compound pairs.
Activity cliffs, for instance, are formed by structurally related compound pairs
with large variation in their potencies and represent the most significant land-
scape features [3, 4]. Additionally, structurally similar and dissimilar compound
pairs having equivalent potencies also constitute other landscape features rele-
vant for SAR analysis.
Various modeling techniques provide a qualitative description of activity
landscape features. In a recent study, these features have quantitatively been
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characterized using an information-theoretic approach [5]. Information entropy
calculations were performed to characterize the information associated with
different landscape features and the results were compared with their SAR
information content.
On the basis of probability theory, a methodology has recently been intro-
duced for the quantitative assessment of predefined activity landscape features
[6]. Conditional probabilities for individual compounds to form these landscape
features were computed using their pairwise structural similarity and potency
difference data. This computational approach was applied to several data sets
and compounds with significant feature probabilities were identified. In addi-
tion, compounds were assigned to various feature categories on the basis of their
conditional probabilities. The conceptual advantages of conditional probabil-
ity calculations and the resulting compound assignments have been highlighted
with the help of graphical landscape representations [6]. The study reported
herein has been published in reference [6] of this chapter. My contributions
to this study included the systematic calculation of conditional feature proba-
bilities for different data sets as well as the generation of exemplary graphical
representations.
Methodology
Similarity-Activity Similarity Maps
The activity landscape features have initially been categorized with the help
of SAS maps, the first 2D landscape representations [7]. SAS maps represent
activity landscapes at the level of compound pairs and are appropriately suited
for the classification of landscape features. SAS maps were originally imple-
mented as 2D plots of structural versus activity similarity of molecules within
a data set obtained from systematic pairwise comparisons.
Typically, chemical relatedness is determined by comparing molecular fin-
gerprints using the Tanimoto coefficient (Tc) [8] as the similarity metric and
activity similarity is expressed in terms of potency differences (normalized, if re-
quired) between all compound pairs. Structural similarity is represented along
the x-axis while the y-axis reports the absolute differences in activity. Different
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SAS map variants have been proposed for various practical applications [9, 10].
Data points in the SAS map represent similarity and potency relationships be-
tween compound pairs. The map can be divided into four distinct regions on
the basis of predefined chemical similarity and activity difference thresholds.
Similarity and Activity Difference Thresholds
Clear definition of threshold values for structural similarity and potency differ-
ence is a necessary requirement for the quantitative analysis of activity land-
scape features [1, 4]. The chemical similarity was assessed using extended con-
nectivity fingerprints [11] with a bond diameter 4 (ECFP4) and a Tc value of
0.55 served as the similarity threshold while absolute potency difference thresh-
old was set to 2 pKi units corresponding to 2 orders of magnitude (OoM)
difference in activity [6]. These threshold values have often been used to define
activity cliffs in various computational studies [4, 12]. Compound pairs with
ECFP4 Tc values of 0.55 or higher are typically structurally related [13] and
absolute potency differences of 2 OoM or more account for significant activity
cliffs within a data set [12].
Activity Landscape Features
The predefined molecular similarity and potency difference thresholds divide
the SAS maps into four distinct sections that represent the different activity
landscape features. The lower left portion is composed of compound pairs that
are chemically dissimilar but have similar potencies. Such pairs consist of com-
pounds having different molecular scaffolds or otherwise dissimilar structures
and are referred to as similarity cliffs [5]. Therefore, molecule pairs forming
similarity cliffs are located far apart in the chemical reference space.
Pairs of compounds contained in the lower right region exhibit high chemical
similarity and low potency differences. These are typically associated with
smooth landscape areas and accordingly, known as smooth pairs. The upper
right part of the SAS map comprises of activity cliffs, i.e., structurally related
compound pairs having large potency differences. The entire right section of the
SAS map is composed of molecule pairs that are located in close proximity in the
chemical space due to their high structural similarities. The upper left section
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containing structurally dissimilar compound pairs with large potency differences
forms the nondescript region and has relatively low SAR information. Hence,
similarity cliffs, smooth pairs and activity cliffs were considered as principal
activity landscape features [6].
Characterization of the activity landscape features derived from SAS maps
using compound pair frequencies and information entropy calculations has been
performed in a previous study [5]. From a statistical perspective, activity cliffs
are considered most informative due to their sparse distribution. By contrast,
similarity cliffs have relatively low information as they occur with high fre-
quency. However, from an SAR point of view, similarity cliffs provide impor-
tant information about chemically dissimilar compounds with similar potencies.
Smooth pairs are observed less frequently than similarity cliffs and therefore,
have moderate information content.
Per-compound Feature Probabilities
The core objective of the approach described in [6] has been the derivation of
landscape feature probabilities for individual compounds. The propensities of
every compound in a data set to form activity cliffs, similarity cliffs or smooth
pairs have been determined as feature probabilities. Feature combinations have
also been considered. Compound-based or local SAS maps that report pairwise
similarity and potency relationships formed by specific molecules have been in-
troduced in support of this methodology. Thus, using the information present
in a local SAS map for a given molecule, the frequencies with which it partic-
ipates in the formation of activity cliffs, similarity cliffs or smooth pairs have
been determined [6].
Crisp and Fuzzy Boundaries
Using predefined thresholds, pairwise structural similarity and potency differ-
ence relationships formed by a particular compound can be assigned to any
one of the four different regions according to their values. Nevertheless, assign-
ments of compound pairs to specific map regions are prone to boundary effects
if precise bounds as mentioned previously are applied. For example, small vari-
ation in similarity might determine if a compound pair falls into activity cliff or
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nondescript region. Furthermore, minute changes in potency differences might
distinguish between pairs of compounds classified as activity cliffs or smooth
pairs. Such dramatic shifts in classification resulting from small transitions
about the thresholds are not chemically meaningful.
Therefore, crisp threshold values have been replaced with fuzzy boundaries,
in order to balance the boundary effects that negatively affect feature assign-
ments. Twilight zones or boundary intervals have been introduced in order to
assign a weighted joint membership for neighboring landscape regions to the
compound pairs falling into these areas [6]. Due to its mathematical foundation
in fuzzy set theory concept [14], this approach made it possible to adhere to
the original data partitioning scheme of local SAS maps while softening the
boundaries between the different regions.
Thus, a Tc range of 0.45 to 0.65 represented the boundary interval for struc-
tural similarity while a range of one to two OoM marked the twilight region
for potency difference. The weighting schemes for compound pairs within the
similarity and potency difference twilight zones defined partial memberships to
neighboring regions and produced values that ranged between 0 and 1. Accord-
ingly, the fractional frequencies were also obtained for compounds when the
magnitude of partial memberships within the twilight regions was less than one
[6].
Conditional Probabilities for Fuzzy Landscape Features
An additional conditioning has been applied so that the ability of a given com-
pound to form similarity cliffs or activity cliffs is evaluated only with respect
to other compounds having similar potencies or similar structures, respectively.
The resulting conditional probabilities can be calculated from the probability of
a given feature by relating it to the frequencies of all compound pairs satisfying
the conditional relationship.
Hence, the respective conditional probabilities for a given compound k par-
ticipating in a set Vk of compound pairs have been generated as follows:
57
1. For a pair of compounds having similar potencies,
a. the probability to form a similarity cliff, P (S˜<|A˜<, Vk), is given by:
P (S˜<|A˜<, Vk) = |R˜00(k)||R˜00(k)|+ |R˜10(k)|
b. the probability to form a smooth pair, P (S˜≥|A˜<, Vk), is given by:
P (S˜≥|A˜<, Vk) = |R˜10(k)||R˜00(k)|+ |R˜10(k)|
2. and for a structurally similar compound pair,
a. the probability to form a smooth pair, P (A˜<|S˜≥, Vk), is given by:
P (A˜<|S˜≥, Vk) = |R˜10(k)||R˜10(k)|+ |R˜11(k)|
b. the probability to form an activity cliff, P (A˜≥|S˜≥, Vk), is given by:
P (A˜≥|S˜≥, Vk) = |R˜11(k)||R˜10(k)|+ |R˜11(k)|
where |R˜00(k)|, |R˜10(k)| and |R˜11(k)| correspond to the feature proba-
bilities for the formation of similarity cliffs, smooth pairs and activity cliffs,
respectively [6].
Although the conditional probabilities given by equations 1b and 2a esti-
mate the ability of a compound to form smooth pairs, they are distinct because
the probability in the first case is calculated for all compound pairs with sim-
ilar potency differences while in the second, it is computed for all structurally
similar pairs of compounds [6].
If the denominators of the conditional probabilities specified above become
very small, artificially high probabilities might be obtained. For example, this
situation would apply to the conditional probabilities calculated using equa-
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tions 2a and 2b if a compound had very few structural neighbors. Thus, de-
nominators (|R˜00(k)|+ |R˜10(k)| and |R˜10(k)|+ |R˜11(k)|) less than 2.0 were not
considered for probability calculations. In order to identify significant probabili-
ties, thresholds PT (S˜
<|A˜<, Vk), PT (S˜≥|A˜<, Vk), PT (A˜<|S˜≥, Vk), PT (A˜≥|S˜≥, Vk),
were determined at the 90th percentile using sorted conditional probabilities
P (S˜<|A˜<, Vk), P (S˜≥|A˜<, Vk), P (A˜<|S˜≥, Vk), P (A˜≥|S˜≥, Vk), respectively for a
representative collection of data sets. Probabilities greater than their corre-
sponding threshold values were considered significant [6].
Assessment of the respective significant conditional probabilities using a
large collection of data sets allows for the identification of exceptional probabil-
ities without taking into account their absolute magnitudes. For instance, due
to the relatively rare occurrences of activity cliffs, only very few compounds
in a data set are expected to form activity cliffs with their structurally similar
neighbors. As a result, comparatively low probabilities might be significant for
activity cliffs, although these probabilities would be substantially lower than
those for similarity cliffs that typically dominate activity landscapes.
Furthermore, the use of conditional feature probabilities is also conceptu-
ally advantageous, especially for data sets of small size. For example, the
conditional probability of a specific compound to form activity cliffs only takes
structural neighbors into consideration and the calculation is independent of
the dissimilarity relationships formed by this compound. The absolute feature
probabilities on the other hand are greatly affected by the number of dissimilar
compounds, making them difficult to interpret. These also reflect poorly on the
ability of a compound to form activity cliffs.
Refined Activity Landscape Features
The analysis of various landscape features can be refined further on the basis
of conditional probabilities. Since a compound can have high probability for
either category 1a or 1b and also for either category 2a or 2b, eight feature
(and feature combination) categories can be defined for SAR-relevant activity
landscape regions, as reported in Table 1. Utilizing the second conditioning,
probabilities can be assigned to a compound to form similarity cliffs, smooth
pairs, activity cliffs or different combinations of these features. For instance,
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category 1a in Table 1 represents compounds having a high probability to form
similarity cliffs with similarly potent compounds.
Table 1. Activity landscape feature probability classification
category type significance criterion activity landscape feature probabilities
0 - - no significance
1 1a P (S˜<|A˜<, Vk) > PT (S˜<|A˜<, Vk) similarity cliffs likely
2 1b P (S˜≥|A˜<, Vk) > PT (S˜≥|A˜<, Vk) smooth pairs likely/similarity cliffs unlikely
3 2a P (A˜<|S˜≥, Vk) > PT (A˜<|S˜≥, Vk) smooth pairs likely/activity cliffs unlikely
4 2b P (A˜≥|S˜≥, Vk) > PT (A˜≥|S˜≥, Vk) activity cliffs likely
5 1a, 2a P (S˜<|A˜<, Vk) > PT (S˜<|A˜<, Vk) similarity cliffs likely/activity cliffs unlikely
and
P (A˜<|S˜≥, Vk) > PT (A˜<|S˜≥, Vk)
6 1a, 2b P (S˜<|A˜<, Vk) > PT (S˜<|A˜<, Vk) similarity cliffs likely/activity cliffs likely
and
P (A˜≥|S˜≥, Vk) > PT (A˜≥|S˜≥, Vk)
7 1b, 2a P (S˜≥|A˜<, Vk) > PT (S˜≥|A˜<, Vk) similarity cliffs unlikely/activity cliffs unlikely
and
P (A˜<|S˜≥, Vk) > PT (A˜<|S˜≥, Vk)
8 1b, 2b P (S˜≥|A˜<, Vk) > PT (S˜≥|A˜<, Vk) similarity cliffs unlikely/activity cliffs likely
and
P (A˜≥|S˜≥, Vk) > PT (A˜≥|S˜≥, Vk)
Different activity landscape feature categories are reported. Categories consist of single
features or combinations of features. For each category, the significance criterion is given
and the corresponding landscape feature probabilities are described. (taken from Vogt et.
al[6])
The significance criterion is satisfied if the corresponding probability exceeds
the respective threshold. Likewise, compounds in category 2b have a high prob-
ability to form activity cliffs with immediate structural neighbors. Compounds
that are likely to form smooth pairs can be further differentiated depending on
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their inability to form similarity cliffs (category 1b) or activity cliffs (category
2a).
Four additional categories can be identified using combinations of these fea-
tures, given that a compound has similar activity or is structurally related to
other compounds. For example, combined category 1a-2a characterizes com-
pounds that are likely to form similarity cliffs and unlikely to form activity
cliffs. The opposite case is accounted for by category 1b-2b, i.e. compounds
that are likely to form activity cliffs but unlikely to form similarity cliffs.
The per-compound conditional probabilities as well as their corresponding
combinations calculated for all the compounds in a data set provide a refined
view of the activity landscape features and their distribution. These are derived
using full or partial memberships to different regions in the local SAS map [6].
Applications
Feature Probabilities and Thresholds
Conditional feature probabilities were calculated for 139 different activity anno-
tated compound sets obtained from BindingDB [15]. The corresponding thresh-
olds, i.e. PT (S˜
<|A˜<, Vk), PT (S˜≥|A˜<, Vk), PT (A˜<|S˜≥, Vk), PT (A˜≥|S˜≥, Vk), were
estimated from the combined conditional probabilities of all 139 data sets.
Compound Assignment
For each compound, assignment to a category was performed according to
the criteria outlined in Table 1 if the corresponding conditional probability
or a combination of conditional probabilities exceeded the respective thresh-
old. Few categories reported in Table 1 are mutually exclusive. For instance,
a compound cannot be assigned to categories 2a and 2b ( i.e. smooth pairs
likely/activity cliffs unlikely and activity cliffs likely). Other categories are not
exclusive and give rise to combined categories.
For example, a compound can be assigned to categories 1a and 2b (i.e. sim-
ilarity cliffs likely and activity cliffs likely), thus forming the combined category
1a-2b (i.e. similarity cliffs likely/activity cliffs likely). If a compound exceeded
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threshold values for single as well as a combination of features, it was assigned
to the combination.
Visualization and Exemplary Results
SAS maps can be utilized to visualize and characterize activity landscape fea-
tures as they provide a basis for the analysis described herein. However,
SAS maps are not suitable for analyzing feature probabilities of individual
compounds as these represent compound pairs. Network-like similarity graph
(NSG), a compound network-based activity landscape representation was uti-
lized for the visualization of feature probabilities and compound assignment as
the activity landscape is resolved at the level of individual compounds instead
of compound pairs [16].
In an NSG representation, compounds are depicted as nodes colored accord-
ing to their potency values from green (low potency) over yellow to red (high
potency) and edges denote similarity relationships. Compound pairs are con-
nected by an edge if their calculated ECFP4 Tc value is equal to 0.55 or greater.
In addition, nodes are scaled in size according to compound discontinuity scores
[16, 17].
Therefore, the larger the discontinuity introduced by the compound, the
larger the node. Activity cliffs represent extreme forms of SAR discontinuity in
an activity landscape [4]. Accordingly, in an NSG, the most prominent activity
cliffs present in a data set are displayed as combinations of large red and green
nodes connected by edges.
It should also be noted that the 2D arrangements of compounds and clusters
in an NSG have no chemical meaning. Instead, the placement of compounds
and the distances between them are determined by a graphical layout algorithm
such that densely connected subsets of similar compounds are separated for
clarity. In order to visualize compound feature probability information, nodes
are annotated with the assigned categories according to Table 1.
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Figure 1: Representative data sets. Complete NSG representation for data sets contain-
ing (a) serotonin receptor 7 and (b) endothelin receptor et-b ligands are shown. Compound
subsets in these representations are highlighted in blue. Enlarged views of these regions are
provided and the numbers of compounds in various categories are reported. (adapted from
Vogt et. al[6]) 63
Following the systematic derivation of feature probabilities for individual
compounds comprising all 139 data sets, significant differences were observed
in conditional feature probability distribution. A number of data sets were
identified that contained compounds belonging to one or two feature categories
while others were dominated by compounds belonging to diverse categories
without obvious preferences.
Varying numbers of compounds belonging only to categories 1 to 4 were
found in 27 data sets but no data set contained compounds belonging only to
feature combinations (categories 5 -8 ). Furthermore, it was also observed that
data sets typically contained different numbers of compounds with probabilities
lower than the respective thresholds (category 0 ). These compounds were less
likely to yield interpretable SAR information.
Selected data sets focusing on each of the eight feature categories (1 -8 )
according to Table 1 have been discussed further and the distribution of com-
pounds within these categories has been reported. These exemplary compound
sets demonstrate the variety of distributions observed and focus on individual
feature categories. Complete NSGs for these data sets with enlarged highlighted
sections for a detailed inspection has been utilized in the following as illustrated
in Figures 1-4.
The serotonin receptor 7 data set in Figure 1a consists of 117 compounds
that have a high probability to form similarity cliffs (category 1 ). Several of
these compounds have intermediate potencies and are structurally similar to
a limited number of other compounds. Additionally, many category 0 com-
pounds are also present in this data set. The conditional probabilities for these
compounds do not reach their corresponding threshold values, including one
within the selected subset. Thus, only limited SAR information content can be
obtained from this structurally diverse ligand set.
By contrast, majority of compounds in the endothelin receptor data set
as seen in Figure 1b belong to category 2. These compounds are likely to
participate in the formation of smooth pairs and unlikely to form similarity
cliffs. The NSG for this data set is dominated by densely connected compound
clusters, consistent with this observation.
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Figure 2: Representative data sets. Ligand sets for (a) melanocortin receptor 3 and (b)
melatonin receptor 1b are shown according to the global versus local view used in Figure 1.
(adapted from Vogt et. al[6])
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Analogously, several compounds that are likely to form smooth pairs but
unlikely to form activity cliffs (category 3 ) are observed in the data set con-
taining melanocortin receptor 3 ligands as shown in Figure 2a. The graphical
representation is characterized by structurally distinct subsets of compounds
with different SAR information content.
The melatonin receptor 1b data set contains 55 compounds that are most
likely to form activity cliffs (category 4 ). In the NSG and the densely connected
compound subset displayed in Figure 2b, prominent activity cliffs indicated
by combinations of large red and green nodes can be clearly identified. The
data set also contains several category 0 compounds of intermediate potencies.
These compounds illustrated as nodes of small size introduce very little SAR
discontinuity, although they are structurally related to activity cliffs. Category
4 and 0 compounds can not be differentiated on the basis of graphical represen-
tation alone. In such instances, compounds having a significant probability to
form activity cliffs can only be distinguished from others by taking into account
their conditional feature probabilities, thereby refining the activity landscape
view.
The data set containing plasmin inhibitors in Figure 3a includes com-
pounds belonging to category 5 that are likely to form similarity cliffs and un-
likely to form activity cliffs. A small subset of category 5 compounds connected
with those annotated as category 3, i.e. compounds likely to form smooth pairs
but unlikely to participate in activity cliff formation, is highlighted in the NSG.
The graphical representation does not support the distinction between these
compounds which can only be made on the basis of conditional probability
calculations.
The cathepsin k inhibitor set reported in Figure 3b consists of eight com-
pounds belonging to category 6 with significant probabilities for the formation
of similarity cliffs and activity cliffs. The selected cluster includes four of these
inhibitors, three of which have relatively low potency. Two compounds within
the subset form an activity cliff but are structurally distinct from the other two
as indicated by the absence of edges.
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Figure 3: Representative data sets. Inhibitor sets for (a) plasmin and (b) cathepsin k
data sets are shown. The arragement is consistent with the scheme used in Figure 1. (adapted
from Vogt et. al[6])
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In addition, the weakly potent cliff partner participates in the formation of
similarity cliffs with the remaining three compounds.
This information is evident from the graphical representation. The two ac-
tivity cliff partners are also connected to a category 4 compound that is likely to
form activity cliffs. Furthermore, two compounds within the selection also form
activity cliffs with compounds having a high probability to form smooth pairs
(category 2 ) that exhibit chemical and activity similarity. Therefore, this com-
pound subset is an example of a highly differentiated SAR micro environment
that can be identified on the basis of conditional probabilities.
The data set composed of furin inhibitors in Figure 4a contain 47 com-
pounds that are highly unlikely to participate in the formation of similarity
cliffs and activity cliffs. The densely connected cluster highlighted in Figure
4a contains all of these compounds. In addition, these inhibitors have compa-
rable potencies. Compounds within the subset belong to category 7, i.e. they
are structurally dissimilar to others in the data set and form smooth pairs with
each other.
Finally, as seen in Figure 4b, the cholecystokinin-1 receptor data set pre-
dominantly consists of compounds belonging to category 8 that are unlikely to
form similarity cliffs but likely to be involved in activity cliff formation.
Additionally, the subset also contains small numbers of category 0, 2 and
4 compounds. Many category 8 compounds in the cluster produce multiple
activity cliffs of large magnitude. Two weakly potent category 4 compounds
also participate in cliff formation with category 8 compounds in this cluster.
Overall, the cluster represents a rich source of SAR-relevant information as
indicated by the presence of many large red and green nodes.
Hence, the examples shown in Figures 1-4 clearly indicate that conditional
activity landscape feature probabilities provide a refinement to the landscape
views and aid in the differentiation of active compounds with respect to the
associated SAR information.
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Figure 4: Representative data sets. Data sets containing (a) furin and (b)
cholecystokinin-1 receptor ligands are shown according to the scheme used in Figure 1.
(adapted from Vogt et. al[6])
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Summary
A novel approach for the assignment of activity landscape features at the level
of individual compounds has been introduced and the derivation of conditional
feature probabilities using fuzzy boundaries to delineate the different activity
landscape regions formed the basis of this methodology. Utilization of fuzzy
boundaries results in partial feature memberships for compounds and balances
possible boundary effects. Conditional probabilities have been obtained from
pairwise chemical similarity and activity difference relationships between com-
pounds and the frequency derived feature analysis has been carried out for
individual compounds in a data set. Local SAS maps have been introduced
for this purpose. The resulting per-compound conditional feature probabilities
provides a conceptual advance in the analysis of activity landscape. Further-
more, conditional probability calculations have made it possible to derive eight
different feature categories from the existing three compound pair-based SAR-
relevant landscape regions, i.e. activity cliffs, smooth pairs and similarity cliffs.
Assignment of compounds to these categories allows their further distinction in
local SAR environments. These localized SAR environments were difficult to
interpret on the basis of graphical landscape representations alone, despite tak-
ing into account numerical SAR discontinuity measures. Herein, the emphasis
has been to demonstrate the differentiation of SAR micro environments using
compound conditional probabilities in these graphical representations. Thus,
the conditional probability calculations and the ensuing categorization scheme
further refine the current activity landscape views and aid in the systematic
SAR analysis at level of individual compounds.
The study reported herein has been published in reference [6] of this chap-
ter. My contributions to this study have been the systematic calculation of
conditional feature probabilities for the 139 data sets and the generation of
exemplary NSGs.
70
References
[1] Wassermann A. M., Wawer M., Bajorath J. Activity landscape representa-
tions for structure-activity relationship analysis. J. Med. Chem., 2010, 53,
8209-8223.
[2] Stumpfe D., Bajorath J. Methods for SAR visualization. RSC Adv., 2012,
2, 369-378.
[3] Maggiora G. M. On outliers and activity cliffs - why QSAR often disap-
points. J. Chem. Inf. Model., 2006, 46, 1535-1535.
[4] Stumpfe D., Bajorath, J. Exploring activity cliffs in medicinal chemistry. J.
Med. Chem., 2012, 55, 2932-2942.
[5] Iyer P., Stumpfe D., Vogt M., Bajorath J., Maggiora G. M. Activity land-
scapes, information theory, and structure-activity relationships. Mol. Inf.,
2013, 32, 421-430.
[6] Vogt M., Iyer P., Maggiora G. M. and Bajorath J. Conditional probabilities
of activity landscape features for individual compounds. J. Chem. Inf. Model.,
2013, 53, 1602-1612.
[7] Shanmugasundaram V., Maggiora G. M. Characterizing property and activ-
ity landscapes using an information-theoretic approach. 222nd ACS National
Meeting., 2001, Division of Chemical Information, Abstract no. 77.
[8] Willett P. Searching techniques for databases of two- and three-dimensional
structures. J. Med. Chem., 2005, 48, 4183-4199.
[9] Perez-Villanueva J., Santos R., Hernandez-Campos A., Giulianotti M. A.,
Castillo R., Medina-Franco J. L. Structure-activity relationships of benzim-
idazole derivatives as anti-parasitic agents: dual-activity difference (DAD)
maps. Med. Chem. Commun., 2011, 2, 44-49.
[10] Yongye A. B., Byler K., Santos R., Martínez-Mayorga K., Maggiora G. M.,
Medina-Franco J. L. Consensus models of activity landscapes with multiple
chemical, conformer, and property representations. J. Chem. Inf. Model.,
2011, 51, 2427-2439.
71
[11] Rogers D., Hahn M. Extended-connectivity fingerprints. J. Chem. Inf.
Model., 2010, 50, 742-754.
[12] 11. Stumpfe D., Bajorath J. Frequency of occurrence and potency range
distribution of activity cliffs in bioactive compounds. J. Chem. Inf. Model.,
2012, 52, 2348-2353.
[13] Wawer M., Bajorath J. Similarity-Potency Trees: a method to search for
SAR information in compound data sets and derive SAR rules. J. Chem. Inf.
Model., 2010, 50, 1395-1409.
[14] Zimmermann, H. -J. Fuzzy Set Theory. WIRES Computational Statistics,
2010, 2, 317-332.
[15] Liu T., Lin Y., Wen X., Jorissen R. N., Gilson M. K. Binding-DB: a
web-accessible database of experimentally determined protein-ligand binding
affinities. Nucleic Acids Res., 2007, 35, D198-D201.
[16] Wawer M., Peltason L., Weskamp N., Teckentrup A., Bajorath J.
Structure-activity relationship anatomy by network-like similarity graphs and
local structure-activity relationship indices. J. Med. Chem., 2008, 51, 6075-
6084.
[17] Peltason L., Bajorath J. SAR Index: quantifying the nature of structure-
activity relationships. J. Med. Chem., 2007, 50, 5571-5578.
72
Systematic SAR analyses using activity landscape representations focus on
the distribution of molecular similarities and activity data associated with
bioactive compounds. In the next chapter, the existing framework of landscape
modeling has been modified to integrate mechanism of action information of
receptor ligands.
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Chapter 4
Molecular mechanism-based
network-like similarity graphs
reveal relationships between
different types of receptor ligands
and structural changes that
determine agonistic,
inverse-agonistic and antagonistic
effects
Introduction
An important objective of SAR analyses is to examine the associations that
exist between chemical structures of bioactive compounds and their activity.
Biological targets may include different enzymes or receptors. Receptors are
important targets for therapeutic drugs. Pharmacological theory postulates
that the types of functional responses produced by chemical agents are deter-
mined by their interactions with target receptors. Thus, ligands can be classified
75
as full agonists, partial agonists, antagonists or inverse agonists, depending on
their mechanism of action. However, the mechanisms of action of ligands have
not been considered during typical SAR analyses thus far. A modified activity
landscape model has been introduced that accounts for the mechanistic infor-
mation of receptor ligands. This resulted in a graphical network representation
that combined systematic similarity and potency relationships in addition to
mechanism-related information. Simultaneous analysis of SAR and mechanism
of action is helpful in the identification of structurally similar compounds with
different mechanistic behavior. Following the inspection of such ligands, struc-
tural changes that lead to "mechanism hops" can be inferred.
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’ INTRODUCTION
Pharmacological effects of receptor ligands arise from diverse
mechanisms of action.1,2 For example, ligands might act as
agonists, partial agonists, inverse agonists, or antagonists. In
general terms, the mechanisms of these types of ligands can be
defined as follows: (1) An agonist binds to the physiological
ligand binding site of a receptor and activates it. (2) An antagonist
blocks this binding site and thereby prevents receptor activation
and signaling. (3) A partial agonist also competes with the natural
ligand but does not fully activate the receptor. (4) An inverse
agonist stabilizes an inactive conformation of a receptor and
thereby prevents activation and signal transduction.
Mechanistic effects are in general closely linked to different
conformational states, or conformational ensembles, of receptors
and their ability to interact with effector proteins. G protein-
coupled receptors (GPCRs), for which receptorligand inter-
actions are just beginning to be understood at the molecular level
of detail,3,4 are prime examples of receptors that engage in highly
complex mechanisms controlling functional effects.3 Differences
in the cellular context of GPCR-ligand interactions are also
known to alter pharmacological profiles of ligands,5 giving rise
to an intricate network of factors that ultimately determine
pharmacological effects. From amedicinal chemistry perspective,
it is often difficult to differentiate between different modes of
action of GPCR ligands and identify structural determinants of a
specific mechanism.6 Consequently, approaches that help to
reveal structural features that influence or determine the me-
chanism of action of GPCR or other receptor ligands are
particularly attractive for medicinal chemistry applications.
In recent years, molecular network representations have been
increasingly utilized to systematically account for ligand-target
interactions and predict targets of active compounds7 or analyze
structureactivity relationships (SARs).8 Such molecular net-
works make it possible to analyze large data sets using a
consistent representation frame and often provide graphical
access to unexpected ligand-target interactions7 or complex
SAR features.8 As such, they complement more traditional
approaches to analyze ligand-target interactions or SARs.
Given the often complex mechanistic spectrum of receptor
ligands, as discussed above, we have been interested in the design
of molecular network representations that help to compare
ligands with different mechanisms. Therefore, we have generated
similarity-based compound networks that incorporate mechan-
istic and SAR information. These graphical representations make
it possible to identify compounds that are related to each other
but act by different mechanisms and determine structural
features that lead to “mechanism hopping”.
’MATERIALS AND METHODS
Compound Data Sets. For five different GPCRs, ligand sets
were collected from the ChEMBL database.9 These data sets
were assembled to contain ligands having different mechanisms
of action including agonists, partial agonists, inverse agonists, and
antagonists. The composition of these compound sets is
Received: March 21, 2011
ABSTRACT: Receptor ligands might act as agonists, partial agonists, inverse
agonists, or antagonists and it is often difficult to understand structural modifica-
tions that alter the mechanism of action. In order to compare ligands that are
active against a given receptor but have different mechanisms of action, we have
designed molecular networks that mirror similarity relationships and incorporate
both mechanism of action information and mechanism-specific SAR features.
These network representations make it possible to systematically evaluate
relationships between different types of receptor ligands and identify commu-
nities of structurally very similar ligands with different mechanisms. From a series
of such ligands, structural modifications can often be deduced that lead to
“mechanism hops”.
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summarized in Table 1. The sets contained between 148 (AM1)
and 307 (AA1) ligands. In two of five cases, S1A and AM1, no
inverse agonists were available. All mechanistic annotations for
ligands taken from ChEMBL were extracted from original
literature sources. Molecules with both agonist and partial
agonist annotations were classified as partial agonists, and mol-
ecules designated as full agonists were classified as agonists. In
addition, ligands with only inverse agonist or both antagonist and
inverse agonist annotations were classified as inverse agonists,
owing to the observation that compounds that are apparent
GPCR antagonists act in many cases by an inverse agonist
mechanism.6 Ligands designated only as antagonists were classi-
fied as antagonists. As potency annotations, only Ki (or pKi) were
considered. If multiple Ki values were reported for a ligand in
original literature sources, the geometric mean was calculated to
yield a final potency value.
Network-like Similarity Graphs. The network-like similarity
graph (NSG) data structure10 is a similarity-based molecular
network representation that is annotated with additional infor-
mation layers. Nodes are molecules and edges between them
indicate pairwise similarity relationships. Nodes are color-coded
using a continuous spectrum to reflect the potency distribution in
a compound data set and scaled in size according to the
distribution of per-compound discontinuity scores. The per-
compound discontinuity score indicates the amount of local
SAR discontinuity a compound introduces.10 Hence, a
compound that greatly differs in potency from its immediate
structural neighbors makes a large contribution to local SAR
discontinuity, and, accordingly, the corresponding node is large.
NSGs are generated utilizing the Java implementation in the
publicly available SARANEA program11 and applying a graphical
layout algorithm12 that places densely connected compound
subsets in close proximity and separates weakly interconnected
regions (compound clusters) from each other. NSGs are usually
generated for a set of compounds active (with different potencies)
against a given target, i.e. a compound activity class.
Mechanism-Based NSGs. In order to compare receptors
ligands with different mechanisms of action using a consistent
representation frame, we designed an NSG variant that incorpo-
rates mechanism of action information. Therefore, the NSG
data structure was modified in different ways, as further
detailed in the Results and Discussion section. Pairwise similarity
relationships were calculated using the stereochemistry-sensitive
Extended Connectivity Fingerprint with bond diameter 4
(ECFP4)13 as implemented in Pipeline Pilot.14 An ECFP4
Tanimoto coefficient (Tc) value of 0.4 was applied as the
similarity threshold for edges between nodes. This ECFP4 Tc
value roughly corresponds to a MACCS structural keys15
Tc value of 0.8 and indicates the presence of compounds with
visible structural similarity. Different from NSGs, nodes were
not calculated by potency, but rather by mechanism, using the
following color scheme: agonists, blue; partial agonists, green;
inverse agonists, gray; antagonists, red. For each mechanistic
class (compound subset), potency information was conveyed
by shading, i.e. for each mechanism color, a continuous shade
spectrum from transparent (lowest potency) to opaque (highest
potency) was applied. These graphs were implemented in Java,
further extending the SARANEA implementation,11 and termed
Mechanism-based NSGs (M-NSGs). Table 2 summarizes the
design elements of M-NSGs.
’RESULTS AND DISCUSSION
Graph Design.M-NSG generation involved different types of
calculations, either for an entire ligand set or for each separate
mechanism-based subset. First, the graph layout was computed
for a complete ligand set after calculating pairwise Tanimoto
similarity for all ligands, regardless of their mechanisms of action,
thus providing the similarity-based compound network, in
analogy to original NSGs. Then, however, similarity- and po-
tency-based discontinuity scores were separately calculated for
each ligand subset. On the basis of subset-specific discontinuity
scores, the nodes of ligands sharing the same mechanism were
scaled in size, hence providing SAR information for each
mechanism-based subset. Node scaling is interpreted in the
following manner: the larger a node, the higher the degree of
SAR discontinuity the compound introduces; combinations of
connected medium to large nodes represent discontinuous local
SARs and combinations of small nodes continuous local SARs.
Finally, mechanism and compound potency information was
Table 1. Receptor Ligand Setsa
pKi
target receptor
ligand
mechanism
no. of
compounds maximum minimum
adenosine A1
receptor (AA1)
agonist 107 9.8 4.9
partial agonist 54 8.7 5.3
antagonist 94 9.5 6.0
inverse agonist 52 9.4 4.2
muscarinic
acetylcholine
receptor M1 (AM1)
agonist 26 8.6 3.6
partial agonist 49 9.5 4.5
antagonist 73 10.0 4.5
dopamine D2
receptor (DD2)
agonist 40 9.0 5.6
partial agonist 44 9.7 6.2
antagonist 76 9.8 6.6
inverse agonist 13 11.5 6.1
histamine H3
receptor (H3R)
agonist 44 9.6 4.9
partial agonist 46 9.1 5.0
antagonist 92 10.0 6.8
inverse agonist 31 10.1 5.8
serotonin 1a
receptor (S1A)
agonist 46 10.2 5.4
partial agonist 78 10.1 4.9
antagonist 63 9.4 6.4
aReceptor abbreviations are used in the text to designate ligand sets.
Table 2. M-NSG Design Elements
mechanism color node size shading edge layout
agonist blue mechanism-specific per compound discontinuity score potency range Tanimoto similarity >0.4 connectivity-based
partial agonist green
antagonist red
inverse agonist gray
1283 dx.doi.org/10.1021/ci2001378 |J. Chem. Inf. Model. 2011, 51, 1281–1286
Journal of Chemical Information and Modeling ARTICLE
incorporated through color and shade coding. Each ligand
mechanismwas assigned a specific color, and compounds sharing
the same mechanism were shaded according to their potency
level (within the potency range in the subset). Hence, combina-
tions of the largest transparent and opaque nodes sharing the
same color mark the most prominent activity cliffs that occur in
each subset. Activity cliffs are structurally similar compounds
with very different potency (representing the extreme form of
SAR discontinuity).8 On the basis of these design components,
M-NSGs provide similarity and mechanism information across
an entire receptor ligand set and, in addition, relative potency and
SAR information for each mechanism-specific subset. Thus,
M-NSGs also contain all the information provided by NSGs of
individual compound sets sharing a specific mechanism of action.
Because SAR information can also be obtained from NSGs of
individual mechanism-based ligand subsets, we predominantly
focus in the following on the exploration of mechanism hopping
and underlying structural changes, for which M-NSGs are
specifically designed.
Ligand M-NSGs. Figure 1 shows the M-NSG representations
for the five receptor ligand sets in Table 1. The M-NSG of the
AA1 ligand set in Figure 1a reveals a central graph component
(region 1) and several other densely connected compound
clusters. In many instances, these clusters mostly, or exclusively,
consist of ligands having the same mechanism, e.g. antagonist
clusters (red nodes). The central graph component contains
partial (green), full agonists (blue), a few inverse agonists (gray),
and many differently sized nodes. This indicates the presence of
substantial SAR information for agonists in this region. Similarly,
the mostly gray-scaled compound community (region 2) at the
bottom in Figure 1a contains many inverse agonists with
differently sized nodes and a few antagonists having small nodes.
Although the AA1 M-NSG displays a notable clustering of
compounds by mechanism, there are exceptions, in particular,
a densely connected community of ligands with all four mechan-
isms of action (region 3). Such densely connected mechanisti-
cally heterogeneous ligand communities represent prime
candidates for further analysis to explore the structural basis of
mechanistic changes among similar ligands. In addition, mechan-
istically more homogeneous regions such as the central graph
component in Figure 1a are a source of SAR information for
compounds sharing the same or similar mechanisms.
The DD2 M-NSG in Figure 1b represents the smallest of the
five data sets and is characterized by the presence of structurally
diverse compounds. Structural diversity is mirrored by the
low edge density in the graph. The most notable feature of the
DD2 M-NSG is its largest ligand community in the center of
Figure 1b (region 1) that also contains compounds with all four
mechanisms of action.
By contrast, the H3R M-NSG in Figure 1c is characterized by
the presence of a densely connected central graph component
that essentially consists of four separate ligand communities that
are connected via compound bridges. These include two antago-
nist communities (regions 1 and 2) with different node size and
potency distributions and, in addition, two other communities
that are characterized by distinct mechanistic heterogeneity
(regions 3 and 4). In particular, the community in the center
of Figure 1c (region 4) consists of very similar ligands that cover
the entire spectrum of mechanisms and thus provides a focal
point for further analysis.
Different from the ligand sets discussed so far the remaining
AM1 and S1A sets in Figure 1d and 1e, respectively, do not
contain inverse agonists. The AM1 M-NSG shows a notable
clustering of different series of compounds by mechanism.
However, in some cases, individual ligands with different me-
chanisms occur in an otherwise mechanistically homogeneous
cluster including, for example, a weakly potent antagonist found
in a partial agonist community (region 1 in Figure 1d), another
single antagonist in an agonist/partial agonist community (region 2),
and a weakly potent partial agonist within an antagonist com-
munity (region 3). Such observations might raise the question as
to whether the mechanisms of these individual ligands located in
an otherwise mechanistically homogeneous environment have
been correctly identified and might thus suggest further experi-
mental evaluation. In addition, another small community (region 4)
shows a sequence of agonists with increasing potency where
structural neighbors of potent agonists include partial agonists
and a weakly potent antagonist, which represents another inter-
esting and perhaps puzzling mechanistic pattern. Furthermore,
another ligand community is encircled in Figure 1d (region 5)
that contains multiple agonists, partial agonists, and antagonists
with different potencies.
The S1A M-NSG in Figure 1e also contains both mechan-
istically homogeneous and heterogeneous ligand communities.
For example, two densely connected ligand communities are
observed (regions 1 and 2) that each comprise multiple partial
agonists and multiple antagonists. Furthermore, region 3 in the
S1A M-NSG contains a pair of compounds representing an
agonist/antagonist hop and a small community of structurally
related ligands including an antagonist, an agonist, and two
partial agonists.
Mechanism Hopping. Selected mechanistically heteroge-
neous ligand communities were analyzed in detail to explore
structural modifications that lead to mechanistic changes.
M-NSG regions shown in Figure 2 are labeled with red numbers
in Figure 1. In each community, a series of analogs were identified
that revealed structural changes altering their mechanisms of
action.
The series of AA1 ligands in Figure 2a includes agonists, partial
agonists, inverse agonists, and an antagonist. All of these ligands
are analogs and only distinguished by different substituents at the
same site, i.e. a meta-position of the phenyl ring. An agonist
(ligand 1) contains a hydroxyl group at this position. Ligands
with a methoxy or methyl group (2 and 3) are partial agonists,
and the same mechanism is observed for a fluorine substituent
(4). However, changing the fluorine atom to a difluoromethy-
lether group converts an agonist (4) into an antagonist (5).
Moreover, changing this group to either a trifluoromethylether
or trifluoromethyl substituent generates inverse agonists (6 and
7). Thus, ligands taken from a mechanistically heterogeneous
region in the AA1M-NSG reveal substitutions at a single site that
alter the mechanism of action in different ways.
The largest ligand community in the DD2 M-NSG contains
three tetraline analogs with different mechanisms that are shown
in Figure 2b. These analogs include an agonist (ligand 1),
antagonist (2), and inverse agonist (3). Here substitutions at
multiple positions in both rings and different stereochemistry at
the aliphatic ring distinguish the inverse agonist and antagonist
from the agonist.
Five ligands from a mechanistically highly heterogeneous
region of the H3R M-NSG shown in Figure 2c include an
agonist, a partial agonist, two antagonists, and an inverse agonist.
Their structures are distinguished by the length of the aliphatic
linker between the imidazole ring and the terminal amine and, in
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Figure 1. M-NSGs. Graph representations are shown for each complete ligand set according to Table 1 (agonists, blue; partial agonists, green; inverse
agonists, gray; antagonists, red). Regions of the graph discussed in the text are encircled and numbered. Regions with red numbers are shown in detail in
Figure 2. (a) AA1, (b) DD2, (c) H3R, (d) AM1, (e) S1A. In each M-NSG, selected ligand communities are indicated.
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addition, by substitutions at this amino group. Comparison of
ligands 14 reveals that the linker length is not responsible for
agonistic versus antagonistic effects. Rather, the introduction of
an N,N-diethylamino group (in ligands 3 and 4) generates
antagonists. If the N,N-diethylamine is changed to an N-tertiary
butyl group, an inverse agonist is obtained. Clearly, mechanistic
changes can in this case be attributed to the substitutions at the
terminal amino group.
Figure 2. Ligand communities. For each data set, selected ligand communities are displayed (communities with red numbers in Figure 1). For each
community, a series of ligands is shown that include mechanism hops. In the community graphs, nodes representing pairs of these ligands that constitute
mechanism hops are connected by black edges. Compounds and the corresponding nodes are numbered. Structural modifications in ligands are
highlighted, and they are displayed on a background representing their node colors (mechanisms). (a) AA1, (b) DD2, (c) H3R, (d) AM1, (e) S1A.
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The series of AM1 ligands in Figure 2d contains five agonists
or partial agonists (ligands 15) and two antagonists (6 and 7).
Both agonists and antagonists contain two forms of a bridged
hetereoaliphatic ring, which can thus not be responsible for
changes in the mechanism of action. By contrast, mechanism
hopping from agonists to antagonists is caused by the introduc-
tion of a phenyl substituent at the ester moiety, instead of a small
aliphatic group or a cyclohexyl ring. Comparisons of ligands 2
and 6 and of ligands 5 and 7 reveal that the replacement of the
cyclohexyl by the benzene ring, i.e. the introduction of an
aromatic ring at this position, converts partial agonists into
antagonists, another well-defined chemical modification.
In Figure 2e, a pair of S1A ligands is shown (1 and 2) that are
also tetraline derivatives, similar to the ligands in Figure 2b.
This chemotype is active against both dopamine and serotonin
receptors. The two ligands in Figure 2e represent a mechanism
hop from an agonist to an antagonist. In both analog series in
Figure 2b and 2e, we observe that the stereochemistry at the
nitrogen is a differentiating feature between agonists and
antagonists. Ligands 1 and 2 in Figure 2e are further distin-
guished by a fluorine substituent. In addition, Figure 2e also
shows another series of S1A ligands (3 to 6) containing a
condensated ring system as their core structure. Here different
core ring stereochemistry is observed as well as modifications at
a phenyl moiety. The two partial agonists (ligands 3 and 4)
differ from the full agonist (5) in a ring stereoisomer and a
methyl-tetrahydrofuran fused to the phenyl moiety that is only
present in the full agonist. However, the agonist and the
antagonist (6) in this series are nearly identical; they only differ
in the stereoisomer of the methyl substituent at the tetrahy-
drofuran ring. Thus, in this case, a subtle stereochemical
difference involving a single methyl group in chemically com-
plex and rigid receptor ligands triggers a change in the mechan-
ism of action from an agonist to an antagonist.
’CONCLUSIONS
Herein we have introduced a graphical analysis tool that
incorporates molecular mechanism of action information. The
M-NSG data structure makes it possible to graphically analyze
sets of receptor ligands with different mechanisms of action and
identify mechanistically heterogeneous communities of structu-
rally similar compounds. In the M-NSG implementation, nodes
are directly associated with compound structures for interactive
display. Hence, compound subsets can be easily selected and
further analyzed to explore structural modifications that might
lead to mechanistic changes. M-NSG analysis has been carried
out for five sets of GPCR ligands acting by three or four different
mechanisms. In a number of instances, well-defined structural
changes were identified in analog series prioritized on the basis of
M-NSG analysis that distinguished between ligands with differ-
ent mechanisms. For closely related receptors (e.g., isoforms), it
might also be possible to pool active compounds by mechanism
and study these sets in M-NSGs in order to search for structural
changes that might be responsible for similar mechanistic effects
across multiple receptors.
’AUTHOR INFORMATION
Corresponding Author
*Phone: þ49-228-2699-306. Fax: þ49-228-2699-341. E-mail:
bajorath@bit.uni-bonn.de.
’REFERENCES
(1) Kenakin, T. Principles: Receptor Theory in Pharmacology.
Trends Pharmacol. Sci. 2004, 25, 186–192.
(2) Zhu, B. T. Mechanistic Explanation for the Unique Pharmaco-
logic Properties of Receptor Partial Agonists. Biomed. Pharmacol. 2005,
59, 76–89.
(3) Rosenbaum, D. M.; Rasmussen, S. G.; Kobilka, B. K. The
Structure and Function of G Protein-Coupled Receptors. Nature
2009, 459, 356–363.
(4) Sprang, S. R. Binding the Receptor at Both Ends. Nature 2011,
469, 172–173.
(5) Nelson, C. P.; Challiss, R. A. ‘Phenotypic’ Pharmacology: the
Influence of Cellular Environment on G Protein-Coupled Receptor
Antagonist and Inverse Agonist Pharmacology. Biochem. Pharmacol.
2007, 73, 737–751.
(6) Greasley, P. J.; Clapham, J. C. Inverse Agonism or Neutral
Antagonism at G Protein-Coupled Receptors: a Medicinal Chemistry
Challenge worth Pursuing? Eur. J. Pharmacol. 2006, 553, 1–9.
(7) Keiser, M. J.; Irwin, J. J.; Shoichet, B. K. The Chemical Basis of
Pharmacology. Biochemistry 2010, 49, 10267–10276.
(8) Wassermann, A. M.; Wawer, M.; Bajorath, J. Activity Landscape
Representations for Structure-Activity Relationship Analysis. J. Med.
Chem. 2010, 53, 8209–8223.
(9) ChEMBL; European Bioinformatics Institute (EBI): Cambridge,
2010. http://www.ebi.ac.uk/chembl/ (accessed March 2, 2011).
(10) Wawer, M.; Peltason, L.; Weskamp, N.; Teckentrup, A.;
Bajorath, J. Structure-Activity Relationship Anatomy by Network-like
Similarity Graphs and Local Structure-Activity Relationship Indices.
J. Med. Chem. 2008, 51, 6075–6084.
(11) Lounkine, E.; Wawer, M.; Wassermann, A. M.; Bajorath, J.
SARANEA: A Freely Available Program toMine StructureActivity and
StructureSelectivity Relationship Information in Compound Data
Sets. J. Chem. Inf. Model 2010, 50, 68–78.
(12) Fruchterman, T. M. J.; Reingold, E. M. Graph Drawing by
Force-directed Placement. Software  Pract. Exper. 1991, 21, 1129–
1164.
(13) Rogers, D.; Hahn, M. Extended-Connectivity Fingerprints.
J. Chem. Inf. Model. 2010, 50, 742–754.
(14) Scitegic Pipeline Pilot, Student ed.; Version 6.1; Accelrys, Inc.:
San Diego, CA, 2007.
(15) MACCS Structural Keys; Symyx Software: San Ramon, CA,
2005.
 
Summary
This chapter outlines a computational methodology to systematically analyze
the mechanism of action information associated with ligand sets for target
receptors in addition to their molecular similarity and activity distribution.
Chemical similarity is accessed using molecular fingerprint representation dur-
ing the generation of these network-based activity landscapes. This results in
a graphical organization of both SAR and mechanism-specific content underly-
ing various receptor ligand sets. Such combined views highlight ligand subsets
with mechanistic homogeneity and heterogeneity. Further exploration of these
heterogeneous compound clusters reveal chemical substitutions that introduce
mechanistic transitions. In addition, SAR trends present in compounds with a
given mechanism of action help to identify structural modifications that lead
to improvements in potency.
A second activity landscape representation that incorporates mechanism of ac-
tion information is introduced in the next chapter.
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Chapter 5
Mechanism-based bipartite
matching molecular series graphs
to identify structural modifications
of receptor ligands that lead to
mechanism hopping
Introduction
Identification of chemical substitutions that improve or adversely affect com-
pound potencies help in deducing SAR rules necessary for compound optimiza-
tion. Computational techniques based on molecular fingerprint representations
require close examination of the 2D structures to identify such modifications.
However, the matched molecular pair (MMP) paradigm helps to readily identify
those structural changes that are favorably associated with activity. MMPs are
formed by pairs of compounds that differ only by a single substructure exchange
[1]. MMP-based similarity criterion has recently been applied in the design of
a novel graphical tool with the objective of illustrating substructure relation-
ships within compound data sets. This approach has been extended to account
for mechanism of action information to highlight those chemical replacements
that lead to mechanistic switches or mechanism hops with relative ease. Fur-
87
ther, organization of substructures in a hierarchy aids in the identification of
increasingly smaller substructure changes involved in mechanism hopping.
[1] Kenny P. W., Sadowski J. Structure modification in chemical databases.
In Oprea T. I. (Ed.), Chemoinformatics in Drug Discovery, Wiley-VCH,
Weinheim, Germany, 2004, 271-285.
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Mechanism-based bipartite matching molecular series graphs to identify
structural modifications of receptor ligands that lead to mechanism hopping
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The rationalization of structural features that distinguish between different mechanisms of action of
ligands active against a given receptor is of high importance in medicinal chemistry and drug design.
We have adapted a bipartite molecular network structure that organizes compound datasets on the
basis of substructure relationships to incorporate mechanism of action information. The resulting data
structure readily identifies subsets of ligands with different mechanisms of action that display well-
defined structural relationships. From the structural subset organization of the graph, structural
changes that lead to mechanism hopping (i.e., a transition from one mechanism of action to another)
can be directly selected, as demonstrated for different classes of receptor ligands. For medicinal
chemistry applications, the ability to immediately access structural modifications that distinguish
ligands having different mechanisms of action is a key aspect of the methodology introduced herein.
The knowledge of substituents in receptor ligands that trigger mechanistic changes can be utilized for
compound design.
Introduction
Compounds that are active against a given receptor often display
different mechanisms of action that ultimately lead to receptor
activation or inactivation.1–3 The mechanistic spectrum of
receptor ligands and the ensuing functional effects are often more
complex, and even more difficult to understand, than mecha-
nisms of enzyme inhibitors, which might sterically block access to
a catalytic site or act as transition state analogs,4,5 or mechanisms
of allosteric enzyme activators.6 In medicinal chemistry, under-
standing structural features that determine the mechanisms of
action of different types of receptor ligands represents a chal-
lenging task of central relevance.2,3 For receptor ligands, it is
often very difficult to discern the molecular basis of different
mechanistic and functional effects.2
Mechanism of action studies are typically carried out in the
context of compound structure–activity relationship (SAR)
analysis. In order to extract SAR information from large and
chemically diverse compound datasets, numerical SAR analysis
functions and molecular network representations have increas-
ingly been used.7–9 Similarly, network representations have also
been utilized to systematically account for ligand–target associ-
ations and explore the molecular basis of compound
pharmacology.10,11
In order to further refine SAR investigations of receptor
ligands, similarity-based compound networks might also be
annotated with mechanistic information. For this purpose,
network-like similarity graphs (NSGs)12 have recently been
employed. The NSG structure captures compounds as nodes that
are connected by edges if pair-wise compound similarity reaches
a pre-defined threshold level. Nodes and edges can be annotated
with additional information. Typically, nodes are color-coded by
compound potency to provide a basis for graphical SAR anal-
ysis.12 However, in order to incorporate mechanistic information
into these network representations, a molecular mechanism-
based color code for nodes has also been introduced in the design
of an NSG variant.13 In this case, subsets of structurally similar
compounds with different mechanisms of action can be identified
in the graph representation and selected from ligand datasets.
A general feature of all similarity-based compound networks
introduced until recently is that they rely on calculated whole-
molecule similarity,8 typically Tanimoto similarity14 of chosen
molecular representations (such as fingerprints). While the
calculation of Tanimoto similarity is usually appropriate for
chemoinformatics tasks including network analysis, its use is
often insufficient for medicinal chemistry applications. This is the
case because in medicinal chemistry, a major focus is the iden-
tification of regions in molecules and structural modifications
that determine observed SAR characteristics of a compound
series or a specific mechanism of action. These ‘‘local’’ and
pharmacophore-type analyses are difficult to carry out on the
basis of calculated whole-molecule similarity relationships and
typically require subsequent structural comparisons.8 For
example, if compounds share 75% global structural similarity,
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they still need to be individually compared in order to deduce
structural changes that might determine their SAR and/or
mechanistic features. This general shortcoming of whole-mole-
cule similarity assessment also affects mechanistic comparisons
on the basis of NSGs.13 In this case, similar ligands with different
mechanisms of action must be selected from the network repre-
sentation and their structures must subsequently be analyzed in
order to understand modifications that lead to mechanism
hopping. Importantly, the network representation itself does not
reveal such changes.
In order to address limitations in structural interpretability
associated with calculated whole-molecule similarity values,
a molecular network structure termed bipartite matching
molecular series graph (BMMSG) has recently been intro-
duced.15 In this case, calculated similarity values are replaced
with defined substructure relationships. This is facilitated by
systematically determining all possible substructure relationships
between dataset compounds utilizing the matched molecular pair
(MMP) formalism.16 AnMMP is defined as a pair of compounds
that only differ by the exchange of a single substructure (or, in
other words, by a single chemical transformation), for example,
a specific R-group or ring.
In BMMSGs, structural relationships between MMP
compounds are also indicated by edges, in analogy to calculated
pair-wise similarity values utilized for other network represen-
tations. Compared to conventional similarity-based networks,
a major advance provided by the BMMSG data structure is that
this network immediately reveals structural modifications that
distinguish compounds from each other. This enhanced chemical
interpretability is also the major attraction of the MMP-based
compound network for medicinal chemistry applications.
Because a major goal of mechanism of action studies in
medicinal chemistry is the identification of structural features of
active compounds that are responsible for a specific mechanism,
we introduce an extension of the BMMSG structure that incor-
porates mechanism of action information and makes it readily
possible to determine structural changes implicated in mecha-
nism hopping. Structural subset hierarchies derived from the
graph representation provide high-resolution views of structural
modifications of compound frameworks that lead to different
mechanisms of action in pairs of molecules and analog series.
Methods
Matched molecular pairs
For dataset compounds, MMPs were systematically generated
using an in-house implementation of the algorithm of Hussain
and Rea.17 Following this approach, single bonds that are not
part of a ring system are systematically deleted. The process
yields a table of fragment pairs. Fragments shared by molecule
pairs are termed keys while distinguishing substructures are
recorded as values for these keys. If one single bond is deleted
(‘‘single cut’’), a compound yields two fragments. Each of these
fragments is then once indexed as a key and the other as the
associated value. If two single bonds (‘‘double cut’’) or three
single bonds (‘‘triple cut’’) are deleted, a core fragment and two
or three substituents are produced, respectively. These substitu-
ents are collectively stored as the key and the core fragment as the
corresponding value. All MMPs are identified from the index by
searching for keys having more than one value. In our imple-
mentation, compound pairs only qualify as MMPs if values do
not contain more heavy atoms than keys. However, this restric-
tion is not an essential feature and can easily be omitted if
compounds with small core structures (e.g., a single ring) are
under investigation. Routines to generate and display MMPs
were implemented in Java using the OpenEye chemistry toolkit.18
Bipartite graph representation
The MMP table is utilized as a source for the generation of
a bipartite graph consisting of two types of nodes, i.e., key nodes
and molecule nodes.15 Keys are displayed if they are associated
with more than one value. A key node is connected through edges
to all nodes of molecules that contain this key fragment.
Accordingly, edges correspond to values and are graphically
associated with value fragments.
A matching molecular series (MMS) is defined as a series of
compounds that only differ by a single structural change at
a specific site. Accordingly, each key node represents an MMS,
which can overlap because a compound that differs at one site
from a subset of molecules might differ at another site from
another subset. All molecules of a series that are only connected
to a single key node can be represented as a ‘‘super node’’. It
displays the key node as a rectangle that contains all compound
nodes shown as individual squares. If a key describes a subset of
a series represented by another, it is omitted from the graph to
reduce visual complexity. However, subset relationships between
all keys are displayed in a separate subset hierarchy (as further
detailed in the Results and discussion section). Because the
BMMSG structure captures all possible MMS in a dataset, its
edges (values) comprehensively represent all substructural rela-
tionships between dataset compounds. In the original BMMSG
implementation, all molecule nodes were colored according to
compound potency to enable SAR analysis.15
Molecular mechanism-based BMMSG
In our receptor ligand analysis, four different mechanisms of
action were considered: (1) agonist (activates a receptor through
Table 1 Receptor ligand setsa
Target Class
Ligand
mechanism
No. of
compounds
Potency (Ki)
Min/mM Max/nM
Adenosine A1
receptor
AA1 Agonist 107 12 0.2
Partial agonist 54 5 2
Antagonist 52 66 0.4
Inverse agonist 94 1 0.3
Muscarinic
acetylcholine
receptor M1
AM1 Agonist 26 282 2.5
Partial agonist 49 29 0.3
Antagonist 73 30 0.1
Histamine
H3 receptor
H3R Agonist 44 11 0.3
Partial agonist 46 10 0.9
Antagonist 31 2 0.08
Inverse agonist 92 0.2 0.1
a For three receptor ligand datasets, the target name, class abbreviation,
mechanisms of action, compound numbers, and minimum and maximum
potency values are reported.
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binding to its primary ligand binding site), (2) partial agonist
(also competes with the physiological receptor ligand but does
not exhibit full activation potential), (3) antagonist (prevents
receptor activation by blocking the primary ligand binding site),
and (4) inverse agonist (stabilizes an inactive conformation of the
receptor and thus prevents activation).
In order to incorporate mechanism of action information into
BMMSG representations, we introduced a mechanism-based
node coloring scheme as previously suggested for NSGs.13 Nodes
representing agonists were colored blue, nodes representing
partial agonists green, antagonists red, and inverse agonists gray.
Furthermore, compound potency information was accounted for
by shading such that darker shades indicate increasing and
lighter shades decreasing potency values (with the degree of
shading scaled according to the overall potency range within
each subset of ligands having a specific mechanism). In contrast
to molecule nodes, all key nodes were colored white. These graph
representations were implemented using the Java package
JUNG.19 The graph layout was generated separately for each
subgraph (see Results and discussion) using a JUNG imple-
mentation of an algorithm to display self-organizing maps.
Datasets
Compounds active against three G protein coupled receptors
(GPCRs) with different mechanisms of action were assembled
from ChEMBL.20 Mechanistic annotations for these receptor
ligands were taken from the original publications. Molecules
were classified as agonists, partial agonists, antagonists, and
inverse agonists, provided the mechanism was uniquely defined.
In the case of multiple annotations, the following rules were
applied. If agonist and partial agonist activities were reported,
ligands were classified as partial agonists. If antagonist and
inverse agonist activities were reported, ligands were classified as
inverse agonists (because apparent antagonists are often found to
be inverse agonists3). To ensure consistency in the use of potency
measurements, only Ki values were considered as potency
annotations. For compounds with multiple Ki measurements,
the geometric mean was calculated. The composition of the
receptor ligand datasets is summarized in Table 1.
Results and discussion
Exemplary graph representation
In Fig. 1, the design elements of the mechanism-based BMMSG
(M-BMMSG) are illustrated. Fig. 1a shows a graphical repre-
sentation with all key nodes (white) and molecule nodes (with
mechanism-based coloring) for a model dataset. Each key node
Fig. 1 Prototypic graph. A schematic representation of the mechanism-
based BMMSG structure is shown. (a) The graph for an exemplary
dataset that contains all possible key nodes is displayed. These key nodes
(numbered 1–9) are colored white whereas all molecule nodes are colored
according to their mechanisms of action (agonists: blue, partial agonists:
green, antagonists: red, and inverse agonists: gray) and shaded according
to the compound potency. The structures of correspondingmolecules and
keys (shared fragments) are shown in black and gray, respectively.
Substituent positions in key fragments are indicated by asterisks. (b) The
reduced graph is shown after removal of key nodes involved in subset
relationships. Keys 1 and 4 are now represented as (single compound-
containing) super nodes. In addition, values associated with keys, i.e., the
structures of substituents, are displayed (in brown) next to the edges
representing them. (c) The hierarchical subset relationship between keys 1
and 9 is displayed. Here, all compounds associated with these keys are
contained in super nodes.
This journal is ª The Royal Society of Chemistry 2012 Med. Chem. Commun., 2012, 3, 441–448 | 443
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represents the common substructure (core) of all molecule nodes
connected to it. In key nodes, attachment points for substituents
are labeled with asterisks (the minimal structural modification
distinguishing a key and a molecule is the hydrogen substituent).
The set of molecules attached to each key node represents an
MMS. The graph also illustrates that individual molecules might
belong to different series based on their substitution patterns.
Fig. 1b shows the M-BMMSG following removal of three key
nodes (2, 3, and 9) that are involved in subset relationships and
introduction of super nodes. This reduced graph is utilized as the
standard representation for the display of compound datasets.
The structures of substituents that distinguish keys and mole-
cules from each other are shown next to their edges. In Fig. 1c, an
exemplary subset hierarchy involving keys 1 and 9 is shown. Key
9 was removed from the graph because the series it represents is
a subset of the one represented by key 1. As further discussed in
the following, subset hierarchies are displayed in separate tree
structures that complement the M-BMMSG representation and
help to elucidate structural changes implicated in mechanism
hops.
Dataset representations
Fig. 2 shows the final (reduced) M-BMMSGs for the three
different receptor ligand sets we analyzed. The graphs of the
complete datasets consist of different disjoint subgraphs.
Compounds in each subgraph do not form substructure rela-
tionships with compounds in other subgraphs. The topology of
the three M-BMMSGs in Fig. 2 notably differs, which indicates
the presence of different structural relationships and different
degrees of structural diversity among the ligands in these sets.
The AA1 set in Fig. 2a consists of 307 ligands and its M-
BMMSG contains a large subgraph that predominantly consists
of agonists (blue) and partial agonists (green) with varying
potencies. In addition, there is a medium-sized subgraph con-
sisting of a region with many highly potent inverse agonists (dark
gray) and another region with agonists and partial agonists along
with a few antagonists. These regions are only connected through
a single edge and key node. The AA1 graph also contains three
small subgraphs that consist of highly or weakly potent antag-
onists (red) and six individual compound series, each represented
by a super node, which form no structural relationships to
others. Thus, overall there is a clear separation of compounds by
mechanism of action across these subgraphs, with many struc-
tural relationships formed between compounds sharing the same
mechanism. Similar observations are made for the M-BMMSG
of the AM1 set in Fig. 2b that is approximately half the size of the
AA1 set (148 compounds). However, in this case, six subgraphs
of comparable size are formed and 11 individual compound
series, thus indicating an overall higher degree of structural
diversity among these receptor ligands. Moreover, as further
discussed below, three of the six subgraphs consist of compounds
having three different mechanisms of action. In contrast to the
AM1 set, the M-BMMSG of the H3R set in Fig. 2c (with 213
compounds) consists of a major and in part densely connected
graph component and five individual series, thus indicating the
presence of many substructure relationships between these
ligands (corresponding to a higher degree of structural homo-
geneity than in the previous cases). In the major graph
Fig. 2 Mechanism-based BMMSGs. Shown are M-BMMSG represen-
tations for (a) AA1 (consisting of 11 separate subgraphs), (b) AM1
(17 subgraphs) and (c) H3R (6 subgraphs). Selected regions containing
ligands with multiple mechanisms of action are displayed on a gray
background. Compound nodes are colored according to Fig. 1 and white
nodes are key nodes. For clarity, selected key nodes are displayed as super
nodes.
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Fig. 3 Key subset relationships. Hierarchical subset relationships between keys are shown for the mechanism hopping regions highlighted in Fig. 2.
Super nodes representing keys associated with compounds having the same mechanism of action are shown in black. For the remaining super nodes, the
shared substructure (core) is displayed and molecule nodes are color-coded according to their mechanisms. Nodes containing mechanism hops are
numbered. (a) AA1, (b) AM1, and (c) H3R.
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component, there are regions predominantly populated with
antagonists. However, the most densely connected region in the
center of this large subgraph contains compounds with all four
mechanisms including many partial agonists.
Mechanism hopping regions
The clustering of structurally related compounds by mechanism
that is observed at varying degrees in M-BMMSGs in Fig. 2 is
a characteristic feature of these graphical representations.
However, it is not the only one; rather, all three M-BMMSGs
also contain subgraphs, or parts of subgraphs, that are composed
of structurally related yet mechanistically distinct ligands (indi-
cated by different node colors), which are easily identified
through visual inspection of the graph representations. These
regions are prime candidates for the exploration of mechanism
hops. In each of the three M-BMMSGs in Fig. 2, one exemplary
mechanism hopping region is highlighted. These regions are
further analyzed in the following.
Critical structural modifications
Mechanism hopping regions are explored in order to identify
structural modifications of ligands that lead to mechanistic
changes. In Tanimoto similarity-based graph representations
such as M-NSGs,13 mechanism hopping regions can also be
identified. However, compound subsets comprising such regions
must then be selected and separately analyzed. By contrast, for
the identification of critical structural modifications leading to
mechanism hops, the M-BMMSG structure with its intrinsic
subset hierarchy is ideally suited. In Fig. 3, the complete subset
hierarchies for the mechanism hopping regions highlighted in
Fig. 2 are displayed. These subset hierarchies contain all keys
that are relevant for mechanism hopping as super nodes
including those that are omitted from the final M-BMMSG
representations (but are a part of the underlying graph struc-
ture). Each super node within a hierarchy is associated with the
shared substructure and the molecules it contains are associated
with the distinguishing structural fragments (substituents). As
shown in Fig. 3, following the subset hierarchies from the top to
the bottom, super nodes are associated with key structures of
increasing size and continuously smaller ligand subsets. Impor-
tantly, within these compound subsets, there is increasing sepa-
ration of ligands by mechanism along the tree structure, as also
illustrated in Fig. 3. Nodes that exclusively contain compounds
sharing the same mechanism are colored black because they are
not relevant for mechanism hopping analysis. However, all other
super nodes within the hierarchy contain mechanism hops and
nodes at the bottom of the tree represent pairs of ligands with
individual mechanism hops. From these super nodes, substitu-
ents that lead to mechanistic changes can be directly selected, as
illustrated in Fig. 4. This figure shows the substituents of
compounds from all super nodes containing mechanism hops.
Each super node is associated with a key structure having
a defined substitution site (if the corresponding MMPs result
from a single cut; see Methods) or two or three sites (if the cor-
responding MMPs result from double or triple cuts, respectively,
and the resulting keys consist of two or three fragments). Hence,
in addition to conventional R-groups, central structural moieties
Fig. 4 Value fragments associated with mechanism hops. For super
nodes numbered according to Fig. 3, substituents are shown that lead to
mechanism hopping (and are color-coded accordingly). (a) AA1,
(b) AM1, and (c) H3R.
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can also be replaced in ligands with different mechanisms. This
spectrum of possible structural transformations is illustrated in
Fig. 4a showing substituents of the subset hierarchy of AA1
ligands according to Fig. 3a. For example, in node 1, all
substituents contain, with one exception, a conserved phenyl
moiety with a single R-group at the ring. The presence of
different substituents in the meta or para position at these phenyl
rings characterizes ligands with different mechanisms. In node 2
in Fig. 4a, substructures with two substitution sites are
exchanged (because the corresponding key consists of two frag-
ments; see Fig. 3a). Smaller ligand and corresponding substituent
sets at subsequent nodes reveal increasingly specific structural
modifications. For example, in node 5, hydrogen, methyl, fluoro,
secondary amino, or methoxy groups at the single substitution
site are characteristic of partial AA1 agonists, whereas di- or tri-
fluoro substituents are found in inverse agonists or antagonists.
At the bottom, substituent pairs in nodes 6 and 7 reveal that the
introduction of a fluorine at the single site of the largest key
structures (effectively yielding a tri-fluoro-ether or -methyl
group) converts AA1 antagonists within this series into inverse
agonists.
In Fig. 4b, substituent sets for the nodes of the AM1 hierarchy
in Fig. 3b also reveal well-defined replacements leading to
mechanistic changes. For example, in nodes 3 and 4, exchanges
of differently substituted pyrazine rings convert partial agonists
or agonists into antagonists. Moreover, the substituent pair in
node 6 (one of the terminal nodes of the hierarchy) reveals that
a change in the relative position of the pyrazine ring in this series
of compounds is sufficient to cause an agonist-to-antagonist
switch. Equivalent observations are also made for the H3R
substituent sets in Fig. 4c. For example, the substituent pair in
the terminal node 7 indicates that the introduction of a methyl
group (replacing a hydrogen) at the single substituent site of the
corresponding key structure is sufficient to convert a partial H3R
agonist into an antagonist. Thus, taken together, these findings
illustrate that subset hierarchies of mechanism hopping regions
in M-BMMSGs reveal structural modifications that cause
mechanism hops.
Mechanism hopping in analog series
These structural transformations can also be directly traced back
to the compounds fromwhich they originate.Accordingly, a series
of ligands with multiple mechanism hops can be selected fromM-
BMMSGs,which is particularly attractive formedicinal chemistry
applications. Fig. 5 shows examples of analog series taken from
mechanism hopping regions where substitutions at a single site
change the mechanism of action in different ways. In Fig. 5a,
a series of AA1 ligands is shown. Here, the presence of a hydroxyl
group at the para position of the phenyl moiety characterizes an
agonist. Replacement of this hydroxyl group with a methoxy
group leads to a partial agonist.However, the introduction of a di-
or tri-fluoro-methoxy group at this position converts the partial
agonist into an antagonist or inverse agonist, respectively. In the
series of AM1 ligands in Fig. 5b, changing the 1,2-substitution
pattern at the pyrazine ring to a 1,3-substitution pattern (i.e.,
facilitating a positional shift) leads to an elongated analog struc-
ture and converts the agonist and partial agonist into an antago-
nist. Finally, in the series of H3R ligands in Fig. 5c, extending the
linker length of the di-methyl-amine substituent transforms an
agonist into a partial agonist. However, replacing the di-methyl-
amine group in the agonist with an isopropyl- or isobutyl-amine
converts it into an antagonist or inverse agonist, respectively.
Thus, the hierarchical analysis of structural transformations that
occur in mechanism hopping regions identified in M-BMMSGs
also makes it possible to select a series of analogs with defined
structural modifications that lead to mechanistic changes.
Conclusions
Herein we have introduced a graphical method to study the
structural basis of mechanism hopping in sets of receptor ligands.
Fig. 5 Selected compounds. For each dataset, exemplary compounds
are shown that are distinguished by single chemical transformations and
have different mechanisms of action (indicated by the mechanism-based
color code). (a) AA1, (b) AM1, and (c) H3R.
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Central features of this approach include the ability to identify
local mechanism hopping regions in M-BMMSGs and directly
select structural modifications that are responsible for mecha-
nistic changes from corresponding key node subset hierarchies.
These subset hierarchies provide high-resolution views of
mechanism hops and underlying structural changes because
there often is an increasing separation of ligands by mechanism
along the tree structure. At each level of the tree, the corre-
sponding structural modifications are immediately accessible. In
practical applications, one initially generates an M-BMMSG
representation of an entire dataset and then selects mechanism
hopping regions, if available, for subset hierarchy display and the
identification of important structural modifications. Subset
hierarchies of mechanism hopping regions often describe series
of ligands with multiple mechanism hops. The M-BMMSG
representations of the original datasets then also offer the
opportunity to further analyze the neighborhood of such series
and their structural organization. Thus, the M-BMMSG
approach facilitates the analysis of mechanism hopping at
multiple levels.
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Summary
This chapter reports the modification of an existing graphical landscape repre-
sentation that integrates systematic SAR information to include the mechanism
of action of receptor ligands. This data structure organizes compounds using
clearly defined substructure relationships that facilitates a smooth transition
from SAR and mechanistic explorations to the identification of structural mod-
ifications associated with mechanism hops. In addition, subset hierarchies allow
inspection of these chemical changes at various levels of resolution ranging from
analog series to compound pairs. Separation of ligands with respect to their
mechanism of action increases with increase in the hierarchical levels. Informa-
tion obtained after exploration of substitutions that bring about mechanistic
transitions can be utilized in various compound design and optimization appli-
cations.
A common feature of the approaches reported thus far is that these have
been designed to focus on compound activities against a single target. However,
methodologies that can be applied to compound sets with activities against mul-
tiple targets are also of interest, especially in the study of polypharmacology. A
novel multi-target graphical representation is reported in the following chapter.
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Chapter 6
Representation of multi-target
activity landscapes through target
pair-based compound encoding in
self-organizing maps
Introduction
Systematic SAR investigations are often performed using activity landscape
modeling as it provides a framework for the integration of structural similar-
ity relationships with potency information. Traditional SAR analyses focus
on compounds with activity annotations against individual targets. Attempts
have been made to design selectivity landscape representations to investigate
potency distributions for two targets. However, activity landscapes that con-
sistently account for pair-wise compound similarities and multi-target activities
are necessary to study polypharmacological compounds, i.e. compounds that
interact with different targets. For this purpose, a novel multi-target activity
landscape has been introduced where the chemical similarities were projected
into 2D space using self-organizing maps (SOMs) [1]. Compounds with re-
ported activities against multiple targets were represented as arrays of cells
colored according to binned pairwise target potency differences. Using this
landscape model, it was possible to rationalize discontinuity in multi-target ac-
101
tivity space. This multi-target landscape representation has successfully been
applied to ligand sets with activities against three to five targets.
[1] Kohonen T. Self-organizing maps, Springer, Heidelberg, Germany, 1996.
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Representation of Multi-Target Activity
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Activity landscape representations provide access
to structure-activity relationships information in
compound data sets. In general, activity landscape
models integrate molecular similarity relation-
ships with biological activity data. Typically, activ-
ity against a single target is monitored. However,
for steadily increasing numbers of compounds,
activity against multiple targets is reported,
resulting in an opportunity, and often a need, to
explore multi-target structure-activity relation-
ships. It would be attractive to utilize activity
landscape representations to aid in this process,
but the design of activity landscapes for multiple
targets is a complicated task. Only recently has a
first multi-target landscape model been intro-
duced, consisting of an annotated compound net-
work focused on the systematic detection of
activity cliffs. Herein, we report a conceptually
different multi-target activity landscape design
that is based on a 2D projection of chemical refer-
ence space using self-organizing maps and
encodes compounds as arrays of pair-wise target
activity relationships. In this context, we intro-
duce the concept of discontinuity in multi-target
activity space. The well-ordered activity landscape
model highlights centers of discontinuity in activ-
ity space and is straightforward to interpret. It has
been applied to analyze compound data sets with
three, four, and five target annotations and iden-
tify multi-target structure-activity relationships
determinants in analog series.
Key words: activity landscapes, data mining, graphical representations,
multi-target SARs, self-organizing maps, structure-activity relationships
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Graphical representations of activity landscapes have become increas-
ingly popular for the qualitative analysis of structure-activity relation-
ships (SARs), identification of activity cliffs, characterization of local
SAR environments, and extraction of SAR information from large
compound data sets (1–3). In general, an activity landscape is best
rationalized as a hypersurface in chemical space that accounts for
the biological activity of a compound set. If one envisions a 2D (x, y-)
projection of chemical space in which distances between compounds
indicate molecular (dis-)similarity relationships, compound potency
can be added as the third (z-) dimension to this representation. Then,
a potency surface can be interpolated, giving rise to intuitive 3D
landscape representations (1,3) that are reminiscent of geographical
maps. Such 3D landscapes have often been discussed in idealized
form (3) but can also be approximated for actual compound data sets
(4). In addition to 3D activity landscapes, a variety of different 2D
landscape representations have been generated (3,5–7). In fact, the
first landscape views of compound data sets were 2D representa-
tions, beginning with the introduction of so-called structure-activity
similarity maps (7), for which a number of derivatives have been
reported (8,9). In addition to such graphs, which systematically
account for similarity and potency relationships on the basis of pair-
wise compound comparisons, annotated molecular network represen-
tations have become popular for 2D landscape design (5,6).
Regardless of their dimensionality or design characteristics, conven-
tional activity landscapes monitor the activity of compound data
sets against individual targets (3). However, with mounting evidence
of polypharmacological compound behavior and network pharmacol-
ogy (10–12), multi-target compound activity profiles are increasingly
considered in SAR analysis (13–15). Ideally, one would also like to
employ activity landscape models for the evaluation of multi-target
SARs. An extension of conventional activity landscape models has
been introduced where network-like similarity graphs, a molecular
network–based 2D landscape representation (5), have been trans-
formed into dual-target selectivity landscapes by considering
potency ratios instead of single-target potency values (16). On this
basis, the concept of selectivity cliffs has been introduced (16).
However, the design of activity landscape representations for three
or more targets has proven to be a difficult task. Recently, a first
design of a multi-target activity landscape (MTAL) has been intro-
duced (17), which captures compound potency relationships across
multiple targets in a formally consistent manner by introducing
numerical codes for multi-target activity profiles. These codes were
mapped onto compounds (nodes) in similarity-based compound data
set layouts where edges indicate the presence of single- or multi-
target activity cliffs formed by pairs of compounds (17).
We have continued to explore alternative ways to generate MTAL
models and present herein a conceptually different approach, which
778
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departs from molecular network representations. A neural network–
based projection of chemical reference space is utilized to provide a
similarity-based 2D organization of compounds with multiple target
annotations. Then, compounds are represented as arrays of pair-
wise target potency relationships, which add a new data structure
to the self-organizing map (SOM)-based structural organization. Ele-
ments of the arrays are color-coded according to the degree of activ-
ity discontinuity a compound displays. The resulting data structure is
straightforward to analyze and reveals multi-target SAR hotspots.
Methods and Materials
Data sets
Compound data sets with multiple target annotations were extracted
from ChEMBLa (18). Only potency measurements (Ki or, if not available,
IC50 values) with defined endpoints and designated maximum confi-
dence level were considered. Other less well-defined potency measures
such as '% inhibition' or reported ranges of Ki or IC50 values were not
considered because of their intrinsic accuracy limitations. Data sets with
reported activity against three, four, and five targets were obtained, as
summarized in Table 1. These sets include 342 adenosine receptor
antagonists with reported activity against three different adenosine
receptors (designated 3AR), 98 opioid-like receptor antagonists with
activity against three different opioid receptors and the nociceptin
receptor (4OR), and 53 inhibitors of five thrombin-related serine prote-
ases (5PR). In currently available public domain compound data, it is dif-
ficult to find significant numbers of compounds that share five or more
target annotations (17). Therefore, the compound sets studied herein
reflect the current spectrum of multi-target activity data.
Molecular representation
For all compounds, the stereochemistry-sensitive form of the
Extended Connectivity Fingerprint with bond diameter 4 (ECFP4)b
(19) was calculated as an input representation for compound classi-
fication. ECFP4 monitors layered atom environments in test com-
pounds and is generally considered a high-resolution fingerprint.
Chemical reference space projection
Pair-wise Tanimoto coefficient (Tc) values were calculated for all
compound fingerprints to constitute a low-complexity co-ordinate-
free reference space. A 2D projection of this chemical reference
space was obtained through the calculation of a SOM (20) using
the SONNIA programc (20). Self-organizing map is a neural network
method that facilitates dimension reduction in chemical space rep-
resentations and assigns compounds to neurons organized in a
plane. This 2D projection mirrors similarity relationships by cluster-
ing compounds such that similar ones are assigned to the same or
adjacent neurons. Hence, distance between compounds in a SOM
is a measure of (dis-)similarity (i.e., the shorter the distance
between compounds is, the more similar they are). Pair-wise Tc val-
ues were used as input for SOM calculation. The dimension for
neuron generation was set to the size of each data set. SONNIA
default parameters were applied to derive the neuron grid.
Multi-target activity landscape
The grid of neurons of each SOM was used as the template for
activity landscape design. Neurons to which compounds were
assigned were shown with black borders and 'empty' neurons with
gray borders. Compounds were represented as follows: (i) For each
compound, all possible pairs of targets were enumerated (i.e., for
activity against three targets 1, 2, and 3, three pairs 1_2, 1_3, and
2_3 were obtained). (ii) Each compound was represented by n
squares, each accounting for a target pair, drawn on a light blue
background (to distinguish different compounds from each other).
Each square was labeled with the corresponding target pair (e.g.,
1_2) (iii) For each pair, the logarithmic potency difference in the
compound was calculated. Potency differences were assigned to
five bins, and the squares were color-coded according to the magni-
tude of the difference: DpKi (or DIC50) < 1 (green), 1 £ DpKi < 2
(light green), 2 £ DpKi < 3 (yellow), 3 £ DpKi < 4 (orange), and
DpKi ‡ 4 (red). Thus, squares with smallest target pair-wise
potency differences within one order of magnitude were colored
green, and squares with largest potency differences in four or more
orders of magnitude were colored red. For interactive display and
navigation, the activity landscape design was implemented in Java.
Results and Discussion
The analysis of multi-target SARs generally is a complicated task.
Here, we present a model of a MTAL that is designed to provide
an intuitive access to local multi-target SAR components with a
particular focus on regions that are characterized by high disconti-
nuity in multi-target activity space. However, as shown in the fol-
lowing, regions of multi-target SAR continuity can also be identified
in these representations. In MTALs, regions of continuity correspond
to compounds having similar activity against each target. Hence,
such regions are less informative for the analysis of multi-target
SARs than regions of significant discontinuity. This is the case
because discontinuity is introduced by compounds that display dif-
ferential activity against multiple targets, and from such com-
pounds, SAR determinants might be deduced.
Table 1: Compound data sets
with multi-target activity
Class Activity Size
No of
targets Targets
3AR Adenosine receptor antagonists 342 3 Adenosine receptors A1, A2a, A3
4OR Opioid-like receptor antagonists 98 4 d-, j-, l-Opioid receptors, Nociceptin receptor
5PR Urokinase-type plasminogen
activator-like inhibitors
53 5 Thrombin, Plasminogen, Coagulation factor X,
Urokinase-type plasminogen activator, Matriptase
For the three data sets assembled from ChEMBL, the class abbreviation, activity, size, and target information are
provided.
Multi-Target Activity Landscape
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Methodological concept and design elements
The generation of activity landscape models principally requires the
integration of molecular similarity relationships and compound
potency information. For activity against individual targets (or at
most two targets), potency (selectivity) information can be directly
added to chemical space representations or systematically moni-
tored pair-wise compound similarity relationships. For activity
against three or more targets, other approaches are required. For
MTAL design, the chemical space ⁄ similarity relationship display is
analogous to single-target landscapes (i.e., compound similarity
relationships are independent of the number of target annotations).
By contrast, a key question is how to best represent compounds in
multi-target activity space. For the MTAL model reported herein, we
utilize a SOM-based 2D projection of a co-ordinate-free fingerprint
space. By computing SOMs, structurally similar compounds are
assigned to the same or neighboring neurons resulting in a cluster-
ing effect. It should be stressed that the SOM projection provides
the initial well-ordered structural reference frame for compound
representation. However, to represent a MTAL, a new data struc-
ture must be added to it. Hence, to account for multi-target activity,
each compound is represented as an array of pair-wise target com-
binations. Each element (square) of the array is then color-coded
according to the potency difference in the compound against the
two targets. This design strategy is illustrated in Figure 1. To repre-
sent potency differences in a consistent manner throughout the
activity landscape, logarithmic potency differences are assigned to
five bins. The elements are then color-coded according to the mag-
nitude of the potency difference in a compound against a target
pair, from green (potency difference within an order of magnitude)
over light green (one to two orders of magnitude), yellow (two to
three), and orange (three to four) to red (potency difference in more
than four orders of magnitude). As illustrated in Figure 1, this com-
pound representation scheme produces color patterns that reflect
differential potency against pairs of targets. In Figure 2A, B, we
represent an MTAL model of a largely discontinuous and continuous
SAR region, respectively. The region of discontinuity in Figure 2A is
characterized by the dominance of mixed color patterns, as dis-
cussed in more detail later. Here, it should be noted that the cells
in our MTAL model do not convey information about potency direc-
tionality (i.e., against which target a compound is highly or weakly
potent) because pair-wise potency differences are not directional.
However, this information is relevant for the subsequent analysis of
strongly discontinuous regions. Therefore, once a discontinuous
region of interest has been identified in an MTAL representation,
the compound subset forming this region can be displayed together
with directional potency differences, as suggested previously for
the analysis of multi-target activity cliffs (21). In contrast to discon-
tinuous regions, the region of continuity in Figure 2B is mostly col-
ored in green, reflecting small pair-wise target potency differences.
Green regions in MTALs are characteristic of multi-target SAR conti-
nuity. To further differentiate between small potency differences
resulting from either high or low compound potencies in regions of
SAR continuity, the color code can be modified, as illustrated in Fig-
ure 2C. For this purpose, absolute potency values are divided into a
high (pKi ⁄ IC50 > 8), intermediate (pKi ⁄ IC50 between 8 and 6), and
low (pKi ⁄ IC50 < 6) potency category. Cells representing differences
between high, intermediate, and low values are then color-coded in
dark blue, blue, and light blue, respectively, which replaces the
standard green coloring of cells corresponding to low-potency differ-
ences within an order of magnitude. For cells representing potency
differences within two orders of magnitude, the standard green col-
oring scheme still applies, as also illustrated in Figure 2C. However,
in our analysis, we predominantly focus on the regions of multi-tar-
get SAR discontinuity, as rationalized earlier. Accordingly, the fur-
ther refined color-coding scheme for continuous MTAL regions is
not applied in the examples discussed in the following to limit the
complexity of the activity landscape representations.
Interpretation of MTAL patterns
Figure 3A shows the complete MTAL representation for the 4OR
data set. The figure illustrates the well-ordered structure of the
neuron grid and the compound clustering effect. The grid layout
provides an easy access to compound information. The 4OR MTAL
reveals different color patterns and a separation of predominantly
green compounds from compounds with mixed color patterns. If
arrays are colored green, the corresponding compounds display sim-
ilar potency against multiple targets and hence no apparent selec-
tivity. By contrast, yellow-to-red squares reflect 100- to more than
10 000-fold potency differences against target pairs. As can be
seen in Figure 3A, there are no antagonists that consistently display
large potency differences against all pairs of targets. Rather, orange
and ⁄ or red squares usually occur in combination with green
squares. This means that a compound displays comparable potency
against two or more targets and significantly different potency
against at least one or more others. Therefore, such mixed color
A B C
Figure 1: Multi-target activity landscape (MTAL) design. (A) A schematic self-organizing map-based MTAL consisting of only four neurons
is shown. From the top left in clockwise direction, the neurons contain four, two (encircled), three, and no compounds (with three hypothetical
activity annotations). The target pair array representing each compound is depicted on a light blue background. Neurons containing com-
pounds are shown with black borders and empty neurons with gray borders. (B) The neuron containing two compounds encircled in (A) is
enlarged (one of the compounds is encircled). Squares are color-coded by binned potency differences and labeled with the corresponding
target pairs. (C) The compound encircled in (B) is shown in a close-up view.
Iyer and Bajorath
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Figure 2: Exemplary regions of
multi-target structure-activity rela-
tionships (SAR) discontinuity and
continuity. For an exemplary
compound data set with activity
against three targets, enlarged
multi-target activity landscape
views of a highly (A) discontinuous
and (B) continuous SAR region are
shown. In (C), a variant of the
standard representation of the con-
tinuous region in (B) is shown with
modified color code to further dif-
ferentiate between small potency
differences resulting from different
levels of compound potency, as
explained in the text.
Multi-Target Activity Landscape
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patterns indicate that a compound introduces a high level of discon-
tinuity in multi-target activity space.
Extracting SAR information
What type of SAR information can be obtained from the SOM-based
MTAL? A major focal point of activity landscape analysis usually is
the identification of prominent activity cliffs in the regions of high
local SAR discontinuity (1,3). The multi-target landscape concept pre-
viously introduced by Dimova et al. (17) specifically aimed at a com-
prehensive account of single- and multi-target activity cliffs in
compound data sets. A multi-target activity cliff is formed by a pair
of structurally similar compounds that show significantly different
potency against two or more targets. In SAR analysis, one would
then compare the structures of these compounds to identify the mod-
ification(s) that are responsible for cliff formation. Activity cliffs can
also be identified in the newly introduced MTAL design by comparing
the colors of corresponding squares in similar compounds. For exam-
ple, the '2_3' squares of the two adjacent compounds in Figure 1B
form a yellow ⁄ green combination. Accordingly, one compound has
comparable potency against the target pair and the other a 100- to
1000-fold difference in potency. Thus, this compound pair forms an
activity cliff. Upon close inspection, a number of such examples
become apparent in the landscape view in Figure 3A. However, the
detection of activity cliffs is not the primary focal point of our new
MTAL method. Rather, its major purpose is the identification of com-
pound subsets (or individual compounds) that are responsible for the
introduction of significant discontinuity in multi-target activity space.
For example, understanding the basis of such discontinuity is of criti-
cal importance for exploring the design of target-selective com-
pounds. In our landscape views, such regions are indicated by mixed
color patterns, as illustrated in Figure 1, and become immediately
apparent. In Figure 3A, a discontinuous region ⁄ compound subset
consisting of three adjacent neurons is marked. The rationale for
focusing on such regions is as follows: by comparing similar mole-
cules that do or do not introduce discontinuity in multi-target activity
space, substitution sites can be identified that substantially influence
or determine multi-target SARs, as further discussed later.
Opioid-like receptor antagonists
In Figure 3B, the discontinuous three-neuron region outlined in Fig-
ure 3A is depicted, revealing a systematic mixed pattern. The com-
pounds in this region show pronounced potency differences against
targets 2 and 4 and very similar potency against targets 1 and 3
and, in part, 1 and 4. Furthermore, significant differences are
observed in the behavior of compounds against targets 3 and 4. In
Figure 3C, the nine compounds comprising this region are shown
(with neuron grid indices defining their origin and position). As can
be seen, these compounds form an analog series. In all cases stud-
ied here, we have observed that compounds mapping to the same
or neighboring neurons were structurally very similar, often series
of analogs, which assigns confidence to the SOM-based structural
classification underlying the MTAL design. The comparison of the
analogs in Figure 3C reveals the presence of two substitution sites
at adjacent phenyl moieties (highlighted in Figure 3C) where differ-
ent R-groups are responsible for the introduction of discontinuity in
multi-target activity space. Thus, substitutions at these sites play a
major role in determining multi-receptor SARs on the basis of cur-
rently available compound data and can be further explored.
Adenosine receptor antagonists
In Figure S1, the complete MTAL of the large adenosine receptor
antagonist data set is shown. In this case, distinct clustering of pat-
terns is also observed and the landscape representation identifies
several centers of marked discontinuity. One of these centers is out-
lined in Figure S1 and shown in detail in Figure 4A. Here, system-
atic trends can also be identified. The potencies of all 10
compounds comprising this center of discontinuity are very similar
against two of three receptors ('1_2'), but greatly differ against
receptor 3. It follows that this region does not contain notable
activity cliffs because the compounds display very similar potency
patterns. However, in this case, the obvious discontinuity in activity
space directly points at compound selectivity determinants. As
shown in Figure 4B, these compounds also form an analog series
and are only distinguished by R-groups at a single site of a phenyl
moiety (in one instance, the phenyl ring is replaced with a pyridine).
These substitutions differentiate one adenosine receptor subtype
from two others, leading to potency changes of two to more than
four orders of magnitude.
Serine protease inhibitors
In Figure S2, the complete MTAL of the inhibitor set with activity
against five related serine proteases is displayed. In this smaller data
set, many compounds have similar (green) potency patterns. Two
regions are outlined, region 1 with little apparent discontinuity and
region 2 the most discontinuous region in this set. Region 1 is
formed by four compounds mapping to a single neuron and shown in
Figure 5A. Region 2 includes three neighboring neurons with a total
of nine compounds (Figure 5B). These two regions contain two simi-
lar yet distinct series of analogs, shown in Figure 5C, D, respectively.
The analogs in Figure 5C are distinguished by bioisosteric replace-
ments at a single site, consistent with the presence of only low to
moderate discontinuity in the activity landscape. By contrast, the
analog series in Figure 5D is characterized by substitutions at two
sites including bioisosteric replacements in para-position at the
piperidine ring and less conservative substitutions at the sulfonamide
group. In this case, large changes in potency profiles are observed,
leading to the formation of activity cliffs and the introduction of sub-
stantial discontinuity in multi-target activity space (Figure 5B).
Figure 3: Multi-target activity landscape of the 4OR data set. (A) The complete activity landscape representation of 4OR is shown. Here,
each compound is active against four targets and hence represented as an array of six target pair potency differences. A region with neurons
representing a high level of multi-target structure-activity relationships discontinuity is outlined in red. (B) The three adjacent neurons outlined
in (A) are shown. (C) The nine compounds assigned to these three neurons are shown, which represent a series of analogs. Structural modifi-
cations at specific substitution sites are highlighted in gray. Compounds are labeled with their source neurons referring to the respective neu-
ron position in the grid representation of the complete activity landscape (e.g., [1 0 1]).
Multi-Target Activity Landscape
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Conclusions
Herein, we have reported the design of a SOM-based MTAL model that
is, different from other activity landscape representations, primarily
focused on the identification of discontinuity in multi-target activity
space. For this purpose, the target pair potency-based compound repre-
sentation introduced herein is a key design element. From compound
subsets forming regions of high discontinuity, substitution sites and R-
group patterns can be deduced that substantially influence multi-target
SARs. Different compound data sets with three to five target annota-
tions have been analyzed to illustrate the design and analysis princi-
ples. The concept of discontinuity in multi-target activity that is
A
B
Figure 4: Subset of the activity
landscape of 3AR. (A) Neurons
forming a region of high disconti-
nuity are shown that is outlined in
red in Figure S1. (B) Compounds
forming this region are shown. The
representation is according to
Figure 3C.
Iyer and Bajorath
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A B
C
D
Figure 5: Subsets of the activity landscape of 5PR. (A) Neurons forming a region of low discontinuity (region 1 in Figure S2) are shown.
(B) Another highly discontinuous region is shown (region 2 in Figure S2). (C) Compounds forming region 1 in (A) are shown. (D) Compounds
forming region 2 in (B) are shown. The representation is according to Figure 3C.
Multi-Target Activity Landscape
Chem Biol Drug Des 2011; 78: 778–786 785
embedded in the MTAL design is distinct from, yet complementary to,
the study of SAR discontinuity in activity landscapes, which is associ-
ated with the presence of activity cliffs. As we have demonstrated, the
presence of discontinuity in activity space might or might not correlate
with the presence of activity cliffs. Among other aspects, the analysis
of discontinuity in multi-target activity space is often critical for rational-
izing compound selectivity. The newly introduced MTAL model is only
the second representation of multi-target landscapes reported thus far
and conceptually unique. As such, the MTAL design reported herein fur-
ther extends the spectrum of available activity landscape representa-
tions and the knowledge that can be derived from them.
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Summary
A new multi-target activity landscape representation has been reported in this
chapter. Pair-wise similarities obtained from molecular fingerprints for data set
compounds were projected into 2D space with the help of SOMs. Thus, the
compounds were organized into a grid-like landscape. Individual compounds
were displayed as arrays of pair-wise target activity relationships over all the
targets. Such an arrayed arrangement of compounds was suitable for the identi-
fication of multi-target discontinuous regions. Inspection of ligand subsets that
formed these centers of discontinuity provides important insights into substruc-
tural changes responsible for differential activity in multi-target activity space.
It should also be noted that multi-target discontinuity is different from SAR
discontinuity in single-target activity landscapes.
The landscape model described herein provides a unique perspective for study-
ing SAR in multi-target activity space. Nevertheless, such models cannot be
generated for ligands with incomplete activity annotations. In addition, in-
terpretation of these landscapes with increasing numbers of targets becomes
difficult. These limitations have been addressed in a second multi-target land-
scape representation reported in the following chapter.
114

Chapter 7
Navigating high-dimensional
activity landscapes: design and
application of ligand-target
differentiation map
Introduction
Compound profiling experiments serve as fundamental sources of potency in-
formation in the field of chemical biology and medicinal chemistry where com-
pound libraries are simultaneously tested against several biological targets [1].
G protein coupled receptors and protein kinases are considered important drug
targets due to their involvement in many physiological and biochemical pro-
cesses [2, 3]. Therefore, profiling approaches often involve members of these
therapeutically relevant protein families [4, 5]. Compound sets evaluated during
profiling analyses can either show structural diversity or be chemically homoge-
neous. Moreover, the panels of selected targets often constitute representative
members of the chosen target family. The outcome of these studies consists of
a data matrix that contains multiple activity annotations for individual com-
pounds.
Rationalization of these multi-dimensional bioactivity spaces and their ex-
ploration can be challenging. Nevertheless, such activity spaces provide a wide
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variety of information regarding the compound activity profiles and ligand-
target interaction patterns. The knowledge obtained from these analyses can
often be utilized for the identification of molecular probes that differentiate be-
tween related members of a target family [6] as well as in compound design and
optimization processes [5].
The activity landscape concept is often utilized for generating SAR mod-
els that combine pairwise similarity and potency difference distribution within
compound data sets [7]. These landscape representations aid in SAR analysis
as they are interpretable and intuitive in nature. However, these landscapes
primarily focus on compound sets with activity against single targets. Molecu-
lar network-based activity landscape models for two [8] or more targets [9] have
been recently introduced to assess the degree of selectivity within active ligands
or the ability to form multi-target activity cliffs.
In addition to the originally reported network-based multi-target activity
landscape representation, chemical similarity and activity difference maps gen-
erated using compound activity versus structural similarity plots [10] and mod-
els based on SOMs described in the previous section [11] have recently been
reported. Nevertheless, these multi-target landscape representations account
for activity data derived from limited number of targets (i.e. up to five) in
an interpretable manner. Formalisms based on the activity landscape concept
that describe actual high-dimensional activity spaces involving over 50 or more
targets have yet to be introduced.
Availability of compound profiling data in the public domain is a limitation
for the design of such multi-dimensional activity landscapes. Large scale profil-
ing experiments are usually carried out by pharmaceutical companies for many
therapeutically implicated targets, but the results are considered proprietary.
However, a profiling study from Abbott Laboratories has recently been made
public [12]. With the help of the resulting data set, design of a high-dimensional
activity landscape representation has been attempted. This study has been pub-
lished in reference [13] of this chapter. My contributions to the study reported
herein have been to aid in the design of the novel multi-dimensional activity
landscape representation and its implementation [13].
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Methodology
Data Set
Metz et al. analyzed 3858 compounds against 172 diverse kinases spanning the
kinome with the objectives of generating a kinase interaction map and analyzing
various polypharmacological patterns [12]. A part of these results containing
the chemical structures and bioactivity information for 1496 compounds was
reported publicly. From this inhibitor set, 1473 compounds with unique 2D
molecular representations [14] were retained.
Activity information for these 1473 compounds against all the 172 kinases
was available in the form of negative logarithms of inhibitory constant endpoints
or thresholds values. The activity matrix for these compounds was incomplete,
i.e. of 172 kinases, pKi values for one to 122 targets were available for these
compounds. The maximum overlap between the activity profiles of individual
compounds was detected for 101 kinases. The incomplete yet multi-dimensional
nature and several instances of partial overlaps among compound activity pro-
files were the challenging aspects that needed to be addressed during the activity
landscape design. In this case, a difference of one order of magnitude between
pKi values was set as the activity threshold.
Assessment of Chemical Similarity
Incorporation of pairwise structural similarity among the constituent com-
pounds within a ligand data set is a fundamental requirement for the generation
of activity landscape representations. During the analysis, two conceptually
different approaches were utilized to evaluate chemical similarities between the
data set compounds. MACCS structural keys [15], a molecular fingerprint rep-
resentation was used to calculate pairwise whole molecule similarities using the
Tanimoto coefficient (Tc) [16] as the similarity measure. Compound pairs with
a Tc value of at least 0.8 were considered to be structurally similar. Addition-
ally, MMP analysis was applied to assess direct substructural changes within
compounds [17]. Thus, all compound pairs forming MMPs, i.e. differing by
single site chemical modifications, were identified.
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Motivation for Novel Design
Activity landscape representations combine the information originating from
systematic pairwise structural similarities and potency differences within lig-
and sets. Thus, in addition to assessing single and multi-target SAR relevant
features, a high-dimensional activity landscape model must provide complete
coverage of activity data as well as handle its sparseness.
Initial attempts were made to assess activity similarity using nonbinary Tc
(nbTc) [18] for all compound pairs. The nbTc value was calculated using the
activity data for all targets shared by a given compound pair (A,B) as:
nbTc(A,B) =
n∑
i=0
potiA ∗ potiB
n∑
i=0
[(potiA)
2 + (potiB)
2 − potiA ∗ potiB]
where nbTc denotes the activity similarity value while potiA and pot
i
B rep-
resent the potencies of the ith shared target for compounds A, B, respectively.
Systematic pairwise comparison of activity similarities within the data set re-
vealed that a single nbTc value corresponded to a range of overlapping targets
while a given number of shared targets was associated with several nbTc val-
ues. Examination of nbTc distribution for shared targets with more than one
order of magnitude potency difference showed that high similarity values were
obtained by small number of shared targets exceeding the ten fold activity dif-
ference and low activity similarity was observed when the number of shared
targets with significant activity differences was high. These observations were
consistent with the expectation associated with a similarity measure. However,
several instances were also observed when high nbTc values were obtained from
large number of shared targets with potency differences greater than one order
of magnitude and low nbTc values were produced by small number of overlap-
ping targets with more than ten fold activity difference. The high-dimensional
activity landscape design also needed to address this ambiguity observed with
respect to the calculated activity similarities.
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Ligand-Target Differentiation Map
A novel activity landscape representation, the ligand-target differentiation (LTD)
map, has been designed keeping in mind the aforementioned objectives. The
core elements of LTD map are compound pairs and these are analyzed from
three perspectives [13]. Firstly, numbers of compound pairs with varying de-
grees of target overlaps are reported. As a second aspect, the numbers of com-
pound pairs within the first subset having more than ten fold activity differences
for the overlapping targets are analyzed. Structurally similar compound pairs
within the first two subsets comprise the third layer of information. The LTD
map and its various design elements are reported in [13].
A grid representation forms the framework of the LTD map. Bivariate data
containing the numbers of overlapping targets and those with potency difference
over one order of magnitude are plotted along x- and y- axes, respectively.
These values are binned to produce unit cells with a constant dimension of
five by five. Therefore, these squared unit cells account for the entire range of
possible pairwise target and target activity difference relationships underlying
the data set. Compound pair frequencies present within the cell bounds are
calculated and a color spectrum from light pink over magenta to black is applied
to assess the magnitude of their occurrence. Thus, black colored cells contain
one compound pair while those with increasing numbers are shown in various
shades of magenta and the cell containing the largest number of pairs is depicted
in lightest pink color. Absence of any compound pairs within respective data
intervals produce empty cells [13].
Structural similarity information has been added using inlays. The fre-
quency of compound pairs participating in structural relationships is monitored
by an inverse color spectrum from light(est) blue over dark blue to black. Thus,
lighter shades of blue correspond to smaller number of chemically related com-
pound pairs and darker blue shades indicate larger frequencies while the black
cell contains the highest number of compound pairs. For the Abbott data set,
LTD maps were generated for two complementary similarity assessment ap-
proaches, MACCS Tc and MMP, respectively, and shown in Figure 1a and
1b. The LTD maps were implemented in R environment [19].
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Figure 1: LTD map for kinase inhibitor data set. Two LTD maps for the data set con-
sisting of 1473 kinase inhibitors using alternate structural similarity assessment approaches
are shown. Whole molecular similarity relationships determined using MACCS Tc are illus-
trated in (a) while substructure based relationships obtained using MMP analysis are depicted
in (b). Compound pairs participating in MMP formation share a common core structure.
(taken from Iyer et. al[13])
Results
As shown in Figure 1, information associated with high-dimensional activity
space can be readily viewed using the LTD map [13]. For the kinase inhibitor
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data set with activity annotations against 172 kinases, the maximum target
overlap between individual compound pairs was found to be 101 kinases and
for 69 kinases, the potency difference was greater than one order of magnitude.
Majority of the compound pairs were found to lie within the data intervals of
0 to ∼20 shared targets and 0 to ∼10 shared targets with qualifying activity
differences, as portrayed by cell colors. Furthermore, it was also observed that
the number of compound pairs showed a sharp decline with rise in the inter-
val of shared targets and shared targets with significant potency differences.
Cells comprising the leftmost (pseudo-diagonal) region consisted of compound
pairs for which almost all the targets showed significant differences in activ-
ity while cells spanning the bottom rows displayed small activity variations.
Additional information regarding the pairwise similarity relationships with re-
spect to MACCS Tc and substructure equivalences determined by MMP, was
obtained by the examination of the inlays in Figure 1a and 1b, respectively. It
was noted that such similarity relationships were prevalent within compounds
having low target overlap. Moreover, chemically similar compound pairs with
up to ∼50 shared targets and ∼10 shared targets with potency differences above
the activity threshold were also relatively frequent. Closely related compounds
with similar potency against all kinase targets were found in the cells forming
lower rows of the LTD map. Different from these pairs, compound pairs that
were structurally similar but showed significant deviation in activity against
nearly all the shared targets were associated with the diagonally situated cells.
The cells located in the upper right rows consisted of structurally unrelated
compound pairs as inlays were rarely observed. Thus, structural similarity and
activity distributions in multi-dimensional activity space could be navigated
with the help of the LTD map [13].
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Summary
The ligand-target differentiation map, a novel data structure has been intro-
duced that integrates high-dimensional activity data with chemical similar-
ity relationships present between various compounds in a systematic manner.
Thus, the LTD map constitutes a multi-dimensional graphical activity land-
scape model providing access to multi-target SAR information content. Lim-
ited public availability of profiling results has been an important challenge faced
during the design of high-dimensional landscape representations. Recently, a
kinase inhibitor data set containing over 1400 compounds evaluated against
172 kinases was made publicly accessible. Subsequent analysis made possible
by this data set led to the design of the LTD map. The scaling down of the
complexity associated with incomplete multi-dimensional activity information
serves as the key element of the computational methodology described in this
analysis. This simplification has been achieved by systematically determining
pairwise differences between overlapping targets. Further, bivariate binning
of the numbers of shared targets and shared targets with significant activity
differences to form unit cells of constant size has been carried out for the pur-
pose of visualization. Addition of pairwise chemical similarities completes the
landscape view that facilitated navigation of various multi-target SAR relevant
regions. The relative ease of generation and flexibility in application to lower
dimensional activity spaces make LTD map an invaluable tool to carry out
multi-target SAR analysis.
The study reported herein has been published in reference [13] of this chap-
ter. My contributions to this study have been to aid in the design of the LTD
map and its implementation [13].
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In the following chapter, analysis performed using the data obtained from
a second profiling experiment has been reported.
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Chapter 8
Assessing the target differentiation
potential of imidazole-based
protein kinase inhibitors
Introduction
Compound profiling experiments to evaluate ligand sets against a panel of
protein targets are frequently performed for comprehensive characterization of
ligand-target interactions. Such studies are prominent sources of multi-target
activity information and provide valuable insights during SAR and selectivity
analyses. Systematic exploration of activity data obtained from a profiling ex-
periment consisting of 484 imidazole-based inhibitors tested against 24 different
kinases was carried out to identify compounds with high differentiation poten-
tial. The differentiation potential served as a measure to evaluate the ability of
these inhibitors to distinguish between the various kinases.
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ABSTRACT: A library of 484 imidazole-based candidate inhibitors was tested against 24 protein kinases. The resulting activity
data have been systematically analyzed to search for compounds that effectively differentiate between kinases. Six imidazole
derivatives with high kinase differentiation potential were identified. Nearest neighbor analysis revealed the presence of close
analogues with varying differentiation potential. Small structural modifications of active compounds were found to shift their
inhibitory profiles toward kinases with different functions.
■ INTRODUCTION
Profiling of compound collections against target families is an
important source of activity data for chemical biology and drug
discovery.1 Profiling has become a popular approach to
characterize ligand-based relationships between targets2 and
identify new active compounds, especially for high-profile
therapeutic targets such as G protein coupled receptors3,4 or
protein kinases.5,6 Target profiling experiments are frequently
carried out in pharmaceutical research environments, but these
proprietary results are rarely disclosed, with occasional
exceptions.7,8 Exemplary profiling studies have substantially
advanced our understanding of structure−activity relationships
(SARs) and selectivity patterns within important target families.
For example, profiling of kinase inhibitors against different
subfamilies of the kinome revealed unexpected cross-reactivity
of many kinase inhibitors,7 hence providing insights into
polypharmacological behavior of clinically relevant inhibitors.
In addition, molecular network analysis has been applied to
analyze kinase profiling data and rationalize activity patterns.8
On the basis of kinase profiling data,8 matched molecular pair
analysis has also been carried out to propose inhibitors with
increased kinase selectivity.9 However, kinase profiling is a
laborious and expensive part of medicinal chemistry programs,
as it requires large assay efforts and high costs. Consequently, in
silico support or guidance in study design and data analysis,
even if approximate, should be of considerable help for the
community. Several computational studies have analyzed
available kinase activity data. For example, machine learning
models have been derived to search for kinase inhibitors on a
large scale10 or process profiling data and predict cross-
reactivity of kinase inhibitors.11
Herein, we report a kinase profiling experiment using a
library of imidazole-based adenosine triphosphate (ATP) site-
directed kinase inhibitors. Different from previous investiga-
tions, much emphasis has been put on the exploration of kinase
differentiation potential of candidate inhibitors. The concept of
kinase differentiation potential is distinct from kinase selectivity
of inhibitors. Compounds with differentiation potential must
display significantly varying potency levels against multiple
kinases.
■ METHODS AND MATERIALS
Kinases, Inhibitors, and Profiling Assays. A set of 484
pyridinylimidazole based inhibitors with general structure I (Scheme
1) were tested for kinase inhibition using 24 different kinases (AKT1,
ARK5, Aurora-A, Aurora-B, BRAF VE, CDK2/CycA, CDK4/CycD1,
COT, AXL, EGF-R, EPHB4, ERBB2, FAK, IGF1-R, SRC, VEGF-R2,
CK2-α1, JNK3, MET, p38-α, PDGFR-β, PLK1, SAK, TIE2). These
kinases were selected because they are implicated in different forms of
cancer. The 484 different derivates were synthesized and characterized
(including their purity) as described previously.12−17 Kinase activity
data were generated with the ProQinase free choice biochemical kinase
assay system. Activities were determined as residual activities (% of
control).18
Initially, compounds were screened at a single concentration of 10
μM. Subsequently, titration curves were generated for clearly active
compounds. Then the coefficient of variation (CV) between the initial
Received: October 6, 2012
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screen and subsequent assays was determined for each kinase. The
average CV was only 7.7% (for only 3 of 24 kinases, values of 10−12%
were obtained), thus indicating that activity data for the initial single-
point experiments were reliable.
Analysis of Kinase Differentiation Potential. Residual activities
for single-point measurements were logarithmically transformed into a
numerically stable data format for subsequent analysis, as illustrated in
Figure 1. According to this transformation, a logarithmic value of 2
indicates (nearly) full inhibition and a value of 0 no inhibition. On the
basis of these transformed activity values, a raw target differentiation
potential score was calculated as follows (see also Figure 1):
∑= | − |
≤ ≤
>
T Traw ra log ra log
i j
j i
i jdiffPot(A)
1 , 24
Here, the logarithmic terms refer to the transformed activity of a
compound to targets Ti and Tj, respectively. For each compound, all
possible target pairs were formed and activity differences were
summed. Thus, according to this formalism, compounds have high
differentiation potential if they display large activity differences against
many target pairs. Raw scores were then transformed into standard Z-
scores and normalized through mapping onto a cumulative
distribution function assuming a normal distribution, yielding final
scores between 0 (lowest differentiation potential) and 1 (highest
potential). This scoring scheme represents a further refined and
generalized version of a binned cumulative differentiation score
previously used to characterize ligands of different target families.19
Nearest Neighbor Analysis. For selected active compounds,
nearest structural neighbors were identified on the basis of systematic
pairwise comparisons. For this purpose, Tanimoto similarity20 was
calculated using MACCS structural keys21 as a molecular representa-
tion. As a nearest neighbor criterion, a threshold value of more than
80% MACCS Tanimoto similarity was applied.
Activity Profiles. For preferred inhibitors and their nearest
neighbors, activity profiles were generated using the activity-based
color code shown in Figure 1. In these profiles, each bin corresponds
to the activity against a specific kinase.
■ RESULTS AND DISCUSSION
Kinase Inhibitor Data. The complete matrix reporting
activities for all 484 compounds against the 24 kinases is
provided in Table S1 of the Supporting Information. All
residual activities were transformed into a logarithmic format
(as described above) and subjected to computational analysis.
Compound Differentiation Potential. Figure 2 shows
the distribution of normalized Z-scores for all test compounds.
The score distribution directly reflects the kinase differentiation
potential of the inhibitors. The distribution reveals that most of
the compounds fell within the range of low (red) to
intermediate (yellow) differentiation potential, as one might
expect for ATP site-directed inhibitors. However, the
distribution also contained a notable tail toward high (green)
differentiation potential. Hence, a small subset of test
compounds displayed a much higher than average potential
to differentiate between the selected cancer-relevant kinases.
Preferred Inhibitors. On the basis of the score distribution
in Figure 2, we selected the imidazole derivatives with the
highest differentiation potential, falling into the scoring interval
[0.78, 1.00]. The structures of these in part closely related
analogues are shown in Figure 3 with their activity profiles.
In the next step, nearest structural neighbors of each of the
six top-scoring compounds were identified in the data set and
their differentiation potential was compared, as reported in
Figure 4. Here, notable differences were observed. For example,
the top-scoring inhibitor with the highest differentiation
potential had only one nearest neighbor, the fourth-ranked
compound (Figure 4a). Equivalent observations were made for
inhibitors at rank 3 (Figure 4c) and 4 (Figure 4d). By contrast,
the inhibitor at rank 2 (Figure 4b) had a total of 12 nearest
structural neighbors with variable differentiation potentials.
Similar observations were made for inhibitors at ranks 5 (Figure
4e) and 6 (Figure 4f), having four and six neighbors,
respectively. These compounds also displayed low to
intermediate differentiation potential. From these compound
series, SAR patterns emerged, as discussed in the following.
Figure 1. Scoring scheme. Measured residual activities (ra) were
initially converted into logarithmic values used for the calculation of
the raw differential potential (rawdiffPot) of each compound.
Logarithmic values were adjusted such that 2 indicated (nearly)
complete inhibition and 0 no inhibition and aligned with the original
experimental binning scheme. Color code is as follows: dark blue,
≤20%; blue, >20%, ≤60%; light blue, >60%, ≤80%; white >80%
residual wild-type activity.
Figure 2. Distribution of compound differentiation potential. The
histogram shows the distribution of Z-scores for all test compounds. Z-
scores were normalized to the value range between 0 (lowest
differentiation potential) and 1 (highest potential) and binned on the
X-axis into 10 equally sized score intervals. The Y-axis reports the
number of compounds falling into each interval. The differentiation
potential of the compounds (normalized Z-scores) was color-coded
using a spectrum ranging from red (lowest differentiation potential)
over yellow (intermediate) to green (highest differentiation potential).
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SAR Analysis. All tested compounds were initially designed
as potential p38α MAP kinase inhibitors. The major novelty of
these imidazole-based series is the 2-thio substitution, which
greatly reduces their ability to bind to cytochrome P450 (CYP)
enzymes by complexing the iron in the active site. This CYP
interaction presented a general problem associated with first-
generation imidazole-based inhibitors. Kinase profiles of a large
set of structurally closely related inhibitors have not yet been
described. However, the results reported herein demonstrate
how even minor structural modifications of closely related
inhibitors can alter the inhibition profile toward kinases other
than p38, including representatives of kinase families with
rather different functions such as receptor tyrosine kinases.
The computational approach designed for the analysis of the
kinase profiling matrix did not take structural information about
the kinase ATP binding site into account. Nevertheless, it
detected activity differences between compounds that were
consistent with structural data of p38−inhibitor interactions.
Figure 5 shows an outline of p38 bound to the ATP site-
directed pyridinylimidazole inhibitor SB203580,22 as revealed
by the X-ray structure of the complex.23 A critically important
hydrogen bond is formed between the pyridin-4-yl group and
the backbone NH of Met109. Another hydrogen bond is
formed between Lys53 and N-3 of the imidazole core. In
addition, there is a π−π stacking between Tyr35 and the phenyl
ring of the inhibitor. The 4-fluorophenyl ring is accommodated
in hydrophobic region I, while hydrophobic region II is not
occupied. On the basis of these interaction patterns, structural
modifications of imidazole-based inhibitors that led to changes
in their differentiation potential according to Figure 4 can be
rationalized. For example, the compounds in Figure 4b,c very
well reflect the relevance of the π−π interaction of the S-
residues at the R3 position with Tyr35 in p38, as indicated in
Figure 5. In Figure 4b, 2 with an acetonitrile group at this
position had overall highest differentiation potential, whereas
smaller or larger (aromatic) substituents at this position led to a
gradual loss of this potential. Phenyl-based substituents such as
π−π interactors were generally more difficult to accommodate
than the acetonitrile group because they required a coplanar
orientation for best interactions. As illustrated in Figure 4c, loss
of R-group flexibility to adopt a favorable geometry for the π−π
interaction also resulted in a penalty and altered the
differentiation potential observed for a compound with a
conformationally unrestricted phenyl group.
In our kinase panel, JNK3 was most closely related to p38.
The only difference in the ATP-binding site of these kinases is
the gatekeeper residue, which is Thr in p38 and Met in JNK3.
Met is larger but has a flexible side chain and can
conformationally adapt. Given the similarity of these kinases,
Figure 3. Top-ranked kinase inhibitors. Shown are the six top-ranked
compounds with highest differentiation potential (labeled with their
ranks) together with their activity profiles (color-coded according to
Figure 1). In the activity profile, each bin is assigned to one of the 24
kinases.
Figure 4. Top-ranked inhibitors and nearest neighbors. In (a) to (f),
the six compounds with highest differentiation potential are shown
together with their nearest structural neighbors (i.e., all other
compounds having at least 80% 2D structural similarity). In the
center, each of the six top-ranked compounds is represented as the
root node and nearest neighbors form leaves. The nodes are color-
coded according to differentiation potential as in Figure 2. The activity
profile of the root compound is displayed, and compound structures
are drawn proximal to their nodes. Multiple nearest neighbors are
arranged according to decreasing differentiation potential from the left
to the right.
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many compounds inhibited them comparably. However,
nearest neighbor analysis also revealed interesting exceptions.
For example, 2 with its acetonitrile substituent was highly active
against p38 and JNK3. By contrast, 15, a structural neighbor of
2 with a phenyl group at the corresponding position, retained
high activity against p38 but was not active against JNK3.
Similarly, 25, another structural neighbor with an additional
methylene group in the linker presenting the phenyl
substituent, showed reduced activity against P38 and was also
inactive against JNK3. Both of these compounds had overall
only low differentiation potential. In the panel, AKT1 was the
kinase most distantly related to p38. Accordingly, many of the
p38-directed compounds did not inhibit AKT1. However, there
were exceptions among compounds with high differentiation
potential. For example, 1 and 4 strongly inhibited p38 but also
displayed weak activity against AKT1.
Furthermore, very small structural changes between com-
pounds with high differentiation potential preferentially affected
certain subsets of kinases. For example, 1 and 4 were only
distinguished by the presence of a double bond in the linker
between the imidazole core and a phenyl substituent (thus
slightly reducing the conformational flexibility of 4). This
minute change led to overall higher activity of 4 against the
kinase panel than 1. In particular, it affected binding to cyclin-
dependent kinases, against which 4 was active but 1 only
weakly active or inactive. In addition, the presence of a
hydrophilic group in this region of the inhibitors, for example,
in 6, led to a complete loss of activity against these kinases.
Another interesting example was inhibition of PLK1. Among
compounds with significant differentiation potential, only 4, 7,
and 10 inhibited this kinase; all others were inactive.
Compounds 4 and 7 were structurally highly similar, but in
10, the conformationally restricted phenyl substituent was
replaced by an unrestricted naphthalene group. Despite this
change, the activity profiles of all three compounds were overall
similar and distinct from many others.
Differentiation Potential versus Selectivity. Differ-
entiation potential as assessed herein is related to but distinct
from compound selectivity, for which other measures have been
introduced in the kinase inhibitor field. These include, among
others, the Ambit selectivity score24 and the thermodynamic
partition index.25 The latter coefficient reflects the partitioning
of inhibitor binding across a panel of kinases at thermodynamic
equilibrium and should thus be calculated on the basis of
equilibrium constants (i.e., Ki or Kd). Hence, it is not applicable
to residual activities or other approximate measurements. The
Ambit score (AS) is calculated as the fraction of n tested
kinases that are inhibited by a compound at a given threshold
value of residual activity. Hence, a score of 0 indicates a
compound that is inactive at the selected threshold and a score
of 1 a compound that is consistently active and nonselective. By
contrast, a target-selective compound obtains a score of 1/n
(close to 0). We have calculated AS values for all compounds
for a threshold value of less than 60% residual activity, as
reported in Table S2 of the Supporting Information. The mean
and standard deviation of the AS distribution are 0.31 and 0.22,
respectively. For 1−6 with the highest target differentiation
potential, scores range from 0.54 and 0.83. Hence, these
compounds would not be considered on the basis of simple
selectivity scoring. At lower levels of residual activity (e.g.,
30%), the scores consistently decrease and equivalent
conclusions are drawn. These results reflect the conceptual
difference between target differentiation potential and target
selectivity of inhibitors. Compounds with differentiation
potential are often rich in multitarget SAR information.
■ CONCLUSIONS
Herein we have reported a compound profiling experiment on
a set of cancer-relevant kinases using ATP site-directed
imidazole derivatives, combined with a computational study
to identify compounds with kinase differentiation potential.
Several structurally closely related inhibitors with high
differentiation potential were identified, and SAR features
were explored on the basis of nearest neighbor analysis. In a
number of instances, small structural modifications of closely
related compounds led to substantial alterations of their
inhibitory profiles, in part involving kinases with different
functions. On the basis of these results, the evaluated
compound series should merit further consideration in the
development of selective kinase inhibitors. Furthermore, the
computational approach reported herein is readily applicable to
the analysis of other compound profiling experiments and the
identification of active small molecules with target differ-
entiation potential.
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Summary
Profiling data obtained after testing 484 ATP-site directed imidazole deriva-
tives against 24 cancer-associated kinases was systematically analyzed to iden-
tify ligands with extremely variable inhibition profiles. Alterations in inhibi-
tion profiles were measured by quantifying activity differences over all possible
target pairs expressed as compound differential potential. Six ligands with
highest variation in their inhibitory profiles were identified after ranking com-
pounds according to their differential potentials. Nearest neighbor analysis of
these compounds revealed structurally related analogs with differential poten-
tials of varying magnitude. Many instances where minor chemical modifications
produced large variations in compound inhibitory profiles were also identified.
Therefore, different structural features relevant to selectivity could be readily
identified and the information might be further utilized in designing highly se-
lective kinase inhibitors. The flexibility of the computational approach outlined
in this chapter makes it suitable for the analysis of other profiling experiments
with the goal of identifying active compounds that exhibit substantial variation
in their activity profiles against different target proteins.
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Conclusion
Medicinal chemists often have to perform the non-trivial task of identifying var-
ious structural determinants within compound sets that influence their bioac-
tivity. Systematic analysis of pair-wise molecular similarities and potency dif-
ferences also helps to deduce SAR trends and formulate rules in order to guide
different compound design or optimization attempts. The activity landscape
concept is often employed to rationalize SARs in three dimensions, the first two
depicting the chemical space followed by the addition of activity information
as the third dimension. Thus, an activity landscape represents a hypersurface
combining chemical similarity and biological activity data that is very similar
to geographical maps in its topology.
The generation of 3D activity landscape models for real ligand sets has been one
of the objectives of this dissertation. The resulting landscape representations
largely depart from the idealized versions. However, the global SAR character-
istics of bioactive compound sets are well preserved and intuitively accessible
using these 3D views. Since, the topology of the landscapes is greatly influenced
by the choice of the molecular representation, 3D landscape modeling can also
be utilized to study the magnitude of alterations in SAR features brought about
by alternative chemical spaces. Moreover, SAR relevant features like activity
cliffs of varying magnitudes can also be identified.
An important characteristic of 3D activity landscapes is that proximity be-
tween ligands in the 2D projection correlates with their structural relatedness.
By contrast, in 2D graphical landscape models like NSGs, placement of com-
pounds and subsequent clustering is based on layout algorithms and has no
chemical relevance. Therefore, the various conceptual differences in generating
NSGs and 3D activity landscape representations make their comparison infor-
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mative. Indeed, simultaneous examination of the visualizations obtained by
these conceptually different methodologies has provided useful insights regard-
ing the complementary global and local SAR information content associated
with compound sets.
A computational approach has been introduced to calculate feature probabil-
ities for individual compounds on the basis of their various SAR feature fre-
quencies. By using fuzzy thresholds to derive these conditional probabilities,
the existing SAR features have been used to generate eight feature categories.
It has been demonstrated that subsequent assignment of compounds to these
categories aided in their differentiation in local SAR environments when SAR
analysis was performed using graphical activity landscape representations.
Typically, while analyzing SARs, one accounts for systematic structural simi-
larity and potency distribution within ligand data sets. However, for ligands
active against a receptor, information pertaining to its mechanism of action
is also considered relevant. Routine approaches to analyzing SAR do not dis-
tinguish between ligands with different mechanisms of action. Adaptation of
existing SAR analysis-driven data structures to incorporate mechanism related
data has also been addressed in this dissertation. Graph-based landscape repre-
sentations like NSGs are well suited for large-scale computational analysis and
visualization of SAR as they are easy to navigate and interpretable. Introduc-
tion of a new color scheme sufficiently modified this activity landscape model to
allow SAR as well as mechanism of action related analysis. The clear outcome
of using M-NSGs is that compound subsets with either mechanistic homogene-
ity or heterogeneity can be readily identified. In addition, subsequent close
inspection of structurally related ligand communities that are mechanistically
heterogeneous can help characterize structural determinants that are responsi-
ble for switching the mechanism of action or mechanism hops.
An inherent property of activity landscape representations based on chemical
similarity calculated using molecular fingerprints is their black box nature.
Thus, substructures or R-groups associated with compound potency are not
apparent without the inspection of compound 2D structures. MMP-based ap-
proaches are better suited for the direct determination of chemical modifications
resulting in potency improvement. Therefore, in order to facilitate assessment
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of substructure changes accompanied by mechanism hops, an MMP-derived
data structure was suitably modified. Application of M-BMMSGs to exem-
plary receptor ligand sets also demonstrated the ability of this approach to
resolve mechanism hop inducing chemical replacements within these ligands at
multiple levels.
Exploring relationships between chemical structure and bioactivity is commonly
carried out for compound sets that are active against single targets. However,
it is often necessary to monitor SAR trends in ligand data sets with activity
annotations against multiple members of a target family so that compound
selectivity patterns and off-target effects may be identified. Due to the in-
trinsic difficulty in navigating these high dimensional spaces, design of activity
landscape representations that simplify access to multi-target relevant SAR in-
formation has also been attempted. Using a SOM-based 2D chemical space
projection, a multi-target landscape model was generated in which compounds
were represented in terms of binned pair-wise target activity differences. Such
an encoding of compounds aided in the identification of continuous as well
as discontinuous regions in multi-dimensional activity spaces. Examination of
compounds within these regions revealed chemical replacements that retained
or altered compound selectivity profiles.
Profiling experiments to perform simultaneous testing of compound libraries
against many targets, especially high profile targets like protein kinases, have
recently experienced increasing interest. Such profiling studies have made ma-
jor contributions to the growth of multi-target activity data. A novel activity
landscape model was designed to analyze the high-dimensional data generated
from one such publicly available kinase profiling study. Ability to handle bioac-
tivity annotations for very large numbers of targets and at the same time deal
with incomplete activity matrix are two important features of this newly de-
scribed landscape model.
The data obtained from another kinase profiling experiment was utilized to ex-
amine the ability of structurally related inhibitors to distinguish between vari-
ous therapeutically relevant kinases. The differentiation potential was used as a
measure to quantify the differential activity of these compounds against kinase
targets. Compound ranking prioritized six inhibitors with very high differen-
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tiation potential. Variation in the differentiation potential among the nearest
neighbors of these top ranked compounds was also investigated. In addition,
chemical modifications that produced alterations in the inhibition profiles of
these compounds could be identified.
In conclusion, this dissertation reports novel approaches for the design of
2D and 3D activity landscapes to facilitate SAR analysis and visualization.
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